Avalon Trust Co ve 2. čtvrtletí získala nový podíl v The Home Depot, Inc. za zhruba 615 000 USD, když nabyla 1 744 akcií. Home Depot zároveň oznámila čtvrtletní dividendu ve výši 2,33 USD na akcii.
Avalon Trust Co acquired a new stake in shares of The Home Depot, Inc. (NYSE:HD – Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 1,744 shares of the home improvement retailer’s stock, valued at approximately $615,000.
A number of other hedge funds also recently bought and sold shares of the company. Pacific Sage Partners LLC purchased a new stake in Home Depot during the 2nd quarter valued at about $1,967,000. TFR Capital LLC. bought a new position in shares of Home Depot in the second quarter worth approximately $1,294,000. OakTrust Wealth Advisors LLC bought a new stake in Home Depot during the 2nd quarter valued at $240,000. Family Legacy Inc. bought a new stake in Home Depot during the 2nd quarter valued at $5,320,000. Finally, Clearstead Trust LLC purchased a new position in shares of Home Depot in the second quarter valued at about $1,998,000. Institutional investors own 70.86% of the company’s stock.
Home Depot Stock Performance Shares of HD opened at $336.04 on Friday. The firm has a market capitalization of $335.07 billion, a P/E ratio of 23.52, a PEG ratio of 3.68 and a beta of 0.95. The company has a debt-to-equity ratio of 2.64, a current ratio of 1.08 and a quick ratio of 0.28. The Home Depot, Inc. has a one year low of $289.10 and a one year high of $426.75. The business has a fifty day moving average of $340.86 and a 200 day moving average of $340.46.
Home Depot (NYSE:HD – Get Free Report) last posted its quarterly earnings data on Tuesday, August 18th. The home improvement retailer reported $4.92 earnings per share for the quarter, beating analysts’ consensus estimates of $4.73 by $0.19. The firm had revenue of $47.86 billion for the quarter, compared to analysts’ expectations of $47.24 billion. Home Depot had a return on equity of 106.42% and a net margin of 8.41%.The business’s quarterly revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the firm earned $4.68 EPS. Home Depot has set its FY 2026 guidance at 14.690-15.278 EPS. As a group, sell-side analysts anticipate that The Home Depot, Inc. will post 14.99 EPS for the current year. Home Depot Dividend Announcement The company also recently announced a quarterly dividend, which will be paid on Thursday, September 17th. Investors of record on Thursday, September 3rd will be issued a $2.33 dividend. The ex-dividend date of this dividend is Thursday, September 3rd. This represents a $9.32 annualized dividend and a yield of 2.8%. Home Depot’s dividend payout ratio is currently 65.22%.
Insider Transactions at Home Depot In other Home Depot news, CFO Richard V. Mcphail sold 5,989 shares of the firm’s stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $348.40, for a total transaction of $2,086,567.60. Following the sale, the chief financial officer directly owned 48,104 shares of the company’s stock, valued at $16,759,433.60. This trade represents a 11.07% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.08% of the company’s stock.
Key Stories Impacting Home Depot Here are the key news stories impacting Home Depot this week:
Positive Sentiment: Home Depot’s latest quarter showed solid execution: earnings and revenue exceeded consensus estimates, while sales increased year over year. Bank of America characterized the results as resilient despite a difficult housing backdrop. Home Depot Q2 results analysis Positive Sentiment: The board declared a quarterly dividend of $2.33 per share, payable September 17 to shareholders of record September 3. The annualized payout implies a yield of approximately 2.8%, supporting the stock’s income appeal. Home Depot declares quarterly dividend Positive Sentiment: DA Davidson, Argus and Guggenheim reiterated or assigned “Buy” ratings, indicating continued confidence in Home Depot’s long-term positioning. The company is also expanding nationwide express delivery to make smaller projects more convenient for cautious consumers. DA Davidson buy rating Home Depot expands express delivery Neutral Sentiment: Royal Bank of Canada lowered its price target to $342, while KeyCorp maintained a Sector Weight rating. The mixed recommendations suggest limited near-term upside despite the earnings beat. RBC lowers Home Depot price target Neutral Sentiment: Home Depot expanded executive responsibilities and awarded restricted stock, changes intended to support leadership continuity but with no immediate earnings impact. Home Depot executive changes Negative Sentiment: Reports highlight margin pressure and an uphill sales environment as customers delay or reduce spending on major renovations. This could constrain comparable sales and profitability even after the recent quarterly beat. Home Depot margin pressure Home Depot customer spending concerns Negative Sentiment: CFO Richard McPhail sold 5,989 shares worth approximately $2.1 million, reducing his position by 11.1%. While insider sales do not necessarily signal deteriorating fundamentals, the transaction may weigh modestly on sentiment. Home Depot CFO stock sale Analyst Ratings Changes Several brokerages have commented on HD. Wall Street Zen upgraded shares of Home Depot from a “sell” rating to a “hold” rating in a report on Tuesday, June 2nd. Argus reiterated a “buy” rating and set a $400.00 price target on shares of Home Depot in a research report on Wednesday. Piper Sandler decreased their price target on shares of Home Depot from $422.00 to $421.00 and set an “overweight” rating for the company in a research note on Wednesday, May 20th. Robert W. Baird decreased their price target on shares of Home Depot from $430.00 to $380.00 and set an “outperform” rating for the company in a research note on Wednesday, May 20th. Finally, Weiss Ratings upgraded shares of Home Depot from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, July 7th. Eighteen research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $375.54.
Read Our Latest Analysis on HD
Home Depot Profile (Free Report)
The Home Depot, Inc (NYSE: HD) is a leading home improvement retailer that operates large-format stores and an integrated online platform offering a broad range of products and services for do-it-yourself consumers, professional contractors and businesses. The company was founded in 1978 by Bernard Marcus and Arthur Blank and is headquartered in Atlanta, Georgia. Since opening its first stores at the end of the 1970s, Home Depot has grown into a multinational retailer known for its orange-branded stores and wide assortment of home improvement merchandise.
Home Depot’s core business includes the sale of building materials, lumber, tools, hardware, appliances, paint, plumbing and electrical supplies, lawn and garden products, and home décor.
Featured Stories Five stocks we like better than Home Depot Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Home Depot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Home Depot and related companies with MarketBeat.com's FREE daily email newsletter.
Auxano Advisors LLC během druhého čtvrtletí nově nakoupila 679 akcií Goldman Sachs za zhruba 687 000 USD. Goldman Sachs zároveň za čtvrtletí vykázala EPS 20,98 USD a tržby 20,34 miliardy USD.
Auxano Advisors LLC acquired a new position in shares of The Goldman Sachs Group, Inc. (NYSE:GS – Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 679 shares of the investment management company’s stock, valued at approximately $687,000.
Other hedge funds have also made changes to their positions in the company. Audent Global Asset Management LLC grew its holdings in The Goldman Sachs Group by 10.1% during the fourth quarter. Audent Global Asset Management LLC now owns 5,238 shares of the investment management company’s stock worth $4,604,000 after acquiring an additional 479 shares during the period. Oak Grove Capital LLC acquired a new stake in shares of The Goldman Sachs Group in the fourth quarter valued at about $1,890,000. Nomura Asset Management Co. Ltd. lifted its stake in shares of The Goldman Sachs Group by 2.6% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 141,990 shares of the investment management company’s stock valued at $124,809,000 after purchasing an additional 3,653 shares during the period. Global Retirement Partners LLC boosted its holdings in The Goldman Sachs Group by 35.0% during the fourth quarter. Global Retirement Partners LLC now owns 11,944 shares of the investment management company’s stock worth $10,499,000 after buying an additional 3,098 shares in the last quarter. Finally, New Age Alpha Advisors LLC grew its position in The Goldman Sachs Group by 92.4% during the fourth quarter. New Age Alpha Advisors LLC now owns 14,298 shares of the investment management company’s stock worth $12,568,000 after buying an additional 6,867 shares during the period. Hedge funds and other institutional investors own 71.21% of the company’s stock.
Key Stories Impacting The Goldman Sachs Group Here are the key news stories impacting The Goldman Sachs Group this week:
Positive Sentiment: Goldman Sachs was among the financial giants receiving a “Buy” growth grade, reinforcing the view that its earnings growth, capital-markets franchise and strategic positioning remain attractive. Citigroup and Goldman Sachs lead as most financial giants earn Buy growth grades Positive Sentiment: The firm is reportedly expanding into India’s government share-sale market. Greater participation in equity offerings could create additional investment-banking revenue and deepen Goldman’s presence in a fast-growing market. Goldman Sachs expands into India’s government share sale market Positive Sentiment: Goldman agreed to pay up to $2.25 billion for NEOS Investments, the issuer of high-income ETFs. The acquisition supports Goldman’s asset-management and wealth-products strategy, although investors will monitor the price paid and integration execution. Goldman Sachs acquisition of NEOS Investments Neutral Sentiment: Goldman research said gold could exceed its $4,900 year-end forecast amid options demand, Western investor buying and central-bank purchases. The call may benefit the firm’s commodities and trading franchise, but changing interest-rate expectations could increase market volatility and forecasting risk. Gold could top Goldman’s forecast Negative Sentiment: Goldman strategists described July as one of the sharpest hedge-fund de-grossing episodes of the past decade, with hedge funds posting an unusually weak month relative to the S&P 500. Continued de-risking could pressure trading activity and investment-banking sentiment across Wall Street. Goldman Sachs hedge funds worst month versus S&P 500 Analysts Set New Price Targets A number of brokerages have issued reports on GS. Zacks Research upgraded shares of The Goldman Sachs Group from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 16th. Jefferies Financial Group set a $1,299.00 target price on The Goldman Sachs Group in a research note on Wednesday, July 15th. Evercore reiterated an “outperform” rating on shares of The Goldman Sachs Group in a report on Monday, July 6th. Citigroup lifted their price objective on The Goldman Sachs Group from $1,100.00 to $1,200.00 and gave the stock a “neutral” rating in a research report on Thursday, July 16th. Finally, Dbs Bank raised their price target on shares of The Goldman Sachs Group from $890.00 to $1,050.00 in a research note on Thursday, May 7th. Two analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, The Goldman Sachs Group has an average rating of “Moderate Buy” and an average price target of $1,062.86. View Our Latest Report on The Goldman Sachs Group
The Goldman Sachs Group Stock Performance Shares of NYSE:GS opened at $1,041.35 on Friday. The business has a 50-day moving average of $1,053.96 and a two-hundred day moving average of $964.40. The firm has a market capitalization of $303.21 billion, a PE ratio of 16.07, a P/E/G ratio of 1.02 and a beta of 1.30. The company has a debt-to-equity ratio of 3.17, a current ratio of 0.63 and a quick ratio of 0.63. The Goldman Sachs Group, Inc. has a 12 month low of $718.58 and a 12 month high of $1,153.99.
The Goldman Sachs Group (NYSE:GS – Get Free Report) last released its quarterly earnings data on Tuesday, July 14th. The investment management company reported $20.98 earnings per share for the quarter, beating the consensus estimate of $14.47 by $6.51. The Goldman Sachs Group had a return on equity of 19.16% and a net margin of 15.53%.The business had revenue of $20.34 billion for the quarter, compared to analyst estimates of $16.22 billion. During the same period in the previous year, the company posted $10.91 EPS. The company’s revenue was up 39.4% compared to the same quarter last year. As a group, research analysts forecast that The Goldman Sachs Group, Inc. will post 68.89 earnings per share for the current year.
The Goldman Sachs Group Increases Dividend The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 29th. Shareholders of record on Tuesday, September 1st will be given a dividend of $5.00 per share. This represents a $20.00 dividend on an annualized basis and a yield of 1.9%. This is a positive change from The Goldman Sachs Group’s previous quarterly dividend of $4.50. The ex-dividend date of this dividend is Tuesday, September 1st. The Goldman Sachs Group’s dividend payout ratio is presently 27.78%.
(Free Report)
The Goldman Sachs Group, Inc is a global investment banking and financial services firm headquartered in New York City. Founded in 1869 as a commercial paper business, the company has grown into a diversified financial institution that provides a broad range of services to corporations, financial institutions, governments and individuals. The firm is led by Chief Executive Officer David M. Solomon and operates across major financial centers worldwide.
Goldman Sachs’ core businesses include investment banking, global markets, asset and wealth management, and consumer banking.
Featured Articles Five stocks we like better than The Goldman Sachs Group Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for The Goldman Sachs Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Goldman Sachs Group and related companies with MarketBeat.com's FREE daily email newsletter.
Bank of New York Mellon Corp purchased a new position in Starbucks Corporation (NASDAQ:SBUX – Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 7,630,782 shares of the coffee company’s stock, valued at approximately $779,790,000. Bank of New York Mellon Corp owned 0.67% of Starbucks at the end of the most recent quarter.
Other institutional investors and hedge funds have also modified their holdings of the company. Leeward Financial Partners LLC purchased a new position in shares of Starbucks in the second quarter worth about $994,000. Centric Wealth Management acquired a new stake in Starbucks in the 2nd quarter valued at about $269,000. Private Advisory Group LLC purchased a new position in Starbucks in the 2nd quarter worth approximately $579,000. ABN AMRO Bank N.V. purchased a new position in Starbucks during the second quarter worth about $832,000. Finally, Kelleher Financial Advisors purchased a new position in Starbucks during the second quarter worth about $53,000. Hedge funds and other institutional investors own 72.29% of the company’s stock.
Insiders Place Their Bets In other Starbucks news, CEO Brady Brewer sold 2,229 shares of the business’s stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $105.99, for a total transaction of $236,251.71. Following the completion of the transaction, the chief executive officer directly owned 75,135 shares of the company’s stock, valued at $7,963,558.65. The trade was a 2.88% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 6,687 shares of company stock valued at $681,663. Company insiders own 0.03% of the company’s stock.
Starbucks Trading Up 3.0% Shares of SBUX opened at $107.08 on Friday. The stock’s fifty day simple moving average is $104.45 and its 200 day simple moving average is $100.36. The firm has a market capitalization of $122.07 billion, a P/E ratio of 61.54, a price-to-earnings-growth ratio of 1.79 and a beta of 0.97. Starbucks Corporation has a twelve month low of $77.99 and a twelve month high of $110.51. Starbucks (NASDAQ:SBUX – Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The coffee company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.66 by $0.19. The firm had revenue of $9.32 billion for the quarter, compared to analyst estimates of $9.17 billion. Starbucks had a net margin of 5.17% and a negative return on equity of 34.10%. Starbucks’s revenue for the quarter was down 1.4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.50 earnings per share. Starbucks has set its FY 2026 guidance at 2.550-2.650 EPS. Sell-side analysts predict that Starbucks Corporation will post 2.64 earnings per share for the current year.
Starbucks Dividend Announcement The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 28th. Investors of record on Friday, August 14th will be given a dividend of $0.62 per share. The ex-dividend date is Friday, August 14th. This represents a $2.48 dividend on an annualized basis and a yield of 2.3%. Starbucks’s payout ratio is currently 142.53%.
Analyst Upgrades and Downgrades Several analysts have recently weighed in on the stock. Wedbush initiated coverage on shares of Starbucks in a research note on Thursday, May 14th. They issued an “outperform” rating for the company. Weiss Ratings restated a “hold (c)” rating on shares of Starbucks in a report on Monday, July 20th. JPMorgan Chase & Co. lifted their price objective on shares of Starbucks from $95.00 to $100.00 and gave the stock an “overweight” rating in a research report on Friday, April 24th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $126.00 target price on shares of Starbucks in a research note on Thursday, July 30th. Finally, Melius Research set a $110.00 target price on Starbucks in a report on Monday, August 3rd. Nineteen investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $110.30.
Get Our Latest Analysis on SBUX
More Starbucks News Here are the key news stories impacting Starbucks this week:
Positive Sentiment: Starbucks is eliminating more than 200 corporate positions as part of a broader restructuring and approximately $2 billion cost-reduction effort. Lower overhead could support profitability if the company maintains service levels and directs more resources toward its stores. The reductions do not involve cafe closures. Starbucks trims corporate ranks as coffeehouse investments deliver Positive Sentiment: Recent market commentary highlights Starbucks’ roughly 25% 2026 gain and suggests investors are rewarding its operational reset and investments in the cafe experience. The rally follows the company’s latest quarterly earnings beat, with adjusted EPS of $0.85 versus a $0.66 consensus estimate and revenue above expectations. Neutral Sentiment: The restructuring is relocating some corporate operations to a new, approximately $100 million Nashville office. Around 120 Seattle employees reportedly declined the move, while another 104 roles in store design and construction are being eliminated. Management characterizes the actions as part of the restructuring winding down, but the savings and impact on execution remain to be demonstrated. Starbucks cuts another 224 Seattle jobs Negative Sentiment: Starbucks continues to face challenges in China, where domestic competitors, shifting consumer preferences and geopolitical tensions are eroding the position of major U.S. brands. China weakness could limit international growth and pressure comparable sales. Why some of America’s biggest brands are losing ground in China Negative Sentiment: The stock’s strong performance has also produced a demanding valuation, with the supplied data showing a P/E ratio above 60. Investors may require sustained earnings growth from the turnaround to justify the premium, leaving SBUX vulnerable to disappointment. Starbucks Profile (Free Report)
Starbucks Corporation is a global coffeehouse chain and roaster that operates, licenses and franchises coffee shops and related retail businesses. Founded in Seattle, Washington in 1971 by Jerry Baldwin, Zev Siegl and Gordon Bowker, the company grew from a single store focused on whole-bean coffee and equipment into a broad consumer-facing brand. Howard Schultz, who joined the company later and served in senior leadership roles, is widely credited with transforming Starbucks into a mass-market specialty coffee retailer and expanding its footprint internationally.
Starbucks’ core activities center on the retail sale of hot and cold specialty beverages, whole-bean and packaged coffees, teas and ready-to-drink products, along with complementary food items and merchandise such as mugs and brewing equipment.
Recommended Stories Five stocks we like better than Starbucks Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding SBUX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Starbucks Corporation (NASDAQ:SBUX – Free Report).
Receive News & Ratings for Starbucks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starbucks and related companies with MarketBeat.com's FREE daily email newsletter.
Bank of New York Mellon Corp ve 2. čtvrtletí koupila novou pozici ve FedEx v rozsahu 1 491 211 akcií za zhruba 466,9 mil. USD. Na konci období držela asi 0,63 % společnosti.
Bank of New York Mellon Corp acquired a new position in shares of FedEx Corporation (NYSE:FDX – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 1,491,211 shares of the shipping service provider’s stock, valued at approximately $466,943,000. Bank of New York Mellon Corp owned approximately 0.63% of FedEx at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently modified their holdings of FDX. Hollencrest Capital Management acquired a new stake in FedEx during the 1st quarter valued at $25,000. Bayban acquired a new position in FedEx in the 1st quarter worth $26,000. Cedar Mountain Advisors LLC lifted its holdings in FedEx by 77.4% in the 1st quarter. Cedar Mountain Advisors LLC now owns 94 shares of the shipping service provider’s stock worth $33,000 after buying an additional 41 shares in the last quarter. EFG International AG purchased a new position in FedEx in the 4th quarter valued at about $27,000. Finally, Tucker Asset Management LLC purchased a new stake in shares of FedEx during the fourth quarter worth about $29,000. Hedge funds and other institutional investors own 84.47% of the company’s stock.
FedEx News Roundup Here are the key news stories impacting FedEx this week:
Positive Sentiment: FedEx’s board declared a quarterly cash dividend of $1.22 per share, payable October 1 to shareholders of record on September 14. The unchanged dividend reinforces the company’s commitment to returning capital and may support income-oriented investor interest. FedEx Corp. Board Declares Quarterly Dividend Positive Sentiment: FedEx and UPS reportedly secured modifications to government delivery contracts, potentially providing additional volume and revenue visibility for FedEx’s network. UPS and FedEx land government delivery contract modifications Neutral Sentiment: Wall Street analysts remain cautiously optimistic about FedEx, citing its strong performance over the past year but maintaining a measured outlook on future prospects. This suggests support for the stock but limited expectations for near-term upside. Are Wall Street Analysts Bullish on FedEx Stock? Negative Sentiment: Reports that UPS, FedEx and DHL are returning billions in tariff-related charges to eligible U.S. customers could create reimbursement costs and administrative complexity, although the ultimate financial impact on FedEx remains unclear. UPS, FedEx and DHL are giving back billions in Trump tariffs Negative Sentiment: FedEx reportedly paid its top executives $81 million in fiscal 2026, a 131% increase from the prior year. The sharp rise may draw investor scrutiny regarding compensation discipline and corporate governance. Memphis-based FedEx paid top executives $81M Negative Sentiment: Amazon’s planned expansion of drone delivery to nearly 500 U.S. cities increases competitive pressure in last-mile shipping and could challenge FedEx’s parcel volumes over time. Amazon to Bring Drone Delivery to 500 Cities Analyst Ratings Changes Several research analysts recently commented on the company. Stephens upgraded FedEx to a “strong-buy” rating in a research note on Wednesday, July 8th. JPMorgan Chase & Co. restated a “buy” rating on shares of FedEx in a report on Friday, June 26th. TD Cowen cut their target price on FedEx from $426.00 to $354.00 in a research report on Wednesday, June 24th. BNP Paribas Exane reduced their target price on FedEx from $335.00 to $269.76 and set a “neutral” rating for the company in a research note on Tuesday, June 2nd. Finally, Weiss Ratings raised shares of FedEx from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, FedEx presently has a consensus rating of “Moderate Buy” and an average price target of $350.54. View Our Latest Stock Report on FedEx
Insider Buying and Selling In other FedEx news, Director Paul S. Walsh sold 5,042 shares of the company’s stock in a transaction that occurred on Tuesday, June 30th. The stock was sold at an average price of $324.56, for a total value of $1,636,431.52. Following the completion of the sale, the director directly owned 16,359 shares in the company, valued at $5,309,477.04. This represents a 23.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.53% of the stock is currently owned by insiders.
FedEx Stock Performance FDX stock opened at $325.03 on Friday. The company has a market capitalization of $76.92 billion, a P/E ratio of 17.56, a PEG ratio of 1.68 and a beta of 1.30. The company has a 50-day simple moving average of $319.03 and a 200 day simple moving average of $351.53. FedEx Corporation has a fifty-two week low of $177.05 and a fifty-two week high of $345.36. The company has a quick ratio of 1.44, a current ratio of 1.48 and a debt-to-equity ratio of 0.74.
FedEx (NYSE:FDX – Get Free Report) last announced its earnings results on Tuesday, July 21st. The shipping service provider reported $5.88 earnings per share (EPS) for the quarter. FedEx had a net margin of 4.68% and a return on equity of 16.49%. The firm had revenue of $23.26 billion during the quarter. Sell-side analysts predict that FedEx Corporation will post 17.6 earnings per share for the current fiscal year.
FedEx Dividend Announcement The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Monday, September 14th will be paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 1.5%. The ex-dividend date is Monday, September 14th. FedEx’s dividend payout ratio (DPR) is currently 26.36%.
FedEx Company Profile (Free Report)
FedEx Corporation (NYSE: FDX) is a global logistics and courier company headquartered in Memphis, Tennessee. Founded by Frederick W. Smith in 1971 and beginning operations in the early 1970s, the company pioneered overnight express shipping and has since expanded into a diversified portfolio of transportation, e-commerce and supply-chain services. FedEx operates an integrated air-and-ground network that moves parcels, freight and documents for businesses and consumers worldwide.
FedEx’s core operating segments include express parcel delivery via its FedEx Express division, domestic and residential parcel delivery through FedEx Ground, less-than-truckload (LTL) freight services, and logistics and supply-chain management solutions.
Recommended Stories Five stocks we like better than FedEx Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding FDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for FedEx Corporation (NYSE:FDX – Free Report).
Receive News & Ratings for FedEx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FedEx and related companies with MarketBeat.com's FREE daily email newsletter.
BlackRock Inc. raised its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 6.3% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 529,670,433 shares of the biopharmaceutical company’s stock after acquiring an additional 31,412,883 shares during the quarter. BlackRock Inc. owned approximately 9.29% of Pfizer worth $12,754,464,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also bought and sold shares of the company. Norges Bank bought a new position in Pfizer in the 4th quarter worth approximately $1,830,986,000. Morgan Stanley grew its position in shares of Pfizer by 19.2% in the fourth quarter. Morgan Stanley now owns 89,113,604 shares of the biopharmaceutical company’s stock valued at $2,218,929,000 after purchasing an additional 14,342,946 shares in the last quarter. Bank of New York Mellon Corp increased its position in shares of Pfizer by 38.9% during the fourth quarter. Bank of New York Mellon Corp now owns 48,514,971 shares of the biopharmaceutical company’s stock valued at $1,208,023,000 after buying an additional 13,581,757 shares during the period. Janus Henderson Group PLC grew its stake in Pfizer by 577.5% during the fourth quarter. Janus Henderson Group PLC now owns 8,786,084 shares of the biopharmaceutical company’s stock valued at $218,817,000 after acquiring an additional 7,489,189 shares in the last quarter. Finally, Capital World Investors increased its holdings in shares of Pfizer by 51.5% in the fourth quarter. Capital World Investors now owns 21,433,890 shares of the biopharmaceutical company’s stock worth $533,704,000 after purchasing an additional 7,287,194 shares during the period. Hedge funds and other institutional investors own 68.36% of the company’s stock.
Pfizer Trading Up 0.8% Pfizer stock opened at $28.00 on Friday. The company has a market capitalization of $159.59 billion, a price-to-earnings ratio of 36.84 and a beta of 0.34. The business’s fifty day simple moving average is $25.30 and its two-hundred day simple moving average is $26.25. Pfizer Inc. has a 12 month low of $23.58 and a 12 month high of $28.75. The company has a current ratio of 1.27, a quick ratio of 0.96 and a debt-to-equity ratio of 0.71.
Pfizer (NYSE:PFE – Get Free Report) last issued its earnings results on Tuesday, August 4th. The biopharmaceutical company reported $0.77 earnings per share for the quarter, topping analysts’ consensus estimates of $0.68 by $0.09. Pfizer had a return on equity of 19.63% and a net margin of 6.80%.The business had revenue of $15.03 billion during the quarter, compared to analyst estimates of $14.40 billion. During the same quarter in the previous year, the firm earned $0.78 EPS. Pfizer’s revenue was up 2.6% on a year-over-year basis. Pfizer has set its FY 2026 guidance at 2.800-3.000 EPS. As a group, equities analysts predict that Pfizer Inc. will post 2.98 earnings per share for the current fiscal year. Pfizer Announces Dividend The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 1st. Stockholders of record on Friday, July 24th will be given a dividend of $0.43 per share. The ex-dividend date of this dividend is Friday, July 24th. This represents a $1.72 annualized dividend and a dividend yield of 6.1%. Pfizer’s dividend payout ratio is presently 226.32%.
Key Pfizer News Here are the key news stories impacting Pfizer this week:
Positive Sentiment: Pfizer completed a Phase 1/2 study of PF-07868489, an experimental treatment for pulmonary arterial hypertension. The milestone supports early-stage pipeline progress, though additional clinical testing will be needed before any potential commercialization. Pfizer’s PF-07868489 PAH Study Reaches Completion Positive Sentiment: Several additional clinical updates highlighted progress across Pfizer’s development portfolio: completion of a Phase 1 atirmociclib study, completion of a drug-interaction study for PF-07248144, and a new Phase 1 liver study for atirmociclib. These milestones may reinforce confidence in Pfizer’s ability to replenish revenue as older products face competition. Atirmociclib Study Update PF-07248144 Study Update Positive Sentiment: Pfizer is also expanding real-world evidence efforts for prostate cancer therapies, Ibrance in advanced breast cancer, and a migraine treatment study in India. These studies could support broader use and strengthen commercial evidence for existing medicines. Pfizer Real-World Prostate Cancer Study Positive Sentiment: Investor-oriented coverage remains constructive, citing Pfizer’s roughly 19% year-to-date gain, attractive dividend yield, and reported hedge-fund buying. The stock’s move toward its 52-week high suggests improving sentiment. Hedge Funds Buying Pfizer Neutral Sentiment: Unusually large options activity may increase short-term trading interest, but it does not establish a clear fundamental direction for PFE. Pfizer Options Trading Negative Sentiment: Coverage of settlements involving thousands of Depo-Provera lawsuits raises concerns about potential legal costs and ongoing liability. Analysts also continue to weigh whether new drugs and acquisitions can offset revenue losses from expiring patents. Pfizer Legal Claims Analyst Ratings Changes Several equities research analysts recently issued reports on the company. Bank of America dropped their price objective on Pfizer from $27.00 to $26.00 and set a “neutral” rating for the company in a research note on Friday, July 10th. Cantor Fitzgerald restated a “neutral” rating and issued a $27.00 price objective on shares of Pfizer in a research report on Monday, July 6th. Guggenheim decreased their price target on shares of Pfizer from $35.00 to $31.00 and set a “buy” rating on the stock in a report on Friday, August 7th. Weiss Ratings cut shares of Pfizer from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday. Finally, HSBC downgraded Pfizer from a “buy” rating to a “hold” rating and lowered their price target for the company from $32.00 to $28.00 in a research report on Monday, July 6th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, fourteen have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Pfizer currently has an average rating of “Hold” and a consensus price target of $28.28.
View Our Latest Stock Analysis on Pfizer
About Pfizer (Free Report)
Pfizer Inc (NYSE: PFE) is a multinational biopharmaceutical company headquartered in New York City. Founded in 1849 by Charles Pfizer and Charles Erhart, the company researches, develops, manufactures and commercializes a broad range of medicines and vaccines for human health. Its activities span discovery research, clinical development, regulatory affairs, manufacturing and global commercial distribution across multiple therapeutic areas.
Pfizer’s portfolio and pipeline cover oncology, immunology, cardiology, endocrinology, rare diseases, hospital acute care and anti-infectives, along with a substantial vaccine business.
Read More Five stocks we like better than Pfizer Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding PFE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pfizer Inc. (NYSE:PFE – Free Report).
Receive News & Ratings for Pfizer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pfizer and related companies with MarketBeat.com's FREE daily email newsletter.
Bank of New York Mellon Corp purchased a new position in The Travelers Companies, Inc. (NYSE:TRV – Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,422,225 shares of the insurance provider’s stock, valued at approximately $469,505,000. Bank of New York Mellon Corp owned 0.68% of Travelers Companies at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently bought and sold shares of TRV. Focus Partners Advisor Solutions LLC bought a new position in shares of Travelers Companies during the 2nd quarter worth about $3,143,000. State of Wyoming bought a new stake in Travelers Companies in the 2nd quarter valued at about $720,000. Sutton Place Investors LLC acquired a new position in Travelers Companies during the 2nd quarter worth approximately $221,000. GSA Capital Partners LLP acquired a new position in Travelers Companies during the 2nd quarter worth approximately $928,000. Finally, Avalon Trust Co bought a new position in Travelers Companies in the second quarter worth approximately $2,883,000. 82.45% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In TRV has been the subject of several research reports. Keefe, Bruyette & Woods reissued a “market perform” rating and issued a $356.00 price target (up from $342.00) on shares of Travelers Companies in a research report on Wednesday, July 8th. HSBC raised their price objective on shares of Travelers Companies from $321.00 to $351.00 and gave the company a “hold” rating in a research note on Monday, July 6th. BMO Capital Markets cut shares of Travelers Companies from an “outperform” rating to a “market perform” rating and lifted their price objective for the company from $314.00 to $379.00 in a report on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Travelers Companies in a research report on Tuesday, July 21st. Finally, Raymond James Financial set a $430.00 target price on shares of Travelers Companies in a report on Monday, July 20th. Four analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating, thirteen have given a Hold rating and five have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Travelers Companies has an average rating of “Hold” and a consensus price target of $354.26.
Get Our Latest Research Report on Travelers Companies Travelers Companies Stock Down 0.2% TRV opened at $363.83 on Friday. The company has a quick ratio of 0.33, a current ratio of 0.33 and a debt-to-equity ratio of 0.27. The stock has a market cap of $75.88 billion, a price-to-earnings ratio of 9.74, a PEG ratio of 3.46 and a beta of 0.45. The Travelers Companies, Inc. has a twelve month low of $252.26 and a twelve month high of $398.70. The company’s 50-day moving average price is $352.28 and its two-hundred day moving average price is $318.12.
Travelers Companies (NYSE:TRV – Get Free Report) last issued its quarterly earnings results on Friday, July 17th. The insurance provider reported $10.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.41 by $4.63. The company had revenue of $12.15 billion during the quarter, compared to analyst estimates of $11.26 billion. Travelers Companies had a net margin of 16.95% and a return on equity of 25.41%. Travelers Companies’s quarterly revenue was up .3% compared to the same quarter last year. During the same quarter last year, the business posted $6.51 EPS. As a group, equities analysts expect that The Travelers Companies, Inc. will post 33.82 earnings per share for the current year.
Travelers Companies Dividend Announcement The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Thursday, September 10th will be issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend is Thursday, September 10th. Travelers Companies’s dividend payout ratio is 13.39%.
Insiders Place Their Bets In other Travelers Companies news, EVP Daniel Tei-Hwa Yin sold 7,153 shares of the business’s stock in a transaction on Friday, July 24th. The stock was sold at an average price of $387.00, for a total value of $2,768,211.00. Following the sale, the executive vice president directly owned 68,834 shares in the company, valued at $26,638,758. The trade was a 9.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP David Donnay Rowland sold 5,000 shares of the company’s stock in a transaction on Wednesday, July 22nd. The shares were sold at an average price of $371.69, for a total value of $1,858,450.00. Following the transaction, the executive vice president directly owned 10,479 shares in the company, valued at $3,894,939.51. This represents a 32.30% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 62,667 shares of company stock valued at $22,688,329. Company insiders own 1.39% of the company’s stock.
Travelers Companies Profile (Free Report)
The Travelers Companies, Inc (NYSE: TRV) is a leading provider of property and casualty insurance products and services. The company underwrites a broad range of commercial and personal insurance lines, offering coverage designed to protect individuals, small and midsize businesses, and large corporate clients against property loss, liability, and other operational risks. Travelers is known for combining underwriting, claims management and risk control services to help clients prevent losses and recover when incidents occur.
On the commercial side, Travelers writes primary and specialty coverages including property, general liability, commercial auto, workers’ compensation, professional and management liability, surety and inland marine.
Recommended Stories Five stocks we like better than Travelers Companies Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding TRV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Travelers Companies, Inc. (NYSE:TRV – Free Report).
Receive News & Ratings for Travelers Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Travelers Companies and related companies with MarketBeat.com's FREE daily email newsletter.
Alpine Woods Capital Investors LLC purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 1,888 shares of the healthcare conglomerate’s stock, valued at approximately $785,000.
A number of other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. raised its position in UnitedHealth Group by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 91,600,260 shares of the healthcare conglomerate’s stock valued at $30,238,162,000 after purchasing an additional 995,210 shares during the period. BlackRock Inc. raised its holdings in UnitedHealth Group by 4.6% in the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock valued at $31,946,594,000 after acquiring an additional 3,395,530 shares in the last quarter. State Street Corp grew its holdings in UnitedHealth Group by 2.5% during the 4th quarter. State Street Corp now owns 45,232,170 shares of the healthcare conglomerate’s stock worth $14,931,592,000 after acquiring an additional 1,119,834 shares in the last quarter. Capital World Investors lifted its position in UnitedHealth Group by 3.8% in the fourth quarter. Capital World Investors now owns 22,591,042 shares of the healthcare conglomerate’s stock valued at $7,457,723,000 after acquiring an additional 824,120 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its position in UnitedHealth Group by 3.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 18,829,054 shares of the healthcare conglomerate’s stock worth $6,215,660,000 after acquiring an additional 680,077 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.
UnitedHealth Group News Summary Here are the key news stories impacting UnitedHealth Group this week:
Positive Sentiment: UnitedHealth is reportedly prioritizing Medicare Advantage profitability over rapid membership growth by tightening benefits, improving pricing and controlling costs. The strategy could support stronger margins and more sustainable earnings, even if enrollment growth moderates. Is UnitedHealth Finding a Better Path to Medicare Advantage Growth? Positive Sentiment: Zacks Research added UNH to its Rank #1, or “Strong Buy,” lists for overall stocks, value stocks and income stocks. The repeated favorable rankings may reinforce investor confidence in the shares. New Strong Buy Stocks for August 21st Positive Sentiment: Analysts raised several forward EPS estimates, including Q1 2028 to $7.36 from $6.78 and Q2 2028 to $7.19 from $5.84. A separate report also noted an increase in the Q1 EPS estimate, while Zacks maintained a Strong Buy rating. Q1 EPS Estimate for UnitedHealth Group Increased by Analyst Neutral Sentiment: Forecast revisions were mixed: Q3 2027 EPS was reduced to $4.74 from $4.81 and Q4 2027 to $4.07 from $4.12, partially offsetting the increases for 2028. Negative Sentiment: Aon expects U.S. employer health-care costs to rise 9.5% in 2027. Persistent medical-cost inflation could pressure insurers’ margins and increase pricing, benefit and utilization-management challenges for UnitedHealth. AON Sees No Relief From Health-Cost Inflation Insider Buying and Selling In other news, CEO Patrick Hugh Conway sold 500 shares of the stock in a transaction that occurred on Wednesday, August 5th. The shares were sold at an average price of $410.00, for a total transaction of $205,000.00. Following the sale, the chief executive officer directly owned 16,497 shares of the company’s stock, valued at $6,763,770. This represents a 2.94% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.19% of the stock is currently owned by corporate insiders. Wall Street Analysts Forecast Growth Several equities analysts have weighed in on UNH shares. UBS Group raised their price target on UnitedHealth Group from $460.00 to $490.00 and gave the stock a “buy” rating in a research report on Friday, July 17th. Oppenheimer upped their price objective on shares of UnitedHealth Group from $420.00 to $500.00 and gave the company an “outperform” rating in a research report on Friday, July 17th. Weiss Ratings downgraded UnitedHealth Group from a “hold (c)” rating to a “hold (c-)” rating in a report on Tuesday, July 28th. Mizuho increased their target price on UnitedHealth Group from $470.00 to $493.00 and gave the stock an “outperform” rating in a report on Monday, July 20th. Finally, Piper Sandler set a $477.00 price objective on shares of UnitedHealth Group in a research note on Thursday, July 16th. Two analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $455.92.
View Our Latest Stock Analysis on UnitedHealth Group
UnitedHealth Group Stock Up 1.6% Shares of UnitedHealth Group stock opened at $390.94 on Friday. The company has a market cap of $350.90 billion, a P/E ratio of 25.16, a P/E/G ratio of 1.34 and a beta of 0.62. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The stock has a 50-day moving average price of $413.99 and a 200 day moving average price of $355.96. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The company had revenue of $112.03 billion during the quarter, compared to the consensus estimate of $110.81 billion. During the same quarter in the prior year, the firm earned $4.08 EPS. The company’s revenue was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 19.69 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be issued a dividend of $2.32 per share. The ex-dividend date of this dividend is Monday, September 14th. This represents a $9.28 annualized dividend and a dividend yield of 2.4%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 59.72%.
UnitedHealth Group Profile (Free Report)
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Further Reading Five stocks we like better than UnitedHealth Group Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
71 West Capital Partners increased its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 46.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,058 shares of the company’s stock after buying an additional 5,071 shares during the quarter. 71 West Capital Partners’ holdings in Merck & Co., Inc. were worth $2,063,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also bought and sold shares of the company. Kingdom Financial Group LLC. bought a new position in shares of Merck & Co., Inc. during the 4th quarter valued at approximately $25,000. Abound Financial LLC purchased a new stake in Merck & Co., Inc. in the fourth quarter worth $26,000. Prosperity Bancshares Inc bought a new position in shares of Merck & Co., Inc. during the 4th quarter worth $26,000. High Note Wealth LLC grew its stake in shares of Merck & Co., Inc. by 58.9% during the 4th quarter. High Note Wealth LLC now owns 294 shares of the company’s stock worth $31,000 after acquiring an additional 109 shares during the period. Finally, IFC & Insurance Marketing Inc. bought a new position in shares of Merck & Co., Inc. during the 4th quarter worth $31,000. 76.07% of the stock is owned by hedge funds and other institutional investors.
Merck & Co., Inc. Trading Up 2.3% Shares of MRK opened at $152.43 on Friday. The stock has a market capitalization of $376.07 billion, a P/E ratio of 121.94, a PEG ratio of 6.43 and a beta of 0.19. Merck & Co., Inc. has a twelve month low of $77.58 and a twelve month high of $154.49. The company has a quick ratio of 1.10, a current ratio of 1.32 and a debt-to-equity ratio of 1.22. The firm has a fifty day simple moving average of $128.09 and a two-hundred day simple moving average of $121.23.
Merck & Co., Inc. (NYSE:MRK – Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported ($0.13) EPS for the quarter, beating analysts’ consensus estimates of ($0.26) by $0.13. Merck & Co., Inc. had a return on equity of 16.73% and a net margin of 4.77%.The business had revenue of $16.61 billion during the quarter, compared to analyst estimates of $16.37 billion. During the same quarter in the prior year, the company posted $2.13 EPS. Merck & Co., Inc.’s quarterly revenue was up 5.1% compared to the same quarter last year. Merck & Co., Inc. has set its FY 2026 guidance at 2.660-2.760 EPS. On average, research analysts anticipate that Merck & Co., Inc. will post 2.77 EPS for the current year. Merck & Co., Inc. Dividend Announcement The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 7th. Investors of record on Tuesday, September 15th will be issued a $0.85 dividend. The ex-dividend date is Tuesday, September 15th. This represents a $3.40 annualized dividend and a yield of 2.2%. Merck & Co., Inc.’s payout ratio is 272.00%.
Analyst Upgrades and Downgrades A number of equities analysts have weighed in on the stock. Bank of America increased their target price on shares of Merck & Co., Inc. from $130.00 to $141.00 and gave the stock a “buy” rating in a research report on Tuesday, June 30th. BMO Capital Markets boosted their price target on shares of Merck & Co., Inc. from $142.00 to $170.00 and gave the company an “outperform” rating in a research report on Thursday. Jefferies Financial Group lowered Merck & Co., Inc. from a “strong-buy” rating to a “hold” rating in a report on Wednesday. Weiss Ratings downgraded Merck & Co., Inc. from a “hold (c)” rating to a “hold (c-)” rating in a research note on Tuesday, August 11th. Finally, The Goldman Sachs Group lifted their target price on Merck & Co., Inc. from $140.00 to $160.00 and gave the company a “buy” rating in a report on Friday. Fifteen equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $144.10.
View Our Latest Stock Report on Merck & Co., Inc.
Trending Headlines about Merck & Co., Inc. Here are the key news stories impacting Merck & Co., Inc. this week:
Positive Sentiment: Merck and Moderna reported that their personalized cancer therapy met key Phase 3 goals, improving recurrence-free and distant metastasis-free survival for high-risk melanoma patients when added to Keytruda. The result is the first major late-stage win for an mRNA cancer vaccine and strengthens the potential for regulatory approval and broader oncology applications. MRK/MRNA’s Personalized Cancer Therapy Delivers First Phase III Win Positive Sentiment: Several Wall Street firms raised their outlooks for MRK: Goldman Sachs increased its price target to $160 and kept a Buy rating, while BMO raised its target to $170 and UBS lifted its target to $175. Morgan Stanley also upgraded the shares to Overweight with a $179 target after the cancer-trial success. Positive Sentiment: Investors see Merck’s newer products, acquired assets and pipeline programs as a potential growth cushion against Keytruda’s eventual patent expiration. The company’s expanding portfolio could help diversify revenue beyond its flagship drug. Can Merck’s New Drugs Offer Growth Cushion Ahead of Keytruda LOE? Neutral Sentiment: Unusually high options activity indicates heightened investor interest and potential volatility, but it does not by itself establish the direction of the stock. Negative Sentiment: RBC Capital Markets downgraded Merck to Sector Perform and set a $150 target, arguing that execution risks and the 2028 Keytruda loss of exclusivity are being underestimated. RBC said near-term catalysts are attractive, but the stock’s valuation leaves limited room for additional gains. Merck upgraded at Morgan Stanley after cancer trial win; RBC downgrades Negative Sentiment: Jefferies separately moved Merck from Strong Buy to Hold. The central concern is that the shares have already rallied substantially on the trial news, making the current valuation appear demanding relative to the remaining patent and execution risks. Insiders Place Their Bets In other Merck & Co., Inc. news, EVP Chirfi Guindo sold 10,000 shares of the firm’s stock in a transaction dated Thursday, August 13th. The shares were sold at an average price of $135.00, for a total value of $1,350,000.00. Following the completion of the sale, the executive vice president directly owned 36,613 shares in the company, valued at $4,942,755. This trade represents a 21.45% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, EVP Richard R. Deluca sold 11,699 shares of Merck & Co., Inc. stock in a transaction that occurred on Wednesday, August 12th. The shares were sold at an average price of $131.63, for a total value of $1,539,939.37. Following the sale, the executive vice president directly owned 110,167 shares in the company, valued at approximately $14,501,282.21. The trade was a 9.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 228,238 shares of company stock valued at $29,977,783 over the last quarter. 0.17% of the stock is owned by company insiders.
About Merck & Co., Inc. (Free Report)
Merck & Co, Inc is a global biopharmaceutical company engaged in the discovery, development, manufacture and marketing of prescription medicines, vaccines, biologic therapies and animal health products. Its portfolio spans multiple therapeutic areas with a particular emphasis on oncology, vaccines and infectious disease, as well as therapies for metabolic and chronic conditions. Among its well-known products are the cancer immunotherapy Keytruda (pembrolizumab) and the human papillomavirus vaccine Gardasil; the company also markets a range of medicines and vaccines for veterinary use through Merck Animal Health.
Founded in the late 19th century as the U.S.
Further Reading Five stocks we like better than Merck & Co., Inc. Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding MRK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck & Co., Inc. (NYSE:MRK – Free Report).
Receive News & Ratings for Merck & Co. Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck & Co. Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
B. Metzler seel. Sohn & Co. AG purchased a new position in shares of Chevron Corporation (NYSE:CVX – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 62,313 shares of the oil and gas company’s stock, valued at approximately $10,329,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in CVX. Kayne Anderson Capital Advisors LP bought a new position in shares of Chevron during the second quarter worth approximately $11,977,000. NFJ Investment Group LLC bought a new stake in shares of Chevron in the second quarter valued at about $13,461,000. Bernicke Wealth Management Ltd. grew its stake in shares of Chevron by 0.9% in the second quarter. Bernicke Wealth Management Ltd. now owns 10,805 shares of the oil and gas company’s stock valued at $1,791,000 after acquiring an additional 95 shares in the last quarter. Silvant Capital Management LLC acquired a new position in shares of Chevron in the second quarter valued at about $433,000. Finally, LaSalle St. Investment Advisors LLC bought a new position in Chevron during the second quarter worth about $1,043,000. 72.42% of the stock is currently owned by institutional investors and hedge funds.
Key Headlines Impacting Chevron Here are the key news stories impacting Chevron this week:
Positive Sentiment: Brent crude recently approached $94–$95 per barrel amid renewed Middle East tensions and concerns about Strait of Hormuz disruptions. Sustained higher oil prices typically benefit Chevron’s upstream revenue, margins and cash flow. Chevron jumps as Brent crude approaches $94 Positive Sentiment: Chevron confirmed an oil and gas condensate discovery at the 105-4X well in offshore Angola. Its proximity to existing facilities could allow a lower-cost tie-back, creating a potential source of future production. Chevron Angola discovery analysis Positive Sentiment: Chevron’s $1.78 quarterly dividend, equal to $7.12 annually and an approximately 3.5% yield, reinforces its appeal to income investors. The company also recently exceeded quarterly earnings and revenue expectations. Chevron raises dividend Neutral Sentiment: Analysis comparing Chevron with Exxon Mobil highlights differing long-term strategies, including Chevron’s continued emphasis on oil and gas. The approach could benefit from strong commodity prices but leaves CVX more exposed to future oil-demand and price cycles. Chevron versus Exxon Mobil analysis Negative Sentiment: Iraq plans to more than double its oil output over the next six years. If achieved, the added supply could pressure global crude prices and reduce the earnings benefit Chevron receives from today’s elevated prices. Iraq oil output and Chevron Negative Sentiment: Two Chevron insiders sold shares recently: Andrew Benjamin Walz sold 16,800 shares, while R. Hewitt Pate sold 2,470 shares. Although such transactions may reflect personal financial planning, they can create a modest sentiment overhang. Chevron insider sale report Negative Sentiment: A separate analysis says concerns remain centered on Chevron, including issues surrounding its Hess Midstream exposure and broader execution risks. The report may temper enthusiasm after CVX’s recent advance. Hess Midstream: The Issue Remains With Chevron Analyst Upgrades and Downgrades A number of analysts have issued reports on CVX shares. Royal Bank Of Canada reissued an “outperform” rating and issued a $220.00 price objective on shares of Chevron in a report on Tuesday, May 5th. Weiss Ratings upgraded shares of Chevron from a “hold (c)” rating to a “buy (b)” rating in a research report on Tuesday, August 11th. Barclays cut their price target on Chevron from $216.00 to $208.00 and set an “equal weight” rating for the company in a research note on Monday. Dbs Bank raised Chevron to a “moderate buy” rating in a research report on Thursday, August 6th. Finally, Morgan Stanley raised their price objective on Chevron from $210.00 to $218.00 and gave the stock an “overweight” rating in a research note on Wednesday. Twenty equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $207.48. Read Our Latest Stock Report on Chevron
Chevron Stock Performance Shares of CVX stock opened at $205.25 on Friday. The stock has a market capitalization of $405.53 billion, a PE ratio of 19.68, a PEG ratio of 0.62 and a beta of 0.49. The business’s 50 day simple moving average is $185.03 and its 200 day simple moving average is $188.07. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.25 and a quick ratio of 0.98. Chevron Corporation has a one year low of $146.49 and a one year high of $214.71.
Chevron (NYSE:CVX – Get Free Report) last issued its quarterly earnings results on Friday, July 31st. The oil and gas company reported $6.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.55 by $0.51. The firm had revenue of $67.20 billion for the quarter, compared to the consensus estimate of $62.72 billion. Chevron had a net margin of 9.57% and a return on equity of 11.09%. The company’s revenue for the quarter was up 57.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.77 EPS. As a group, research analysts forecast that Chevron Corporation will post 16.17 earnings per share for the current year.
Chevron Dividend Announcement The business also recently declared a quarterly dividend, which will be paid on Thursday, September 10th. Shareholders of record on Wednesday, August 19th will be issued a $1.78 dividend. This represents a $7.12 dividend on an annualized basis and a yield of 3.5%. The ex-dividend date is Wednesday, August 19th. Chevron’s dividend payout ratio (DPR) is presently 68.26%.
Insider Activity at Chevron In other Chevron news, Director John B. Hess sold 100,000 shares of Chevron stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $194.26, for a total value of $19,426,000.00. Following the completion of the sale, the director directly owned 178,045 shares of the company’s stock, valued at approximately $34,587,021.70. The trade was a 35.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Andrew Benjamin Walz sold 16,800 shares of the company’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $201.06, for a total transaction of $3,377,808.00. Following the transaction, the insider owned 14 shares in the company, valued at $2,814.84. This represents a 99.92% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 1,152,582 shares of company stock valued at $225,853,661. Company insiders own 0.56% of the company’s stock.
Chevron Company Profile (Free Report)
Chevron Corporation (NYSE: CVX) is an American multinational energy company engaged in virtually all aspects of the oil and gas industry. As an integrated energy firm, Chevron’s core activities include upstream oil and natural gas exploration and production, midstream transportation and storage, downstream refining and marketing of fuels and lubricants, and petrochemical manufacturing through joint ventures and subsidiaries. The company markets fuels under brands such as Chevron, Texaco and Caltex and supplies a range of products and services to retail customers, industrial users and commercial fleets worldwide.
Chevron traces its corporate lineage to the early petroleum companies that eventually became Standard Oil of California and has evolved through significant mergers and restructurings, including the acquisitions of Gulf Oil and Texaco.
Featured Stories Five stocks we like better than Chevron Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Chevron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chevron and related companies with MarketBeat.com's FREE daily email newsletter.
B. Metzler seel. Sohn & Co. AG ve 2. čtvrtletí nově koupila 13 863 akcií Synopsys za zhruba 6,184 milionu USD. Synopsys zároveň oznámila kvartální EPS 3,35 USD a tržby 2,28 miliardy USD.
B. Metzler seel. Sohn & Co. AG acquired a new position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 13,863 shares of the semiconductor company’s stock, valued at approximately $6,184,000.
Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. lifted its holdings in Synopsys by 1.6% during the 4th quarter. Vanguard Group Inc. now owns 18,464,862 shares of the semiconductor company’s stock worth $8,673,315,000 after buying an additional 283,677 shares in the last quarter. BlackRock Inc. acquired a new stake in shares of Synopsys in the 2nd quarter valued at $7,228,099,000. State Street Corp increased its stake in shares of Synopsys by 0.3% in the 4th quarter. State Street Corp now owns 8,788,890 shares of the semiconductor company’s stock valued at $4,128,317,000 after buying an additional 28,532 shares during the period. Morgan Stanley raised its position in shares of Synopsys by 2.5% during the fourth quarter. Morgan Stanley now owns 4,573,980 shares of the semiconductor company’s stock worth $2,148,491,000 after acquiring an additional 109,917 shares during the last quarter. Finally, Geode Capital Management LLC lifted its stake in shares of Synopsys by 1.3% during the fourth quarter. Geode Capital Management LLC now owns 4,310,846 shares of the semiconductor company’s stock valued at $2,017,256,000 after acquiring an additional 54,329 shares during the period. Institutional investors own 85.47% of the company’s stock.
Synopsys Stock Down 0.0% Shares of SNPS stock opened at $397.87 on Friday. Synopsys, Inc. has a 52-week low of $366.00 and a 52-week high of $615.79. The stock has a market cap of $76.18 billion, a price-to-earnings ratio of 92.10, a PEG ratio of 2.34 and a beta of 1.23. The firm’s 50-day moving average is $419.73 and its 200-day moving average is $440.22. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43.
Synopsys (NASDAQ:SNPS – Get Free Report) last posted its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion during the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.Synopsys’s quarterly revenue was up 41.9% on a year-over-year basis. During the same quarter last year, the company posted $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Sell-side analysts predict that Synopsys, Inc. will post 10.65 EPS for the current year. Insider Transactions at Synopsys In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This represents a 19.12% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the company’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the transaction, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In Several equities analysts recently issued reports on SNPS shares. Rosenblatt Securities raised their price target on Synopsys from $530.00 to $575.00 and gave the company a “buy” rating in a report on Tuesday, May 26th. KeyCorp reissued an “overweight” rating on shares of Synopsys in a report on Wednesday. Wells Fargo & Company cut their target price on shares of Synopsys from $535.00 to $450.00 and set an “equal weight” rating on the stock in a research report on Tuesday, August 11th. Morgan Stanley reduced their target price on shares of Synopsys from $525.00 to $500.00 and set an “equal weight” rating on the stock in a research note on Wednesday. Finally, Benchmark reiterated a “buy” rating on shares of Synopsys in a research report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $563.59.
View Our Latest Report on SNPS
Synopsys Company Profile (Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories Five stocks we like better than Synopsys Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
Allworth Financial LP ve 2. čtvrtletí koupila nový podíl v Nordson, a to 11 475 akcií za zhruba 3,462 milionu USD. Nordson zároveň oznámila zisk na akcii 3,25 USD a tržby 817,67 milionu USD, obojí nad odhady.
Allworth Financial LP bought a new stake in shares of Nordson Corporation (NASDAQ:NDSN – Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 11,475 shares of the industrial products company’s stock, valued at approximately $3,462,000.
A number of other large investors have also recently made changes to their positions in NDSN. Vanguard Group Inc. raised its holdings in Nordson by 3.1% during the fourth quarter. Vanguard Group Inc. now owns 6,257,600 shares of the industrial products company’s stock valued at $1,504,515,000 after acquiring an additional 186,480 shares during the period. BlackRock Inc. purchased a new stake in shares of Nordson during the 2nd quarter worth approximately $1,248,447,000. State Street Corp raised its holdings in shares of Nordson by 4.7% during the 2nd quarter. State Street Corp now owns 2,958,110 shares of the industrial products company’s stock worth $636,375,000 after acquiring an additional 133,229 shares in the last quarter. Morgan Stanley grew its stake in shares of Nordson by 6.2% in the 4th quarter. Morgan Stanley now owns 1,582,637 shares of the industrial products company’s stock worth $380,514,000 after buying an additional 92,970 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its position in shares of Nordson by 24.0% during the 4th quarter. JPMorgan Chase & Co. now owns 891,016 shares of the industrial products company’s stock valued at $214,227,000 after purchasing an additional 172,400 shares during the last quarter. 72.11% of the stock is owned by hedge funds and other institutional investors.
Nordson Trading Down 0.7% Shares of NDSN stock opened at $332.24 on Friday. The stock has a 50 day simple moving average of $298.83 and a 200-day simple moving average of $287.07. Nordson Corporation has a 1-year low of $220.06 and a 1-year high of $338.55. The company has a market cap of $18.51 billion, a price-to-earnings ratio of 33.59, a PEG ratio of 2.16 and a beta of 0.96. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.82 and a quick ratio of 1.65.
Nordson (NASDAQ:NDSN – Get Free Report) last issued its quarterly earnings results on Wednesday, August 19th. The industrial products company reported $3.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.09 by $0.16. The firm had revenue of $817.67 million for the quarter, compared to analyst estimates of $779.49 million. Nordson had a return on equity of 20.49% and a net margin of 18.63%.The business’s revenue was up 10.3% on a year-over-year basis. During the same period in the previous year, the company posted $2.73 earnings per share. Nordson has set its FY 2026 guidance at 11.800-12.000 EPS. On average, equities research analysts expect that Nordson Corporation will post 11.9 EPS for the current fiscal year. Nordson Announces Dividend The business also recently declared a quarterly dividend, which was paid on Monday, July 6th. Shareholders of record on Thursday, June 18th were issued a dividend of $0.82 per share. The ex-dividend date was Thursday, June 18th. This represents a $3.28 annualized dividend and a yield of 1.0%. Nordson’s dividend payout ratio is 33.16%.
Key Stories Impacting Nordson Here are the key news stories impacting Nordson this week:
Positive Sentiment: Strong Q3 beat and broad-based growth: Nordson reported adjusted earnings of $3.25 per share, above the $3.09 consensus and up from $2.73 a year earlier. Revenue reached $817.7 million, exceeding estimates of $779.5 million and increasing 10.3% year over year. Record sales across all segments, stronger orders and broad organic growth supported the results. NDSN Q3 Earnings Beat Estimates on Broad Organic Growth Positive Sentiment: Higher fiscal 2026 outlook: Management raised its outlook for the third time, forecasting fiscal 2026 sales of $3.035 billion to $3.075 billion and adjusted EPS of $11.80 to $12.00. Backlog reportedly increased 35%, reinforcing expectations for continued demand and earnings momentum. Nordson Forecasts Fiscal 2026 Sales and EPS Positive Sentiment: Analyst price-target increases: Oppenheimer raised its target from $335 to $370 and upgraded its view to “outperform.” Robert W. Baird lifted its target from $328 to $351 while maintaining a “neutral” rating. DA Davidson reaffirmed its “buy” rating with a $345 target. Analysts Boost Forecasts on Nordson Neutral Sentiment: New medical product: Nordson MEDICAL introduced its Divert ULTRA line of ultra-high-pressure stopcocks for demanding medical applications. The launch expands the product portfolio but was not accompanied by a specific financial impact. Nordson MEDICAL Introduces Divert ULTRA Negative Sentiment: Insider selling and valuation: Reported insider activity showed 46 sales and no purchases over the past six months, including sizable sales by senior executives. After the rally, Nordson trades at roughly 33.6 times earnings, leaving the stock vulnerable to profit-taking if growth or guidance momentum slows. Wall Street Analyst Weigh In A number of research firms have weighed in on NDSN. Weiss Ratings upgraded shares of Nordson from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, June 29th. Oppenheimer boosted their target price on shares of Nordson from $335.00 to $370.00 and gave the company an “outperform” rating in a research note on Friday. KeyCorp restated a “buy” rating on shares of Nordson in a report on Thursday. Wall Street Zen lowered shares of Nordson from a “buy” rating to a “hold” rating in a report on Saturday, June 27th. Finally, Robert W. Baird boosted their price objective on shares of Nordson from $328.00 to $351.00 and gave the company a “neutral” rating in a research report on Friday. Five research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Nordson currently has a consensus rating of “Moderate Buy” and a consensus target price of $326.57.
Get Our Latest Analysis on NDSN
About Nordson (Free Report)
Nordson Corporation designs, manufactures and markets precision dispensing equipment and systems that apply adhesives, coatings, sealants and polymers in a broad range of industrial and medical applications. The company’s portfolio spans fluid systems, curing and surface preparation technologies, vacuum and thermal management products, and advanced test and inspection solutions. Nordson’s offerings serve critical manufacturing processes by delivering exacting dispensing accuracy and process control to ensure consistent product performance and high production throughput.
Nordson operates through multiple segments that cater to diverse markets including electronics, packaging, medical, energy, automotive and general industrial sectors.
Read More Five stocks we like better than Nordson Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Nordson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nordson and related companies with MarketBeat.com's FREE daily email newsletter.
Blue Capital Inc. ve 2. čtvrtletí koupila 1 281 akcií Deere & Company za zhruba 813 000 USD. Deere zároveň oznámila zisk na akcii 5,10 USD a tržby 12,61 miliardy USD, nad odhady.
Blue Capital Inc. acquired a new position in Deere & Company (NYSE:DE – Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 1,281 shares of the industrial products company’s stock, valued at approximately $813,000.
Several other hedge funds have also recently modified their holdings of the company. Keating Financial Advisory Services Inc. purchased a new stake in shares of Deere & Company during the 2nd quarter worth approximately $336,000. Patron Partners LLC bought a new stake in shares of Deere & Company in the second quarter valued at $1,206,000. OneAscent Family Office LLC purchased a new position in shares of Deere & Company during the 2nd quarter valued at $301,000. OneAscent Financial Services LLC bought a new position in shares of Deere & Company during the 2nd quarter worth $1,979,000. Finally, Allworth Financial LP purchased a new stake in Deere & Company in the 2nd quarter worth about $7,473,000. Institutional investors own 68.58% of the company’s stock.
Analyst Ratings Changes Several equities research analysts have commented on DE shares. JPMorgan Chase & Co. upped their price objective on shares of Deere & Company from $570.00 to $585.00 and gave the company a “neutral” rating in a report on Friday. Truist Financial boosted their price target on shares of Deere & Company from $759.00 to $812.00 and gave the company a “buy” rating in a research report on Thursday, July 2nd. Robert W. Baird upped their price target on shares of Deere & Company from $525.00 to $640.00 and gave the company a “neutral” rating in a research note on Friday. Citigroup raised their price objective on shares of Deere & Company from $610.00 to $650.00 and gave the stock a “neutral” rating in a report on Friday. Finally, Royal Bank Of Canada reissued an “outperform” rating and set a $752.00 target price on shares of Deere & Company in a report on Monday, June 1st. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, Deere & Company presently has a consensus rating of “Moderate Buy” and an average target price of $643.38.
Read Our Latest Research Report on Deere & Company Deere & Company Stock Up 4.5% Shares of DE opened at $648.61 on Friday. Deere & Company has a 1 year low of $433.00 and a 1 year high of $674.19. The company has a debt-to-equity ratio of 1.45, a current ratio of 2.10 and a quick ratio of 1.95. The stock has a 50 day simple moving average of $606.90 and a two-hundred day simple moving average of $590.75. The firm has a market cap of $175.08 billion, a P/E ratio of 36.03, a P/E/G ratio of 2.63 and a beta of 0.90.
Deere & Company (NYSE:DE – Get Free Report) last posted its quarterly earnings results on Thursday, August 20th. The industrial products company reported $5.10 earnings per share for the quarter, topping the consensus estimate of $4.69 by $0.41. Deere & Company had a net margin of 10.16% and a return on equity of 18.10%. The business had revenue of $12.61 billion during the quarter, compared to the consensus estimate of $10.81 billion. During the same period in the previous year, the firm posted $4.75 earnings per share. The firm’s revenue for the quarter was up 6.2% on a year-over-year basis. On average, analysts forecast that Deere & Company will post 18.23 earnings per share for the current fiscal year.
Deere & Company Dividend Announcement The firm also recently announced a quarterly dividend, which was paid on Monday, August 10th. Investors of record on Tuesday, June 30th were issued a dividend of $1.62 per share. This represents a $6.48 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date was Tuesday, June 30th. Deere & Company’s dividend payout ratio is currently 36.00%.
More Deere & Company News Here are the key news stories impacting Deere & Company this week:
Positive Sentiment: Q3 earnings and revenue beat expectations. Deere reported earnings of $5.10 per share, up from $4.75 a year earlier, on revenue of $12.61 billion, which rose about 6% year over year and exceeded analyst estimates. Deere Reports Third Quarter Net Income Positive Sentiment: Management raised its fiscal 2026 outlook. Deere increased its net-income forecast to $4.75 billion-$5.00 billion and expects $5.0 billion-$5.5 billion in equipment-operations cash flow, improving confidence in profitability and cash generation. Deere Raises FY2026 Outlook Positive Sentiment: Construction and forestry provided the key growth engine. Demand for bulldozers, excavators and other earth-moving equipment is largely booked through the rest of the year, supported by data-center and energy-infrastructure construction tied to artificial-intelligence investment. Deere Lifts Sales Guidance Positive Sentiment: The agricultural cycle may be nearing a bottom. Executives characterized fiscal 2026 as the likely trough for the agricultural equipment cycle and pointed to improving early order trends and potentially stronger demand in 2027. Deere also recognized $110 million in tariff refunds during the quarter. DE Q3 Earnings Call Highlights Neutral Sentiment: Analyst reactions were mixed but generally reflected higher estimates. Robert W. Baird raised its target to $640 and JPMorgan increased its target to $585, while both retained neutral ratings. Other analysts lifted targets as high as $685, indicating expectations have improved but also that valuation and limited near-term upside remain concerns. Deere Analysts Increase Forecasts Negative Sentiment: Agriculture remains a constraint. Production and precision agriculture demand is still weak, and Bank of America cautioned that any recovery may be gradual rather than a sharp cyclical rebound. The stock’s elevated valuation could make it vulnerable if farm-market improvement is delayed. Deere & Company Profile (Free Report)
Deere & Company, commonly known by its brand John Deere, is a global manufacturer of agricultural, construction and forestry machinery, as well as turf care equipment and power systems. Founded in 1837 by blacksmith John Deere—who developed a polished steel plow to improve tillage in tough prairie soils—the company is headquartered in Moline, Illinois, and has grown into one of the largest and most recognizable names in equipment manufacturing worldwide.
The company’s principal businesses include a broad portfolio of agricultural equipment such as tractors, combines, planters, sprayers, harvesters and tillage implements, complemented by precision agriculture technologies and telematics that support farm management, yield optimization and equipment connectivity.
Featured Articles Five stocks we like better than Deere & Company Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Deere & Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Deere & Company and related companies with MarketBeat.com's FREE daily email newsletter.
Bank of New York Mellon Corp acquired a new position in shares of Digital Realty Trust, Inc. (NYSE:DLR – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 1,963,128 shares of the real estate investment trust’s stock, valued at approximately $352,539,000. Bank of New York Mellon Corp owned approximately 0.53% of Digital Realty Trust at the end of the most recent quarter.
Other hedge funds also recently modified their holdings of the company. Sunbelt Securities Inc. lifted its holdings in Digital Realty Trust by 347.2% during the third quarter. Sunbelt Securities Inc. now owns 161 shares of the real estate investment trust’s stock worth $28,000 after acquiring an additional 125 shares in the last quarter. Bell Investment Advisors Inc lifted its position in shares of Digital Realty Trust by 56.9% in the first quarter. Bell Investment Advisors Inc now owns 171 shares of the real estate investment trust’s stock valued at $31,000 after buying an additional 62 shares during the last quarter. Harvest Fund Management Co. Ltd lifted its position in shares of Digital Realty Trust by 970.6% in the third quarter. Harvest Fund Management Co. Ltd now owns 182 shares of the real estate investment trust’s stock valued at $31,000 after buying an additional 165 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new position in shares of Digital Realty Trust during the 3rd quarter worth approximately $34,000. Finally, MCF Advisors LLC acquired a new position in shares of Digital Realty Trust during the 4th quarter worth approximately $35,000. Institutional investors own 99.71% of the company’s stock.
Digital Realty Trust Stock Performance Shares of DLR stock opened at $190.81 on Friday. The company has a market capitalization of $70.79 billion, a price-to-earnings ratio of 92.63, a price-to-earnings-growth ratio of 5.51 and a beta of 1.03. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.06 and a current ratio of 1.06. Digital Realty Trust, Inc. has a one year low of $146.23 and a one year high of $208.14. The company’s 50-day moving average is $186.89 and its 200 day moving average is $185.41.
Digital Realty Trust (NYSE:DLR – Get Free Report) last issued its earnings results on Thursday, July 23rd. The real estate investment trust reported $1.21 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.98 by ($0.77). Digital Realty Trust had a return on equity of 3.34% and a net margin of 11.80%.The firm had revenue of $1.92 billion during the quarter, compared to analysts’ expectations of $1.66 billion. During the same period last year, the firm posted $1.87 earnings per share. The firm’s quarterly revenue was up 28.9% on a year-over-year basis. Digital Realty Trust has set its FY 2026 guidance at 8.150-8.200 EPS. Sell-side analysts expect that Digital Realty Trust, Inc. will post 8.4 EPS for the current fiscal year. Digital Realty Trust Announces Dividend The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Tuesday, September 15th will be issued a $1.22 dividend. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a $4.88 annualized dividend and a dividend yield of 2.6%. Digital Realty Trust’s payout ratio is presently 236.89%.
Analyst Upgrades and Downgrades DLR has been the topic of a number of research reports. JPMorgan Chase & Co. upped their price target on shares of Digital Realty Trust from $230.00 to $235.00 and gave the company an “overweight” rating in a research note on Friday, July 24th. HSBC raised Digital Realty Trust from a “hold” rating to a “buy” rating and boosted their target price for the stock from $210.00 to $240.00 in a research note on Thursday, August 13th. BTIG Research started coverage on Digital Realty Trust in a research note on Friday, July 10th. They issued a “buy” rating and a $215.00 price objective on the stock. Royal Bank Of Canada boosted their price objective on Digital Realty Trust from $207.00 to $227.00 and gave the company an “outperform” rating in a report on Monday, July 27th. Finally, KeyCorp reaffirmed a “sector weight” rating on shares of Digital Realty Trust in a report on Friday, July 24th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-five have issued a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Digital Realty Trust presently has a consensus rating of “Moderate Buy” and a consensus target price of $219.45.
Read Our Latest Stock Report on Digital Realty Trust
(Free Report)
Digital Realty Trust, Inc (NYSE: DLR) is a real estate investment trust that owns, acquires and operates carrier-neutral data centers and provides related colocation and interconnection solutions. The company focuses on large-scale, mission-critical facilities that support the physical infrastructure needs of cloud providers, enterprises, network operators and content companies. Digital Realty’s offerings are designed to enable secure, reliable and highly available IT infrastructure with an emphasis on power density, cooling, and physical security.
Digital Realty’s product set spans wholesale data center space, turnkey build-to-suit facilities, and retail colocation suites, complemented by interconnection services that allow customers to establish private and public connections to networks, cloud on-ramps and other ecosystem partners.
Featured Articles Five stocks we like better than Digital Realty Trust Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding DLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Digital Realty Trust, Inc. (NYSE:DLR – Free Report).
Receive News & Ratings for Digital Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digital Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.
BlackRock ve 2. čtvrtletí nakoupil novou pozici v Globe Life za zhruba 987,9 mil. USD a drží asi 7,12 % společnosti. Akcie GL zároveň po otevření přidaly 0,3 %.
BlackRock Inc. purchased a new position in Globe Life Inc. (NYSE:GL – Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 5,528,883 shares of the company’s stock, valued at approximately $987,901,000. BlackRock Inc. owned approximately 7.12% of Globe Life at the end of the most recent quarter.
Several other large investors also recently added to or reduced their stakes in the stock. CYBER HORNET ETFs LLC purchased a new position in shares of Globe Life during the second quarter valued at approximately $28,000. Hilton Head Capital Partners LLC purchased a new stake in Globe Life in the fourth quarter worth $30,000. MUFG Securities EMEA plc bought a new stake in shares of Globe Life during the second quarter worth $31,000. Torren Management LLC purchased a new stake in shares of Globe Life during the fourth quarter valued at $37,000. Finally, AdvisorNet Financial Inc boosted its stake in shares of Globe Life by 41.1% during the first quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after purchasing an additional 92 shares during the period. 81.61% of the stock is owned by institutional investors.
Insider Transactions at Globe Life In other Globe Life news, Director Cheryl Alston sold 8,258 shares of the stock in a transaction on Thursday, June 25th. The shares were sold at an average price of $179.24, for a total transaction of $1,480,163.92. Following the transaction, the director directly owned 16,621 shares of the company’s stock, valued at $2,979,148.04. This trade represents a 33.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Michael Clay Majors sold 37,000 shares of the business’s stock in a transaction that occurred on Wednesday, July 29th. The stock was sold at an average price of $178.64, for a total value of $6,609,680.00. Following the sale, the executive vice president owned 53,518 shares of the company’s stock, valued at approximately $9,560,455.52. This trade represents a 40.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 151,908 shares of company stock worth $27,239,981 in the last ninety days. Company insiders own 2.11% of the company’s stock.
Analyst Ratings Changes GL has been the subject of several research reports. Wells Fargo & Company upped their price target on shares of Globe Life from $172.00 to $193.00 and gave the stock an “overweight” rating in a research report on Thursday, July 9th. Piper Sandler upped their target price on Globe Life from $175.00 to $200.00 and gave the stock an “overweight” rating in a report on Wednesday, July 15th. Weiss Ratings cut Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday, July 20th. TD Cowen lifted their price target on Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a report on Wednesday, July 22nd. Finally, JPMorgan Chase & Co. raised their price objective on Globe Life from $181.00 to $201.00 and gave the company an “overweight” rating in a research report on Tuesday, July 21st. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $191.67. Get Our Latest Analysis on Globe Life
Globe Life Trading Up 0.3% Shares of NYSE:GL opened at $171.07 on Friday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.43. Globe Life Inc. has a 12-month low of $127.85 and a 12-month high of $191.55. The business has a 50 day moving average of $178.36 and a two-hundred day moving average of $158.52. The company has a market capitalization of $13.15 billion, a PE ratio of 11.36 and a beta of 0.48.
Globe Life (NYSE:GL – Get Free Report) last posted its earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing the consensus estimate of $3.67 by ($0.06). The firm had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Globe Life had a net margin of 19.58% and a return on equity of 20.52%. Globe Life’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same period last year, the firm earned $3.05 earnings per share. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. As a group, analysts forecast that Globe Life Inc. will post 15.71 EPS for the current year.
Globe Life announced that its Board of Directors has initiated a stock repurchase program on Monday, August 10th that allows the company to buyback $2.50 billion in outstanding shares. This buyback authorization allows the company to reacquire up to 17.7% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s leadership believes its stock is undervalued.
Globe Life Dividend Announcement The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Monday, October 5th will be paid a $0.33 dividend. The ex-dividend date of this dividend is Monday, October 5th. This represents a $1.32 dividend on an annualized basis and a yield of 0.8%. Globe Life’s dividend payout ratio (DPR) is currently 8.76%.
Globe Life Company Profile (Free Report)
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Recommended Stories Five stocks we like better than Globe Life Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL – Free Report).
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
Bank of New York Mellon Corp acquired a new stake in Enbridge Inc (NYSE:ENB – Free Report) (TSE:ENB) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 7,611,637 shares of the pipeline company’s stock, valued at approximately $412,627,000. Bank of New York Mellon Corp owned about 0.35% of Enbridge at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Arlington Trust Co LLC grew its holdings in shares of Enbridge by 114.6% in the second quarter. Arlington Trust Co LLC now owns 500 shares of the pipeline company’s stock worth $27,000 after purchasing an additional 267 shares during the last quarter. Triumph Capital Management bought a new stake in Enbridge during the 3rd quarter valued at about $26,000. Turning Point Benefit Group Inc. purchased a new stake in Enbridge in the 3rd quarter valued at about $28,000. Inspire Investing LLC purchased a new stake in Enbridge in the 4th quarter valued at about $29,000. Finally, Imprint Wealth LLC bought a new position in Enbridge in the 3rd quarter worth about $31,000. Hedge funds and other institutional investors own 54.60% of the company’s stock.
Enbridge Stock Performance Shares of ENB opened at $50.48 on Friday. The stock has a 50-day moving average of $54.14 and a two-hundred day moving average of $53.99. Enbridge Inc has a one year low of $45.03 and a one year high of $58.45. The company has a debt-to-equity ratio of 1.69, a quick ratio of 0.66 and a current ratio of 0.72. The stock has a market cap of $110.25 billion, a P/E ratio of 26.99 and a beta of 0.58.
Enbridge (NYSE:ENB – Get Free Report) (TSE:ENB) last announced its quarterly earnings data on Friday, July 31st. The pipeline company reported $0.46 earnings per share for the quarter, beating analysts’ consensus estimates of $0.43 by $0.03. The business had revenue of $9.70 billion for the quarter, compared to analyst estimates of $8.67 billion. Enbridge had a return on equity of 11.17% and a net margin of 7.20%.During the same period in the prior year, the company earned $0.65 earnings per share. As a group, research analysts predict that Enbridge Inc will post 2.11 EPS for the current year. Enbridge Dividend Announcement The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 1st. Stockholders of record on Friday, August 14th will be paid a $0.97 dividend. The ex-dividend date is Friday, August 14th. This represents a $3.88 dividend on an annualized basis and a dividend yield of 7.7%. Enbridge’s dividend payout ratio is presently 147.06%.
Wall Street Analyst Weigh In Several research firms have recently weighed in on ENB. Wall Street Zen raised shares of Enbridge from a “sell” rating to a “hold” rating in a research note on Sunday, July 12th. US Capital Advisors upgraded Enbridge from a “hold” rating to a “moderate buy” rating in a report on Thursday. Royal Bank Of Canada lifted their target price on Enbridge from $79.00 to $84.00 and gave the company an “outperform” rating in a research report on Monday, August 3rd. Raymond James Financial cut Enbridge from an “outperform” rating to a “market perform” rating in a report on Friday, July 31st. Finally, Wolfe Research set a $50.00 price target on Enbridge in a research report on Tuesday, August 4th. Five analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $67.00.
Read Our Latest Report on Enbridge
Enbridge News Roundup Here are the key news stories impacting Enbridge this week:
Positive Sentiment: US Capital Advisors upgraded Enbridge from “hold” to “moderate buy,” signaling improved confidence in the company’s risk-reward profile at recent valuation levels. Zacks.com Positive Sentiment: US Capital Advisors raised its earnings forecasts across several periods. Estimates increased to $0.43 per share for Q3 2026, $0.61 for Q4 2026, $0.48 for Q2 2027, $0.46 for Q3 2027 and $0.69 for Q4 2027. Its FY2027 forecast rose to $2.41 per share from $2.24, above the current full-year consensus of $2.11. These revisions suggest expectations for stronger earnings momentum. MarketBeat analyst estimates Positive Sentiment: Enbridge’s long dividend-growth record remains attractive to income investors. The company has increased its dividend for 31 consecutive years, and the recent share-price pullback may improve its yield and valuation appeal. Enbridge dividend analysis Neutral Sentiment: Some analysis suggests Enbridge is fairly valued after generating roughly a 93% total return over five years, limiting the potential for near-term multiple expansion despite its infrastructure cash flows. Enbridge valuation analysis Negative Sentiment: Risks include weaker second-quarter results, elevated leverage and competition. Enbridge has a roughly CAD 41 billion secured growth backlog, but competing egress pipelines could pressure volumes on its Mainline System, which contributes about one-third of EBITDA. Debt-to-EBITDA of approximately 5.1 times also exceeds the company’s preferred range and leaves earnings more exposed to interest costs. Enbridge growth backlog and Mainline risks Enbridge Profile (Free Report)
Enbridge Inc is a Calgary, Alberta–based energy infrastructure company that develops, owns and operates a diversified portfolio of energy transportation, distribution and generation assets. Its core activities include the operation of crude oil and liquids pipelines, natural gas transmission and distribution systems, and energy storage facilities. In addition to midstream transportation and storage, Enbridge has expanded into renewable power generation and energy transition projects, including wind, solar and utility-scale generation assets.
The company serves customers primarily in Canada and the United States and has interests in other international energy projects.
See Also Five stocks we like better than Enbridge Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding ENB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enbridge Inc (NYSE:ENB – Free Report) (TSE:ENB).
Receive News & Ratings for Enbridge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enbridge and related companies with MarketBeat.com's FREE daily email newsletter.
B. Metzler seel. Sohn & Co. AG ve 2. čtvrtletí koupila 3 925 akcií společnosti W.W. Grainger za přibližně 5,34 mil. USD. Akcie GWW v pátek otevřely na 1 312,12 USD.
B. Metzler seel. Sohn & Co. AG acquired a new position in shares of W.W. Grainger, Inc. (NYSE:GWW – Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 3,925 shares of the industrial products company’s stock, valued at approximately $5,340,000.
Other large investors also recently modified their holdings of the company. Brighton Jones LLC lifted its stake in W.W. Grainger by 46.8% during the fourth quarter. Brighton Jones LLC now owns 320 shares of the industrial products company’s stock worth $338,000 after purchasing an additional 102 shares during the last quarter. Empowered Funds LLC lifted its stake in shares of W.W. Grainger by 18.0% in the 1st quarter. Empowered Funds LLC now owns 2,851 shares of the industrial products company’s stock valued at $2,816,000 after acquiring an additional 435 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in shares of W.W. Grainger by 169.6% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,826 shares of the industrial products company’s stock valued at $3,980,000 after acquiring an additional 2,407 shares in the last quarter. Gamco Investors INC. ET AL bought a new stake in W.W. Grainger during the 2nd quarter worth $208,000. Finally, Sei Investments Co. grew its position in W.W. Grainger by 35.2% during the 2nd quarter. Sei Investments Co. now owns 41,388 shares of the industrial products company’s stock worth $43,051,000 after acquiring an additional 10,784 shares during the last quarter. 80.70% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In Several equities analysts have commented on GWW shares. Morgan Stanley increased their target price on W.W. Grainger from $1,190.00 to $1,300.00 and gave the company an “equal weight” rating in a research report on Wednesday, May 27th. DA Davidson raised their price objective on shares of W.W. Grainger from $1,250.00 to $1,260.00 and gave the company a “neutral” rating in a report on Thursday, August 6th. Weiss Ratings upgraded shares of W.W. Grainger from a “buy (b-)” rating to a “buy (b)” rating in a research report on Friday, July 17th. Royal Bank Of Canada reduced their target price on shares of W.W. Grainger from $1,460.00 to $1,428.00 and set a “sector perform” rating on the stock in a report on Wednesday, August 5th. Finally, Oppenheimer upped their price target on shares of W.W. Grainger from $1,350.00 to $1,375.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Two analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $1,274.12.
Get Our Latest Stock Analysis on GWW W.W. Grainger Stock Up 0.9% Shares of NYSE:GWW opened at $1,312.12 on Friday. The business’s 50 day moving average is $1,344.74 and its 200 day moving average is $1,229.54. W.W. Grainger, Inc. has a 12-month low of $906.52 and a 12-month high of $1,419.91. The stock has a market cap of $61.80 billion, a price-to-earnings ratio of 33.46, a PEG ratio of 2.31 and a beta of 1.04. The company has a quick ratio of 1.70, a current ratio of 2.81 and a debt-to-equity ratio of 0.53.
W.W. Grainger (NYSE:GWW – Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The industrial products company reported $12.01 earnings per share for the quarter, beating the consensus estimate of $11.30 by $0.71. W.W. Grainger had a return on equity of 48.73% and a net margin of 9.92%.The business had revenue of $5.02 billion for the quarter, compared to analysts’ expectations of $4.96 billion. During the same period last year, the business earned $9.97 EPS. The business’s revenue was up 10.3% on a year-over-year basis. W.W. Grainger has set its FY 2026 guidance at 45.500-47.250 EPS. On average, sell-side analysts forecast that W.W. Grainger, Inc. will post 46.1 earnings per share for the current fiscal year.
W.W. Grainger Announces Dividend The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 1st. Investors of record on Monday, August 10th will be issued a $2.49 dividend. This represents a $9.96 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Monday, August 10th. W.W. Grainger’s payout ratio is 25.40%.
About W.W. Grainger (Free Report)
W.W. Grainger, Inc (NYSE: GWW) is an industrial supply distributor founded in 1927 and headquartered in Lake Forest, Illinois. The company supplies maintenance, repair and operations (MRO) products and services to businesses, institutions and government customers. Over its long history Grainger has developed a broad product assortment and a national distribution network that supports operations across a range of end markets, including manufacturing, healthcare, hospitality, transportation and public sector organizations.
Grainger’s product portfolio spans core categories such as electrical and lighting, safety and personal protective equipment, material handling, motors and power transmission, plumbing and HVAC, fasteners and adhesives, hand and power tools, and janitorial and facility supplies.
Read More Five stocks we like better than W.W. Grainger Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding GWW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for W.W. Grainger, Inc. (NYSE:GWW – Free Report).
Receive News & Ratings for W.W. Grainger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for W.W. Grainger and related companies with MarketBeat.com's FREE daily email newsletter.
Blue Capital Inc. ve 2. čtvrtletí nově nakoupila 18 381 akcií Bristol Myers Squibb za zhruba 1,059 milionu USD. Akcie BMY v pátek otevřely o 2,4 % výše.
Blue Capital Inc. acquired a new position in shares of Bristol Myers Squibb Company (NYSE:BMY – Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 18,381 shares of the biopharmaceutical company’s stock, valued at approximately $1,059,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. increased its position in shares of Bristol Myers Squibb by 1.4% in the fourth quarter. Vanguard Group Inc. now owns 198,727,768 shares of the biopharmaceutical company’s stock valued at $10,719,376,000 after acquiring an additional 2,743,759 shares during the last quarter. BlackRock Inc. boosted its position in Bristol Myers Squibb by 5.1% during the second quarter. BlackRock Inc. now owns 180,384,994 shares of the biopharmaceutical company’s stock valued at $10,393,783,000 after purchasing an additional 8,702,106 shares during the last quarter. State Street Corp grew its stake in Bristol Myers Squibb by 1.4% in the fourth quarter. State Street Corp now owns 97,980,438 shares of the biopharmaceutical company’s stock valued at $5,285,065,000 after purchasing an additional 1,385,206 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Bristol Myers Squibb by 13.1% during the 4th quarter. Geode Capital Management LLC now owns 52,638,346 shares of the biopharmaceutical company’s stock worth $2,837,026,000 after purchasing an additional 6,084,046 shares during the last quarter. Finally, Norges Bank bought a new stake in shares of Bristol Myers Squibb during the 4th quarter worth approximately $1,947,272,000. Institutional investors and hedge funds own 76.41% of the company’s stock.
More Bristol Myers Squibb News Here are the key news stories impacting Bristol Myers Squibb this week:
Positive Sentiment: Bristol Myers Squibb plans to invest approximately $2.3 billion in a new Houston manufacturing facility, part of a broader $40 billion U.S. investment commitment. The project reinforces BMY’s confidence in domestic production capacity and could support long-term operational growth. Bristol-Myers Squibb Bets $2.3 Billion on Texas Positive Sentiment: BMY is collaborating with Chai Discovery on artificial-intelligence-driven antibody discovery. The partnership could help identify novel therapeutic candidates more efficiently and strengthens the company’s efforts to modernize its drug-development platform. Chai Discovery Collaboration Positive Sentiment: The company is launching a Phase 1 study of an early Alzheimer’s disease antibody. Although the program remains highly experimental, it adds another potential long-term growth opportunity to BMY’s pipeline. Early Alzheimer’s Antibody Study Positive Sentiment: Strong Eliquis performance is helping offset declines in BMY’s older products facing generic pressure, supporting a more favorable 2026 revenue outlook. Elevated call-option activity also signals increased bullish interest, though it is not a fundamental guarantee. Eliquis and Legacy Portfolio Analysis Neutral Sentiment: Early clinical work on navlimetostat shows continued pipeline activity, but the Phase 1-stage program has not yet produced efficacy data that would materially change near-term earnings expectations. Navlimetostat Study Update Negative Sentiment: Generic competition remains a key risk for BMY’s legacy portfolio. Investors must determine whether Eliquis growth and newer pipeline assets can replace revenue lost as established medicines face erosion. Legacy Portfolio Erosion Analysis Bristol Myers Squibb Trading Up 2.4% BMY opened at $67.06 on Friday. The company has a market cap of $136.98 billion, a P/E ratio of 14.77, a PEG ratio of 0.17 and a beta of 0.22. The company has a current ratio of 1.53, a quick ratio of 1.38 and a debt-to-equity ratio of 1.89. The company’s 50 day moving average is $60.55 and its 200-day moving average is $59.37. Bristol Myers Squibb Company has a 1-year low of $42.52 and a 1-year high of $68.64. Bristol Myers Squibb (NYSE:BMY – Get Free Report) last issued its earnings results on Thursday, July 30th. The biopharmaceutical company reported $2.04 earnings per share for the quarter, beating analysts’ consensus estimates of $1.60 by $0.44. Bristol Myers Squibb had a net margin of 18.87% and a return on equity of 66.90%. The firm had revenue of $12.97 billion for the quarter, compared to analyst estimates of $11.74 billion. During the same quarter last year, the business posted $1.46 earnings per share. The company’s quarterly revenue was up 5.7% on a year-over-year basis. Bristol Myers Squibb has set its FY 2026 guidance at 6.750-7.000 EPS. Equities research analysts predict that Bristol Myers Squibb Company will post 6.95 earnings per share for the current fiscal year.
Bristol Myers Squibb Announces Dividend The company also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 2nd were paid a dividend of $0.63 per share. This represents a $2.52 dividend on an annualized basis and a dividend yield of 3.8%. The ex-dividend date of this dividend was Thursday, July 2nd. Bristol Myers Squibb’s dividend payout ratio (DPR) is presently 55.51%.
Analysts Set New Price Targets Several equities analysts recently weighed in on BMY shares. Truist Financial reissued a “buy” rating and issued a $70.00 target price (up from $65.00) on shares of Bristol Myers Squibb in a research note on Friday, July 31st. Royal Bank Of Canada upped their price target on shares of Bristol Myers Squibb from $60.00 to $64.00 and gave the stock a “sector perform” rating in a research report on Friday, July 31st. Jefferies Financial Group downgraded shares of Bristol Myers Squibb from a “buy” rating to a “hold” rating in a research report on Wednesday, August 5th. Sanford C. Bernstein raised shares of Bristol Myers Squibb from a “market perform” rating to an “outperform” rating in a report on Wednesday, August 5th. Finally, Wall Street Zen upgraded shares of Bristol Myers Squibb from a “buy” rating to a “strong-buy” rating in a research note on Saturday, June 27th. One analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Bristol Myers Squibb has a consensus rating of “Moderate Buy” and a consensus price target of $66.06.
View Our Latest Stock Analysis on BMY
(Free Report)
Bristol Myers Squibb is a global biopharmaceutical company headquartered in Princeton, New Jersey, focused on discovering, developing and delivering medicines for serious diseases. The company’s core activities include research and development, clinical development, manufacturing and commercialization of prescription pharmaceuticals across multiple therapeutic areas. BMS concentrates on advancing therapies in oncology, hematology, immunology, cardiovascular disease and specialty areas through both small molecules and biologics.
BMS’s marketed portfolio and late‑stage pipeline reflect a strong emphasis on cancer and immune‑mediated conditions.
Featured Articles Five stocks we like better than Bristol Myers Squibb Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Bristol Myers Squibb Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bristol Myers Squibb and related companies with MarketBeat.com's FREE daily email newsletter.
Bank of New York Mellon Corp bought a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 758,492 shares of the biopharmaceutical company’s stock, valued at approximately $472,950,000. Bank of New York Mellon Corp owned approximately 0.72% of Regeneron Pharmaceuticals as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also made changes to their positions in the company. Focus Partners Advisor Solutions LLC acquired a new stake in shares of Regeneron Pharmaceuticals in the 2nd quarter valued at about $1,350,000. State of Wyoming purchased a new stake in Regeneron Pharmaceuticals in the second quarter valued at approximately $74,000. ABN AMRO Bank N.V. purchased a new stake in Regeneron Pharmaceuticals in the second quarter valued at approximately $422,000. GSA Capital Partners LLP acquired a new stake in shares of Regeneron Pharmaceuticals in the second quarter valued at approximately $509,000. Finally, Stoneridge Investment Partners LLC purchased a new position in shares of Regeneron Pharmaceuticals during the second quarter worth approximately $657,000. 83.31% of the stock is owned by hedge funds and other institutional investors.
Key Stories Impacting Regeneron Pharmaceuticals Here are the key news stories impacting Regeneron Pharmaceuticals this week:
Positive Sentiment: The FDA approved Pasatru (garetosmab-grts) to reduce new heterotopic ossification lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans progressiva (FOP). Approval was supported by the Phase 3 OPTIMA trial, which showed a 90% or greater reduction in new lesions at 56 weeks. As the first approved treatment demonstrating this benefit in FOP, Pasatru could expand Regeneron’s rare-disease portfolio and create a new revenue stream. Regeneron to challenge Ipsen as FDA clears bone disease drug Positive Sentiment: Regeneron is also pursuing growth in obesity treatment. An update on its Phase 2 olatorepatide study has drawn investor attention because the program could give the company exposure to the large and rapidly expanding obesity-drug market, although clinical and commercial risks remain. Regeneron’s Olatorepatide Trial Signals a Bid for Obesity Market Upside Neutral Sentiment: Multiple investor-law-firm notices announced a securities class action and a September 14, 2026 lead-plaintiff deadline. The claims relate to alleged disclosures about the Phase 3 Fianlimab-Libtayo melanoma trial; the notices themselves do not represent a new regulatory or operating development. Regeneron Investors Class Action Notice Negative Sentiment: The underlying litigation alleges that Regeneron misled investors about the viability and prospects of the Fianlimab-Libtayo trial, whose disappointing results reportedly caused a sharp share-price decline and an approximately $11 billion reduction in market value. Continued lawsuit announcements add reputational, legal-cost and potential financial-liability risks. Pomerantz Regeneron Investor Alert Insider Activity at Regeneron Pharmaceuticals In other Regeneron Pharmaceuticals news, Director Arthur F. Ryan sold 200 shares of the company’s stock in a transaction dated Thursday, July 2nd. The shares were sold at an average price of $650.15, for a total value of $130,030.00. Following the sale, the director owned 17,303 shares of the company’s stock, valued at $11,249,545.45. This represents a 1.14% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Huda Y. Zoghbi sold 800 shares of the stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $800.00, for a total transaction of $640,000.00. Following the completion of the sale, the director owned 1,703 shares in the company, valued at $1,362,400. This represents a 31.96% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 1,400 shares of company stock valued at $1,090,030. Insiders own 6.97% of the company’s stock. Analysts Set New Price Targets A number of brokerages recently weighed in on REGN. Benchmark upgraded shares of Regeneron Pharmaceuticals from a “hold” rating to a “buy” rating and set a $185.00 price target for the company in a research note on Tuesday, July 7th. Morgan Stanley lifted their price objective on shares of Regeneron Pharmaceuticals from $730.00 to $758.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. JPMorgan Chase & Co. reduced their target price on shares of Regeneron Pharmaceuticals from $950.00 to $850.00 and set an “overweight” rating for the company in a report on Monday, May 18th. Wells Fargo & Company increased their target price on shares of Regeneron Pharmaceuticals from $700.00 to $750.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Finally, Sanford C. Bernstein raised Regeneron Pharmaceuticals to a “hold” rating in a report on Wednesday, July 29th. Sixteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $801.70.
Read Our Latest Stock Report on Regeneron Pharmaceuticals
Regeneron Pharmaceuticals Stock Up 0.9% REGN stock opened at $834.04 on Friday. The company has a current ratio of 3.34, a quick ratio of 2.78 and a debt-to-equity ratio of 0.06. The company’s 50-day moving average price is $697.09 and its 200 day moving average price is $716.73. Regeneron Pharmaceuticals, Inc. has a 52 week low of $541.00 and a 52 week high of $847.00. The company has a market cap of $85.87 billion, a P/E ratio of 20.61, a P/E/G ratio of 1.41 and a beta of 0.22.
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The biopharmaceutical company reported $14.29 earnings per share for the quarter, beating the consensus estimate of $10.16 by $4.13. Regeneron Pharmaceuticals had a return on equity of 13.47% and a net margin of 27.86%.The firm had revenue of $4.29 billion during the quarter, compared to the consensus estimate of $3.82 billion. During the same period last year, the business posted $12.81 EPS. Regeneron Pharmaceuticals’s quarterly revenue was up 16.7% on a year-over-year basis. On average, research analysts expect that Regeneron Pharmaceuticals, Inc. will post 44.25 earnings per share for the current fiscal year.
Regeneron Pharmaceuticals Dividend Announcement The firm also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Tuesday, August 18th will be given a $0.94 dividend. The ex-dividend date is Tuesday, August 18th. This represents a $3.76 annualized dividend and a dividend yield of 0.5%. Regeneron Pharmaceuticals’s payout ratio is currently 9.29%.
(Free Report)
Regeneron Pharmaceuticals, Inc (NASDAQ: REGN) is a U.S.-based biotechnology company founded in 1988 and headquartered in Tarrytown, New York. It focuses on discovering, developing, manufacturing and commercializing medicines for serious medical conditions. The company combines laboratory research, clinical development and in-house manufacturing to advance a pipeline of biologic therapies across multiple therapeutic areas.
Regeneron is known for its proprietary drug discovery technologies, including its VelocImmune platform, which is used to generate fully human monoclonal antibodies.
Further Reading Five stocks we like better than Regeneron Pharmaceuticals Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Regeneron Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Regeneron Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
Blue Capital Inc. ve 2. čtvrtletí koupila novou pozici v Union Pacific Corporation: 2 470 akcií za zhruba 672 000 USD. Analytici zároveň drží průměrné doporučení „Moderate Buy“ a cílovou cenu 320,89 USD.
Blue Capital Inc. bought a new position in shares of Union Pacific Corporation (NYSE:UNP – Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 2,470 shares of the railroad operator’s stock, valued at approximately $672,000.
Other large investors also recently modified their holdings of the company. Rachor Investment Advisory Services LLC bought a new position in Union Pacific during the 4th quarter worth $25,000. Tucker Asset Management LLC bought a new stake in Union Pacific in the fourth quarter valued at $25,000. SWAN Capital LLC lifted its stake in Union Pacific by 2,575.0% in the fourth quarter. SWAN Capital LLC now owns 107 shares of the railroad operator’s stock valued at $25,000 after buying an additional 103 shares during the last quarter. High Point Wealth Management LLC acquired a new position in shares of Union Pacific during the fourth quarter valued at $26,000. Finally, Cornerstone Financial Management LLC bought a new position in shares of Union Pacific during the fourth quarter worth about $27,000. 80.38% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets A number of research firms recently weighed in on UNP. Raymond James Financial reaffirmed a “strong-buy” rating on shares of Union Pacific in a report on Monday, July 13th. BMO Capital Markets restated a “market perform” rating and issued a $320.00 price target (up from $285.00) on shares of Union Pacific in a research note on Friday, July 24th. Susquehanna lifted their price target on Union Pacific from $305.00 to $333.00 and gave the company a “positive” rating in a report on Tuesday, July 14th. Wells Fargo & Company reiterated an “overweight” rating and set a $335.00 price objective (up from $315.00) on shares of Union Pacific in a research report on Friday, July 24th. Finally, The Goldman Sachs Group set a $317.00 price objective on Union Pacific and gave the stock a “neutral” rating in a report on Thursday, July 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, Union Pacific presently has an average rating of “Moderate Buy” and an average target price of $320.89.
Check Out Our Latest Report on Union Pacific Insider Buying and Selling at Union Pacific In other news, EVP Eric J. Gehringer sold 2,991 shares of the stock in a transaction that occurred on Wednesday, June 3rd. The shares were sold at an average price of $263.96, for a total value of $789,504.36. Following the completion of the sale, the executive vice president directly owned 43,012 shares of the company’s stock, valued at $11,353,447.52. This represents a 6.50% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.22% of the stock is owned by corporate insiders.
Union Pacific Trading Up 1.3% NYSE UNP opened at $307.97 on Friday. Union Pacific Corporation has a twelve month low of $210.84 and a twelve month high of $315.99. The company has a debt-to-equity ratio of 1.40, a quick ratio of 0.82 and a current ratio of 0.99. The stock has a market cap of $182.96 billion, a price-to-earnings ratio of 24.94, a PEG ratio of 3.10 and a beta of 0.96. The firm’s 50 day moving average price is $286.30 and its two-hundred day moving average price is $267.60.
Union Pacific (NYSE:UNP – Get Free Report) last released its earnings results on Thursday, July 23rd. The railroad operator reported $3.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.26 by $0.15. The company had revenue of $6.86 billion during the quarter, compared to analyst estimates of $6.72 billion. Union Pacific had a return on equity of 38.46% and a net margin of 28.85%.The company’s revenue for the quarter was up 11.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.03 earnings per share. Equities analysts anticipate that Union Pacific Corporation will post 12.93 EPS for the current year.
Union Pacific Increases Dividend The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Monday, August 31st will be issued a $1.42 dividend. The ex-dividend date is Monday, August 31st. This represents a $5.68 dividend on an annualized basis and a dividend yield of 1.8%. This is a positive change from Union Pacific’s previous quarterly dividend of $1.38. Union Pacific’s dividend payout ratio is currently 44.70%.
Union Pacific Company Profile (Free Report)
Union Pacific Corporation (NYSE: UNP) is one of the largest freight railroad companies in the United States. Its principal operating subsidiary, Union Pacific Railroad, has roots that trace back to the Pacific Railway Act of 1862 and the construction of the first transcontinental rail link completed in 1869. The company is headquartered in Omaha, Nebraska, and operates as a holding company for rail transportation and related services.
Union Pacific’s core business is the movement of freight by rail across an extensive rail network serving the western two‑thirds of the United States.
Read More Five stocks we like better than Union Pacific Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding UNP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Union Pacific Corporation (NYSE:UNP – Free Report).
Receive News & Ratings for Union Pacific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Union Pacific and related companies with MarketBeat.com's FREE daily email newsletter.
D.E. Shaw & Co. disclosed a brand new position in SpaceX (NASDAQ:SPCX | SPCX Price Prediction) worth $912,392,400 and trimmed its stake in Broadcom (NASDAQ:AVGO) by 58.3% in the same quarterly filing, according to the firm’s Form 13F-HR filed August 14, 2026 for the period ending June 30.
These are two separate line items in a book of 4,833 positions, alongside 977 new positions, 1,734 added, 1,595 trimmed and 614 exited in the quarter. Read them as parallel data points, not a linked trade.
The SpaceX Line Item The filing lists 5,340,000 shares of SPCX common valued at $912,392,400, representing 0.434% of the portfolio. This is a first-time entry, so no prior-quarter comparison exists.
SpaceX completed its IPO on June 12, 2026 at a reported price of $135, widely reported as the largest IPO ever. The stock closed at $146.05 on August 17, 2026, but it is down 13.02% from its June 12 debut through August 14. Market cap sits near $1.13 trillion. Fundamentally, Q2 2026 revenue came in at $7.81 billion, with Starlink subscribers doubling to 12.0 million and adjusted EBITDA of $3.54 billion, up 191%. Backlog stands at $47.50 billion, and CapEx ran $18.37 billion in the quarter.
The Broadcom Line Item D.E. Shaw held 2,722,161 Broadcom shares valued at $1,028,296,318 as of June 30, a share change of -3,805,547. The firm reduced but did not fully exit the position. The firm still owned more than a billion dollars of Broadcom at quarter end.
Broadcom’s Q2 FY2026 was strong on its face: revenue of $22.2 billion, up 48% year over year, with AI semiconductor revenue of $10.8 billion, up 143%. CEO Hock Tan called demand “insatiable” and guided Q3 AI semi revenue to $16 billion. But gross margin is compressing from 77.1% toward roughly 74% as the AI mix grows, and shares have fallen 8.13% in the past week even as they hold a 13.97% YTD gain. Polymarket assigns only a 21.5% probability that Q3 AI revenue exceeds $18 billion, implying the guide is largely priced in.
Should Retirement Investors Follow? D.E. Shaw is a quantitative, systematic, multi-strategy firm, and these are firm-level positions, not personal conviction picks by David E. Shaw. The firm also carries two-sided options exposure. Same filing: Microsoft (NASDAQ:MSFT) PUT positions of 1,446,200 shares valued $539,461,524. A single long equity line is not automatically a directional endorsement, and 13F data is reported roughly 45 days after quarter end. Positions may already have changed.
For a retirement-focused investor, the read is that a quant fund’s disclosed line item is thin evidence for a buy-and-hold decision. SPCX is a newly listed stock trading below its debut with a very short price history, and Broadcom’s setup rewards conviction on AI capex durability (we profiled seven suppliers riding that same buildout, from power to cooling, in a free report you can grab here). Weigh each on its own merits. This article is not investment advice.
Contact [email protected] for any questions or corrections.
Bank of New York Mellon Corp ve druhém čtvrtletí nakoupila nový podíl v Air Products and Chemicals za zhruba 495,201 mil. USD a vlastní 0,76 % společnosti. Akcie APD po otevření vzrostly o 1,7 %.
Bank of New York Mellon Corp bought a new stake in Air Products and Chemicals, Inc. (NYSE:APD – Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,689,067 shares of the basic materials company’s stock, valued at approximately $495,201,000. Bank of New York Mellon Corp owned approximately 0.76% of Air Products and Chemicals as of its most recent SEC filing.
Other hedge funds and other institutional investors have also modified their holdings of the company. Brighton Jones LLC lifted its holdings in Air Products and Chemicals by 14.5% in the 4th quarter. Brighton Jones LLC now owns 3,260 shares of the basic materials company’s stock worth $945,000 after purchasing an additional 412 shares during the last quarter. Bison Wealth LLC bought a new stake in Air Products and Chemicals during the fourth quarter valued at about $245,000. Sei Investments Co. grew its position in shares of Air Products and Chemicals by 197.6% in the second quarter. Sei Investments Co. now owns 281,861 shares of the basic materials company’s stock valued at $79,498,000 after purchasing an additional 187,142 shares during the last quarter. Treasurer of the State of North Carolina grew its position in shares of Air Products and Chemicals by 2.1% in the second quarter. Treasurer of the State of North Carolina now owns 103,777 shares of the basic materials company’s stock valued at $29,271,000 after purchasing an additional 2,171 shares during the last quarter. Finally, Diversify Advisory Services LLC increased its stake in shares of Air Products and Chemicals by 52.5% in the second quarter. Diversify Advisory Services LLC now owns 6,474 shares of the basic materials company’s stock worth $1,873,000 after purchasing an additional 2,229 shares during the period. Institutional investors and hedge funds own 81.66% of the company’s stock.
Analysts Set New Price Targets A number of brokerages recently issued reports on APD. UBS Group boosted their target price on shares of Air Products and Chemicals from $330.00 to $336.00 and gave the stock a “neutral” rating in a research report on Friday, July 31st. Wells Fargo & Company increased their price target on shares of Air Products and Chemicals from $340.00 to $350.00 and gave the company an “overweight” rating in a report on Friday, July 31st. Sanford C. Bernstein restated an “outperform” rating and set a $373.00 price objective on shares of Air Products and Chemicals in a report on Friday, July 31st. Citigroup upped their price target on Air Products and Chemicals from $315.00 to $330.00 and gave the company a “neutral” rating in a report on Friday, July 31st. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $320.00 price objective on shares of Air Products and Chemicals in a report on Monday, August 3rd. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, Air Products and Chemicals currently has an average rating of “Moderate Buy” and an average target price of $332.76.
Check Out Our Latest Stock Analysis on Air Products and Chemicals Air Products and Chemicals Trading Up 1.7% NYSE:APD opened at $305.55 on Friday. The company has a current ratio of 1.08, a quick ratio of 0.92 and a debt-to-equity ratio of 1.01. Air Products and Chemicals, Inc. has a 1-year low of $229.11 and a 1-year high of $314.87. The firm has a market capitalization of $68.04 billion, a price-to-earnings ratio of -1,388.86, a PEG ratio of 2.61 and a beta of 0.73. The business’s 50-day moving average price is $295.82 and its two-hundred day moving average price is $290.75.
Air Products and Chemicals (NYSE:APD – Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The basic materials company reported $3.47 earnings per share for the quarter, beating analysts’ consensus estimates of $3.34 by $0.13. The firm had revenue of $3.16 billion for the quarter, compared to analyst estimates of $3.20 billion. Air Products and Chemicals had a negative net margin of 0.38% and a positive return on equity of 16.87%. The business’s revenue was up 4.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $3.09 earnings per share. Air Products and Chemicals has set its FY 2026 guidance at 13.390-13.490 EPS and its Q4 2026 guidance at 3.550-3.650 EPS. On average, equities analysts expect that Air Products and Chemicals, Inc. will post 13.45 earnings per share for the current year.
Air Products and Chemicals Announces Dividend The company also recently announced a quarterly dividend, which will be paid on Monday, November 9th. Stockholders of record on Thursday, October 1st will be issued a $1.81 dividend. This represents a $7.24 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend is Thursday, October 1st. Air Products and Chemicals’s dividend payout ratio is presently -3,290.91%.
(Free Report)
Air Products and Chemicals, Inc is a global supplier of industrial gases and related equipment and services, headquartered in Allentown, Pennsylvania. The company produces and delivers atmospheric gases such as oxygen, nitrogen and argon, as well as specialty and process gases used across a wide range of industrial applications. Air Products designs, builds and operates gas production facilities, merchant distribution networks and on-site gas systems for customers that require reliable, high-purity gases and integrated supply solutions.
The company’s product and service portfolio includes packaged and bulk gas supply, pipeline distribution, on-site generation, gas handling and storage equipment, and engineered systems for gas liquefaction and purification.
Read More Five stocks we like better than Air Products and Chemicals Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding APD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Air Products and Chemicals, Inc. (NYSE:APD – Free Report).
Receive News & Ratings for Air Products and Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Air Products and Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.
Advisors Capital Management ve 2. čtvrtletí otevřela novou pozici v Illinois Tool Works a koupila 3 650 akcií za zhruba 987 000 USD. ITW zároveň oznámila zvýšení čtvrtletní dividendy na 1,72 USD na akcii.
Advisors Capital Management LLC bought a new position in shares of Illinois Tool Works Inc. (NYSE:ITW – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 3,650 shares of the industrial products company’s stock, valued at approximately $987,000.
A number of other large investors have also recently modified their holdings of ITW. Vanguard Group Inc. raised its holdings in shares of Illinois Tool Works by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 26,887,218 shares of the industrial products company’s stock worth $6,622,322,000 after buying an additional 189,229 shares in the last quarter. BlackRock Inc. bought a new position in Illinois Tool Works in the second quarter valued at about $6,296,349,000. State Street Corp raised its stake in Illinois Tool Works by 1.2% during the fourth quarter. State Street Corp now owns 12,596,511 shares of the industrial products company’s stock worth $3,122,535,000 after acquiring an additional 151,864 shares in the last quarter. Geode Capital Management LLC raised its stake in Illinois Tool Works by 2.7% during the fourth quarter. Geode Capital Management LLC now owns 6,944,651 shares of the industrial products company’s stock worth $1,709,734,000 after acquiring an additional 184,301 shares in the last quarter. Finally, Capital Research Global Investors boosted its stake in shares of Illinois Tool Works by 3.2% in the 4th quarter. Capital Research Global Investors now owns 4,636,392 shares of the industrial products company’s stock valued at $1,141,948,000 after purchasing an additional 142,837 shares in the last quarter. Institutional investors and hedge funds own 79.77% of the company’s stock.
Insider Activity In related news, CAO Matteo C. Pigozzo sold 277 shares of the business’s stock in a transaction on Thursday, August 13th. The shares were sold at an average price of $289.22, for a total value of $80,113.94. Following the transaction, the chief accounting officer owned 3,394 shares in the company, valued at $981,612.68. The trade was a 7.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Jennifer F. Scanlon purchased 806 shares of the business’s stock in a transaction on Tuesday, June 2nd. The shares were purchased at an average cost of $247.99 per share, for a total transaction of $199,879.94. Following the transaction, the director directly owned 1,652 shares of the company’s stock, valued at approximately $409,679.48. The trade was a 95.27% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 0.83% of the company’s stock.
Illinois Tool Works Stock Performance NYSE ITW opened at $282.23 on Friday. The company has a market capitalization of $80.38 billion, a price-to-earnings ratio of 25.59, a PEG ratio of 4.78 and a beta of 0.99. Illinois Tool Works Inc. has a twelve month low of $238.82 and a twelve month high of $303.15. The stock has a fifty day simple moving average of $278.00 and a 200 day simple moving average of $271.50. The company has a quick ratio of 0.81, a current ratio of 1.11 and a debt-to-equity ratio of 2.26. Illinois Tool Works (NYSE:ITW – Get Free Report) last issued its quarterly earnings results on Tuesday, July 28th. The industrial products company reported $2.84 earnings per share for the quarter, beating the consensus estimate of $2.80 by $0.04. The company had revenue of $4.30 billion during the quarter, compared to analysts’ expectations of $4.19 billion. Illinois Tool Works had a return on equity of 101.72% and a net margin of 19.39%.The business’s quarterly revenue was up 6.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.58 earnings per share. Illinois Tool Works has set its FY 2026 guidance at 11.350-11.550 EPS. Sell-side analysts expect that Illinois Tool Works Inc. will post 11.45 EPS for the current year.
Illinois Tool Works Increases Dividend The company also recently declared a quarterly dividend, which will be paid on Friday, October 9th. Stockholders of record on Wednesday, September 30th will be given a $1.72 dividend. This is an increase from Illinois Tool Works’s previous quarterly dividend of $1.61. The ex-dividend date is Wednesday, September 30th. This represents a $6.88 dividend on an annualized basis and a dividend yield of 2.4%. Illinois Tool Works’s dividend payout ratio is presently 58.39%.
Analysts Set New Price Targets A number of research firms recently issued reports on ITW. The Goldman Sachs Group reiterated a “sell” rating and set a $254.00 price objective on shares of Illinois Tool Works in a research report on Thursday, April 30th. UBS Group restated a “neutral” rating and issued a $300.00 target price on shares of Illinois Tool Works in a research report on Wednesday, July 29th. Truist Financial boosted their target price on shares of Illinois Tool Works from $280.00 to $301.00 and gave the stock a “hold” rating in a research note on Thursday, July 2nd. Evercore dropped their price target on Illinois Tool Works from $296.00 to $272.00 in a research note on Monday, May 11th. Finally, JPMorgan Chase & Co. raised their price objective on Illinois Tool Works from $310.00 to $350.00 and gave the company an “overweight” rating in a report on Wednesday, July 29th. Two investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and five have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Reduce” and an average target price of $281.25.
Read Our Latest Report on Illinois Tool Works
(Free Report)
Illinois Tool Works Inc (ITW) is a diversified industrial manufacturer that designs and produces a broad array of engineered products, consumables and related service solutions for industrial customers. Its offerings span engineered fastening systems, specialty components, industrial equipment, welding products, foodservice and packaging equipment, adhesives and polymer products, and test-and-measurement technologies. These products are used as critical inputs by customers across automotive, construction, electronics, foodservice, maintenance and other industrial end markets.
The company operates a decentralized business model in which independently managed businesses focus on niche product lines and close customer relationships.
Featured Articles Five stocks we like better than Illinois Tool Works Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Illinois Tool Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illinois Tool Works and related companies with MarketBeat.com's FREE daily email newsletter.
BlackRock ve 2. čtvrtletí koupil novou pozici ve Stag Industrial za zhruba 1,10 miliardy USD a drží asi 14,95 % firmy. Stag Industrial zároveň oznámil čtvrtletní dividendu 0,3875 USD na akcii.
BlackRock Inc. purchased a new position in Stag Industrial, Inc. (NYSE:STAG – Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 28,826,227 shares of the real estate investment trust’s stock, valued at approximately $1,097,126,000. BlackRock Inc. owned approximately 14.95% of Stag Industrial as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC lifted its position in shares of Stag Industrial by 22.0% during the 1st quarter. EverSource Wealth Advisors LLC now owns 1,583 shares of the real estate investment trust’s stock worth $57,000 after buying an additional 285 shares in the last quarter. Mercer Global Advisors Inc. ADV boosted its position in Stag Industrial by 1.2% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 30,515 shares of the real estate investment trust’s stock worth $1,122,000 after purchasing an additional 367 shares during the last quarter. First National Trust Co boosted its position in Stag Industrial by 1.7% in the fourth quarter. First National Trust Co now owns 23,166 shares of the real estate investment trust’s stock worth $852,000 after purchasing an additional 388 shares during the last quarter. Root Financial Partners LLC grew its stake in Stag Industrial by 32.9% in the 4th quarter. Root Financial Partners LLC now owns 1,603 shares of the real estate investment trust’s stock valued at $59,000 after purchasing an additional 397 shares during the period. Finally, Gamco Investors INC. ET AL grew its stake in Stag Industrial by 1.4% in the 1st quarter. Gamco Investors INC. ET AL now owns 30,042 shares of the real estate investment trust’s stock valued at $1,083,000 after purchasing an additional 402 shares during the period. Institutional investors and hedge funds own 88.67% of the company’s stock.
Stag Industrial Price Performance Shares of Stag Industrial stock opened at $36.68 on Friday. The company’s fifty day simple moving average is $38.66 and its two-hundred day simple moving average is $38.33. Stag Industrial, Inc. has a 12-month low of $34.40 and a 12-month high of $42.61. The firm has a market cap of $7.07 billion, a PE ratio of 28.22 and a beta of 0.96. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.93.
Stag Industrial (NYSE:STAG – Get Free Report) last released its quarterly earnings results on Tuesday, July 28th. The real estate investment trust reported $0.28 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.37). Stag Industrial had a return on equity of 6.79% and a net margin of 28.04%.The company had revenue of $224.37 million during the quarter, compared to the consensus estimate of $223.04 million. During the same period in the previous year, the company earned $0.63 earnings per share. Stag Industrial’s quarterly revenue was up 8.1% on a year-over-year basis. As a group, equities analysts expect that Stag Industrial, Inc. will post 2.63 EPS for the current year. Stag Industrial Dividend Announcement The business also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Wednesday, September 30th will be paid a $0.3875 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $1.55 dividend on an annualized basis and a dividend yield of 4.2%. Stag Industrial’s payout ratio is currently 119.23%.
Wall Street Analysts Forecast Growth A number of research firms have weighed in on STAG. Weiss Ratings reiterated a “buy (b-)” rating on shares of Stag Industrial in a research note on Friday, July 31st. Robert W. Baird set a $138.00 price target on shares of Stag Industrial in a research note on Friday, July 31st. Wall Street Zen upgraded Stag Industrial from a “sell” rating to a “hold” rating in a research note on Sunday, August 16th. Evercore reissued an “outperform” rating and set a $44.00 price objective on shares of Stag Industrial in a report on Wednesday, April 29th. Finally, Barclays increased their price target on Stag Industrial from $38.00 to $41.00 and gave the stock an “underweight” rating in a research note on Thursday, July 16th. Three analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Stag Industrial has a consensus rating of “Hold” and an average target price of $50.50.
View Our Latest Analysis on Stag Industrial
(Free Report)
Stag Industrial, Inc is a real estate investment trust (REIT) that specializes in the acquisition, ownership and operation of single-tenant industrial properties throughout the United States. The company’s portfolio is focused on free-standing warehouses, distribution centers and light manufacturing facilities designed to meet the logistical needs of a diverse tenant base. By concentrating on properties with straightforward layouts and minimal common-area maintenance, Stag Industrial seeks to deliver stable rental income and attractive risk-adjusted returns for its shareholders.
Since its founding in 2010 and initial public offering in 2011, Stag Industrial has pursued a disciplined investment strategy centered on high-quality, well-located assets.
Featured Stories Five stocks we like better than Stag Industrial Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding STAG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stag Industrial, Inc. (NYSE:STAG – Free Report).
Receive News & Ratings for Stag Industrial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stag Industrial and related companies with MarketBeat.com's FREE daily email newsletter.
Advisors Capital Management získala novou pozici v Booking Holdings za zhruba 559 000 USD. Firma zároveň oznámila čtvrtletní EPS 2,54 USD a tržby 7,35 miliardy USD.
Advisors Capital Management LLC purchased a new position in Booking Holdings Inc. (NASDAQ:BKNG – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 3,135 shares of the business services provider’s stock, valued at approximately $559,000.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new stake in shares of Booking during the 2nd quarter valued at about $11,646,302,000. Deutsche Bank AG bought a new stake in shares of Booking during the second quarter valued at approximately $1,691,186,000. Bank of New York Mellon Corp purchased a new stake in Booking in the 2nd quarter worth $1,370,455,000. J. Stern & Co. LLP lifted its stake in Booking by 191,965.8% in the 4th quarter. J. Stern & Co. LLP now owns 2,832,970 shares of the business services provider’s stock worth $15,171,489,000 after purchasing an additional 2,831,495 shares in the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of Booking during the 2nd quarter valued at about $472,723,000. Institutional investors own 92.42% of the company’s stock.
Wall Street Analysts Forecast Growth Several brokerages recently commented on BKNG. B. Riley Financial reiterated a “buy” rating and set a $274.00 price target (up from $264.00) on shares of Booking in a report on Wednesday, August 5th. The Goldman Sachs Group set a $215.00 target price on Booking and gave the stock a “neutral” rating in a research note on Monday, July 20th. Sanford C. Bernstein reiterated a “market perform” rating on shares of Booking in a research report on Thursday, June 11th. DA Davidson set a $240.00 price target on shares of Booking in a report on Thursday, August 6th. Finally, Gordon Haskett upped their price target on shares of Booking from $217.00 to $220.00 and gave the stock a “buy” rating in a research report on Thursday, April 30th. One research analyst has rated the stock with a Strong Buy rating, twenty-seven have issued a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $235.72.
Check Out Our Latest Research Report on Booking Booking Trading Down 0.1% Shares of NASDAQ:BKNG opened at $209.62 on Friday. Booking Holdings Inc. has a twelve month low of $150.14 and a twelve month high of $231.80. The company’s 50 day moving average is $188.60 and its 200 day moving average is $177.19. The company has a market cap of $157.50 billion, a PE ratio of 23.20, a price-to-earnings-growth ratio of 1.27 and a beta of 1.07.
Booking (NASDAQ:BKNG – Get Free Report) last announced its quarterly earnings data on Monday, August 3rd. The business services provider reported $2.54 EPS for the quarter, beating the consensus estimate of $2.43 by $0.11. The business had revenue of $7.35 billion during the quarter, compared to analysts’ expectations of $7.19 billion. Booking had a net margin of 25.53% and a negative return on equity of 102.96%. The business’s quarterly revenue was up 8.1% compared to the same quarter last year. During the same period in the previous year, the business posted $55.40 EPS. Equities research analysts predict that Booking Holdings Inc. will post 10.47 earnings per share for the current fiscal year.
Booking Announces Dividend The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Friday, September 11th will be given a dividend of $0.42 per share. This represents a $1.68 annualized dividend and a yield of 0.8%. The ex-dividend date is Friday, September 11th. Booking’s dividend payout ratio (DPR) is currently 18.58%.
Insider Buying and Selling In other news, Director Vanessa Ames Wittman sold 1,125 shares of the firm’s stock in a transaction that occurred on Tuesday, July 28th. The shares were sold at an average price of $192.00, for a total transaction of $216,000.00. Following the sale, the director owned 16,508 shares of the company’s stock, valued at $3,169,536. This trade represents a 6.38% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Peter J. Millones sold 62,500 shares of Booking stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $163.67, for a total transaction of $10,229,375.00. Following the transaction, the vice president directly owned 425,075 shares of the company’s stock, valued at approximately $69,572,025.25. This trade represents a 12.82% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 140,050 shares of company stock valued at $26,341,680. Insiders own 0.17% of the company’s stock.
Booking Company Profile (Free Report)
Booking Holdings Inc is a global online travel company that operates a portfolio of consumer brands and technology platforms that facilitate the search for and booking of travel services. The company’s businesses focus on accommodations, transportation and related travel services through consumer-facing websites and apps as well as partner distribution channels. Booking Holdings was originally founded as Priceline in the late 1990s and adopted the Booking Holdings name in 2018; it is headquartered in Norwalk, Connecticut.
Its core offerings include online reservations for hotels, vacation rentals and other lodging; flight and car rental search and booking; and ancillary services that support travel planning and on-property experiences.
Read More Five stocks we like better than Booking Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding BKNG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Booking Holdings Inc. (NASDAQ:BKNG – Free Report).
Receive News & Ratings for Booking Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Booking and related companies with MarketBeat.com's FREE daily email newsletter.
B. Metzler seel. Sohn & Co. AG acquired a new position in shares of Autodesk, Inc. (NASDAQ:ADSK – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 32,166 shares of the software company’s stock, valued at approximately $6,254,000.
A number of other large investors have also made changes to their positions in the stock. Torren Management LLC bought a new position in shares of Autodesk in the fourth quarter valued at approximately $25,000. Measured Wealth Private Client Group LLC acquired a new position in shares of Autodesk in the 3rd quarter worth approximately $25,000. Kemnay Advisory Services Inc. bought a new stake in Autodesk during the 4th quarter worth approximately $25,000. Archer Investment Corp grew its position in Autodesk by 112.2% during the 4th quarter. Archer Investment Corp now owns 87 shares of the software company’s stock worth $26,000 after acquiring an additional 46 shares during the last quarter. Finally, Prosperity Bancshares Inc acquired a new stake in Autodesk during the 4th quarter valued at $27,000. Institutional investors and hedge funds own 90.24% of the company’s stock.
Autodesk Stock Up 1.1% Shares of NASDAQ ADSK opened at $253.82 on Friday. The stock has a market capitalization of $53.56 billion, a P/E ratio of 37.00, a PEG ratio of 1.54 and a beta of 1.29. The stock’s fifty day moving average is $219.71 and its 200 day moving average is $231.77. Autodesk, Inc. has a 52 week low of $185.50 and a 52 week high of $329.09. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.83 and a current ratio of 0.83.
Autodesk (NASDAQ:ADSK – Get Free Report) last posted its earnings results on Thursday, May 28th. The software company reported $2.99 earnings per share for the quarter, topping analysts’ consensus estimates of $2.84 by $0.15. Autodesk had a net margin of 19.49% and a return on equity of 57.14%. The firm had revenue of $1.93 billion for the quarter, compared to analysts’ expectations of $1.89 billion. During the same quarter in the previous year, the firm posted $2.29 earnings per share. The company’s revenue was up 18.4% on a year-over-year basis. Autodesk has set its FY 2027 guidance at 12.400-12.650 EPS and its Q2 2027 guidance at 3.100-3.140 EPS. Sell-side analysts forecast that Autodesk, Inc. will post 9.7 earnings per share for the current fiscal year. Insider Transactions at Autodesk In other Autodesk news, Director John T. Cahill acquired 2,000 shares of Autodesk stock in a transaction on Tuesday, June 23rd. The stock was purchased at an average price of $189.20 per share, for a total transaction of $378,400.00. Following the purchase, the director directly owned 4,000 shares of the company’s stock, valued at $756,800. This trade represents a 100.00% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Janesh Moorjani purchased 2,500 shares of the business’s stock in a transaction dated Monday, June 15th. The shares were purchased at an average price of $197.67 per share, with a total value of $494,175.00. Following the purchase, the executive vice president directly owned 50,993 shares in the company, valued at $10,079,786.31. This trade represents a 5.16% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders bought a total of 7,935 shares of company stock worth $1,666,644 in the last quarter. 0.14% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets Several equities analysts have recently issued reports on ADSK shares. BNP Paribas Exane started coverage on Autodesk in a research note on Thursday, June 18th. They set an “outperform” rating and a $295.00 price target on the stock. Bank of America reissued a “buy” rating and set a $300.00 price objective on shares of Autodesk in a report on Tuesday, May 12th. DA Davidson restated a “buy” rating and set a $325.00 target price on shares of Autodesk in a research report on Friday, May 29th. Zacks Research cut shares of Autodesk from a “strong-buy” rating to a “hold” rating in a research report on Thursday, May 14th. Finally, BTIG Research restated a “buy” rating and issued a $300.00 price objective on shares of Autodesk in a report on Friday, May 29th. Two analysts have rated the stock with a Strong Buy rating, twenty-four have issued a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $321.65.
Get Our Latest Stock Analysis on ADSK
Autodesk Profile (Free Report)
Autodesk, Inc (NASDAQ: ADSK) is a software company that develops design and creation tools for the architecture, engineering and construction (AEC), manufacturing, and media and entertainment industries. Headquartered in San Rafael, California, the company was founded in 1982 and is best known for pioneering CAD (computer-aided design) software. Autodesk sells products and services to a global customer base, including architects, engineers, contractors, product designers, and content creators.
The company’s product portfolio includes industry-standard design and modeling applications such as AutoCAD, Revit, Inventor, Fusion 360, Maya and 3ds Max, as well as cloud-based collaboration and project management platforms like BIM 360 and Autodesk Construction Cloud.
See Also Five stocks we like better than Autodesk Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding ADSK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Autodesk, Inc. (NASDAQ:ADSK – Free Report).
Receive News & Ratings for Autodesk Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autodesk and related companies with MarketBeat.com's FREE daily email newsletter.
Bank of New York Mellon Corp acquired a new position in Nucor Corporation (NYSE:NUE – Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,485,531 shares of the basic materials company’s stock, valued at approximately $330,902,000. Bank of New York Mellon Corp owned about 0.65% of Nucor at the end of the most recent quarter.
Several other large investors have also modified their holdings of the company. Strive Financial Group LLC bought a new stake in Nucor in the 4th quarter valued at $27,000. Stance Capital LLC acquired a new stake in Nucor during the third quarter worth about $25,000. Bartlett & CO. Wealth Management LLC increased its stake in Nucor by 49.2% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 191 shares of the basic materials company’s stock valued at $32,000 after acquiring an additional 63 shares during the period. Mcguire Capital Advisors Inc. bought a new position in Nucor during the fourth quarter valued at about $32,000. Finally, Motiv8 Investments LLC acquired a new position in Nucor in the 4th quarter valued at approximately $32,000. 76.48% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth Several analysts have recently weighed in on the company. Wall Street Zen raised Nucor from a “buy” rating to a “strong-buy” rating in a report on Saturday, May 16th. BNP Paribas Exane upped their price objective on Nucor from $210.00 to $248.00 and gave the company an “outperform” rating in a research note on Monday, May 4th. Morgan Stanley set a $270.00 price objective on Nucor in a research note on Wednesday, July 29th. Jefferies Financial Group upped their price objective on Nucor from $225.00 to $250.00 and gave the company a “buy” rating in a report on Tuesday, April 28th. Finally, JPMorgan Chase & Co. upped their price target on shares of Nucor from $240.00 to $282.00 and gave the company an “overweight” rating in a report on Wednesday, June 10th. Twelve equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, Nucor currently has a consensus rating of “Moderate Buy” and a consensus price target of $273.31.
Check Out Our Latest Report on Nucor Nucor Trading Up 1.4% Shares of NYSE NUE opened at $243.89 on Friday. The stock has a market cap of $55.33 billion, a P/E ratio of 19.45, a price-to-earnings-growth ratio of 0.89 and a beta of 1.89. The firm has a 50 day moving average price of $246.88 and a two-hundred day moving average price of $216.80. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.36 and a current ratio of 2.51. Nucor Corporation has a 52-week low of $131.32 and a 52-week high of $280.11.
Nucor (NYSE:NUE – Get Free Report) last issued its earnings results on Monday, July 27th. The basic materials company reported $4.84 earnings per share for the quarter, topping analysts’ consensus estimates of $4.46 by $0.38. Nucor had a return on equity of 12.73% and a net margin of 7.99%.The business had revenue of $10.40 billion during the quarter, compared to the consensus estimate of $10.15 billion. During the same period in the previous year, the company posted $2.60 earnings per share. The firm’s revenue for the quarter was up 23.0% on a year-over-year basis. As a group, equities analysts forecast that Nucor Corporation will post 17.95 EPS for the current year.
Nucor Dividend Announcement The company also recently disclosed a quarterly dividend, which was paid on Tuesday, August 11th. Investors of record on Tuesday, June 30th were paid a dividend of $0.56 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $2.24 annualized dividend and a yield of 0.9%. Nucor’s payout ratio is currently 17.86%.
Insider Activity In related news, EVP John J. Hollatz sold 10,560 shares of the stock in a transaction dated Wednesday, June 3rd. The shares were sold at an average price of $258.46, for a total value of $2,729,337.60. Following the completion of the transaction, the executive vice president directly owned 97,865 shares of the company’s stock, valued at $25,294,187.90. This represents a 9.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, COO Stephen D. Laxton sold 3,968 shares of Nucor stock in a transaction on Thursday, July 30th. The shares were sold at an average price of $256.96, for a total value of $1,019,617.28. Following the transaction, the chief operating officer owned 77,867 shares of the company’s stock, valued at $20,008,704.32. The trade was a 4.85% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 18,528 shares of company stock worth $4,793,035. 0.62% of the stock is currently owned by insiders.
Nucor Company Profile (Free Report)
Nucor Corporation (NYSE: NUE) is an American steel producer headquartered in Charlotte, North Carolina. The company is primarily engaged in the manufacture and sale of steel and steel products, operating a network of steel mills, recycling facilities and fabrication plants across the United States and North America. Nucor’s operations emphasize electric arc furnace steelmaking using recycled scrap metal, which supports a decentralized, mill-based production model focused on efficiency and flexibility.
Product offerings span a broad range of basic and value‑added steel items, including sheet, plate, merchant bar, structural beams, reinforcing bar, tubing, fasteners and fabricated components.
Recommended Stories Five stocks we like better than Nucor Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Nucor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nucor and related companies with MarketBeat.com's FREE daily email newsletter.
B. Metzler seel. Sohn & Co. AG bought a new position in Southern Copper Corporation (NYSE:SCCO – Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm bought 30,217 shares of the basic materials company’s stock, valued at approximately $5,266,000.
A number of other hedge funds have also recently modified their holdings of the company. BlackRock Inc. purchased a new position in shares of Southern Copper during the 2nd quarter worth approximately $1,729,500,000. Bank of New York Mellon Corp acquired a new stake in Southern Copper in the second quarter valued at approximately $696,621,000. State Street Corp grew its holdings in Southern Copper by 2.4% during the 4th quarter. State Street Corp now owns 2,862,244 shares of the basic materials company’s stock worth $410,646,000 after acquiring an additional 66,268 shares in the last quarter. Fisher Asset Management LLC grew its holdings in Southern Copper by 0.3% during the 4th quarter. Fisher Asset Management LLC now owns 2,536,228 shares of the basic materials company’s stock worth $363,873,000 after acquiring an additional 7,194 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Southern Copper by 8.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,181,293 shares of the basic materials company’s stock valued at $169,480,000 after purchasing an additional 90,237 shares during the last quarter. Hedge funds and other institutional investors own 7.94% of the company’s stock.
Wall Street Analysts Forecast Growth Several equities analysts have commented on SCCO shares. Weiss Ratings upgraded shares of Southern Copper from a “buy (b-)” rating to a “buy (b)” rating in a research note on Tuesday, July 28th. UBS Group restated a “sell” rating and issued a $158.10 target price (up from $143.28) on shares of Southern Copper in a report on Tuesday, June 30th. Morgan Stanley lifted their price target on shares of Southern Copper from $144.27 to $156.13 and gave the stock an “underweight” rating in a research note on Wednesday, July 8th. Barclays set a $164.03 price target on shares of Southern Copper and gave the company an “underweight” rating in a research report on Thursday, July 23rd. Finally, Wall Street Zen downgraded shares of Southern Copper from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Three research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and seven have given a Sell rating to the stock. According to MarketBeat, Southern Copper currently has an average rating of “Reduce” and a consensus target price of $146.84.
Check Out Our Latest Analysis on Southern Copper Southern Copper Stock Performance NYSE SCCO opened at $216.30 on Friday. Southern Copper Corporation has a twelve month low of $92.94 and a twelve month high of $223.88. The business’s 50-day moving average price is $182.23 and its 200 day moving average price is $183.20. The company has a market capitalization of $180.47 billion, a PE ratio of 31.62, a price-to-earnings-growth ratio of 1.70 and a beta of 1.11. The company has a current ratio of 5.06, a quick ratio of 4.56 and a debt-to-equity ratio of 0.63.
Southern Copper (NYSE:SCCO – Get Free Report) last issued its quarterly earnings data on Wednesday, July 22nd. The basic materials company reported $1.99 EPS for the quarter, topping analysts’ consensus estimates of $1.93 by $0.06. Southern Copper had a net margin of 35.87% and a return on equity of 49.04%. The firm had revenue of $4.29 billion for the quarter, compared to analyst estimates of $4.37 billion. The company’s quarterly revenue was up 40.6% compared to the same quarter last year. On average, research analysts predict that Southern Copper Corporation will post 7.61 earnings per share for the current year.
Southern Copper Increases Dividend The business also recently announced a quarterly dividend, which will be paid on Thursday, August 27th. Investors of record on Tuesday, August 11th will be given a $1.10 dividend. The ex-dividend date is Tuesday, August 11th. This represents a $4.40 dividend on an annualized basis and a yield of 2.0%. This is a boost from Southern Copper’s previous quarterly dividend of $1.00. Southern Copper’s payout ratio is currently 64.33%.
Insider Buying and Selling In related news, Director Bonilla Luis Miguel Palomino sold 202 shares of the firm’s stock in a transaction dated Wednesday, August 5th. The stock was sold at an average price of $196.79, for a total transaction of $39,751.28. Following the completion of the transaction, the director owned 1,723 shares of the company’s stock, valued at $339,066.65. This trade represents a 10.49% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Over the last 90 days, insiders have sold 509 shares of company stock worth $97,753. 0.07% of the stock is currently owned by company insiders.
(Free Report)
Southern Copper Corporation (NYSE: SCCO) is a large, integrated copper producer whose operations span the full value chain from exploration and mining to smelting, refining and the sale of copper and other metal products. The company produces a range of copper products including copper concentrate and refined cathodes, and recovers valuable byproducts such as molybdenum, silver and zinc. Southern Copper concentrates on high-volume, long-life assets designed to support steady production and processing capabilities.
Southern Copper’s operations are concentrated in Peru and Mexico, where it owns and operates multiple large-scale mining and processing facilities.
Featured Articles Five stocks we like better than Southern Copper Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Southern Copper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Southern Copper and related companies with MarketBeat.com's FREE daily email newsletter.
Bank of New York Mellon Corp bought a new stake in Public Storage (NYSE:PSA – Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,010,960 shares of the real estate investment trust’s stock, valued at approximately $321,799,000. Bank of New York Mellon Corp owned about 0.58% of Public Storage as of its most recent SEC filing.
Other hedge funds have also recently bought and sold shares of the company. Norges Bank acquired a new position in Public Storage during the fourth quarter valued at approximately $1,163,751,000. Capital International Investors boosted its position in shares of Public Storage by 821.4% in the fourth quarter. Capital International Investors now owns 4,134,996 shares of the real estate investment trust’s stock valued at $1,073,032,000 after acquiring an additional 3,686,211 shares during the period. Vanguard Group Inc. boosted its position in shares of Public Storage by 9.9% in the fourth quarter. Vanguard Group Inc. now owns 25,343,098 shares of the real estate investment trust’s stock valued at $6,576,534,000 after acquiring an additional 2,274,397 shares during the period. First Trust Advisors LP grew its stake in shares of Public Storage by 287.7% in the fourth quarter. First Trust Advisors LP now owns 721,588 shares of the real estate investment trust’s stock worth $187,252,000 after acquiring an additional 535,465 shares during the last quarter. Finally, AQR Capital Management LLC grew its stake in shares of Public Storage by 498.7% in the second quarter. AQR Capital Management LLC now owns 578,491 shares of the real estate investment trust’s stock worth $166,970,000 after acquiring an additional 481,872 shares during the last quarter. 78.79% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes A number of research firms recently weighed in on PSA. The Goldman Sachs Group reissued a “buy” rating and set a $341.00 target price on shares of Public Storage in a research report on Wednesday, April 29th. BNP Paribas Exane boosted their price objective on Public Storage from $331.00 to $335.00 and gave the company an “outperform” rating in a research report on Friday, May 22nd. Scotiabank upped their target price on Public Storage from $345.00 to $346.00 and gave the company an “outperform” rating in a research note on Tuesday. Weiss Ratings upgraded shares of Public Storage from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, June 12th. Finally, Raymond James Financial assumed coverage on shares of Public Storage in a research note on Thursday, July 16th. They issued a “market perform” rating on the stock. Seven equities research analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $326.16.
View Our Latest Research Report on Public Storage Insider Buying and Selling at Public Storage In related news, insider Nathaniel A. Vitan sold 1,414 shares of the stock in a transaction that occurred on Thursday, August 13th. The shares were sold at an average price of $327.53, for a total value of $463,127.42. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 11.10% of the stock is currently owned by company insiders.
Public Storage Trading Up 0.0% PSA opened at $322.76 on Friday. The company has a current ratio of 0.66, a quick ratio of 0.66 and a debt-to-equity ratio of 2.06. The stock has a market capitalization of $56.68 billion, a PE ratio of 30.80, a PEG ratio of 3.80 and a beta of 0.96. Public Storage has a 1-year low of $256.54 and a 1-year high of $335.55. The firm has a 50-day moving average price of $322.35 and a two-hundred day moving average price of $306.22.
Public Storage (NYSE:PSA – Get Free Report) last announced its earnings results on Wednesday, July 29th. The real estate investment trust reported $4.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.53 by $1.64. The company had revenue of $1.23 billion for the quarter, compared to analyst estimates of $1.23 billion. Public Storage had a net margin of 41.80% and a return on equity of 40.98%. Public Storage’s quarterly revenue was down .5% on a year-over-year basis. During the same period in the prior year, the business earned $4.28 earnings per share. Public Storage has set its FY 2026 guidance at 16.750-17.050 EPS. As a group, equities analysts anticipate that Public Storage will post 16.93 earnings per share for the current fiscal year.
Public Storage Announces Dividend The firm also recently announced a quarterly dividend, which will be paid on Tuesday, October 6th. Shareholders of record on Tuesday, September 15th will be given a dividend of $3.00 per share. The ex-dividend date is Tuesday, September 15th. This represents a $12.00 dividend on an annualized basis and a yield of 3.7%. Public Storage’s dividend payout ratio is presently 114.50%.
Public Storage Company Profile (Free Report)
Public Storage (NYSE: PSA) is a real estate investment trust (REIT) that specializes in self-storage services. Headquartered in Glendale, California, the company was founded in the early 1970s and has grown through development and acquisitions to become one of the largest owner-operators of self-storage facilities in the United States. It is publicly traded on the New York Stock Exchange under the ticker PSA.
The company’s core business is the ownership, operation and management of self-storage properties that serve both residential and commercial customers.
Featured Stories Five stocks we like better than Public Storage Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Public Storage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Public Storage and related companies with MarketBeat.com's FREE daily email newsletter.
B. Metzler seel. Sohn & Co. AG ve 2. čtvrtletí nově koupila 186 155 akcií Gen Digital za zhruba 4,633 milionu USD. Akcie Gen Digital po otevření vzrostly o 2,7 %.
B. Metzler seel. Sohn & Co. AG acquired a new position in shares of Gen Digital Inc. (NASDAQ:GEN – Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 186,155 shares of the company’s stock, valued at approximately $4,633,000.
Other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. lifted its position in shares of Gen Digital by 1.5% during the 4th quarter. Vanguard Group Inc. now owns 73,310,110 shares of the company’s stock worth $1,993,302,000 after buying an additional 1,096,313 shares during the period. State Street Corp lifted its holdings in shares of Gen Digital by 3.4% during the third quarter. State Street Corp now owns 30,558,806 shares of the company’s stock valued at $867,565,000 after acquiring an additional 1,015,755 shares during the period. Ameriprise Financial Inc. boosted its stake in shares of Gen Digital by 6.7% in the 2nd quarter. Ameriprise Financial Inc. now owns 22,473,917 shares of the company’s stock valued at $660,730,000 after purchasing an additional 1,406,869 shares in the last quarter. First Trust Advisors LP boosted its stake in shares of Gen Digital by 22.3% in the 4th quarter. First Trust Advisors LP now owns 19,941,546 shares of the company’s stock valued at $542,211,000 after purchasing an additional 3,640,451 shares in the last quarter. Finally, Boston Partners grew its holdings in shares of Gen Digital by 14.3% in the 4th quarter. Boston Partners now owns 15,644,289 shares of the company’s stock worth $425,336,000 after purchasing an additional 1,954,712 shares during the last quarter. 81.38% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In Several equities analysts have issued reports on the company. Royal Bank Of Canada lifted their price objective on Gen Digital from $27.00 to $30.00 and gave the company a “sector perform” rating in a research report on Friday, August 7th. Argus upgraded shares of Gen Digital to a “strong-buy” rating in a research report on Friday, May 22nd. Barclays boosted their price objective on shares of Gen Digital from $27.00 to $32.00 and gave the stock an “equal weight” rating in a research report on Friday, August 7th. Weiss Ratings raised Gen Digital from a “hold (c)” rating to a “hold (c+)” rating in a report on Wednesday, July 15th. Finally, Wells Fargo & Company increased their price objective on Gen Digital from $22.00 to $28.00 and gave the company an “equal weight” rating in a research report on Friday, August 7th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $31.67.
View Our Latest Analysis on GEN Gen Digital Stock Up 2.7% Shares of Gen Digital stock opened at $28.93 on Friday. The company has a market capitalization of $17.32 billion, a P/E ratio of 16.82 and a beta of 1.21. The company has a debt-to-equity ratio of 3.00, a current ratio of 0.47 and a quick ratio of 0.47. The business has a 50-day moving average of $26.49 and a two-hundred day moving average of $23.57. Gen Digital Inc. has a 1 year low of $17.78 and a 1 year high of $31.88.
Gen Digital (NASDAQ:GEN – Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.71 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.02. The business had revenue of $1.34 billion for the quarter, compared to analysts’ expectations of $1.31 billion. Gen Digital had a return on equity of 55.93% and a net margin of 20.73%.Gen Digital’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.64 EPS. Gen Digital has set its FY 2027 guidance at 2.870-2.970 EPS and its Q2 2027 guidance at 0.710-0.730 EPS. As a group, equities analysts predict that Gen Digital Inc. will post 2.64 EPS for the current year.
Gen Digital Dividend Announcement The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 9th. Stockholders of record on Monday, August 17th will be paid a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a dividend yield of 1.7%. The ex-dividend date of this dividend is Monday, August 17th. Gen Digital’s dividend payout ratio (DPR) is currently 29.07%.
Insider Transactions at Gen Digital In other news, Director Ondrej Vlcek sold 100,000 shares of Gen Digital stock in a transaction that occurred on Wednesday, June 10th. The shares were sold at an average price of $24.78, for a total value of $2,478,000.00. Following the sale, the director directly owned 3,832,724 shares in the company, valued at $94,974,900.72. This trade represents a 2.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director John C. Chrystal acquired 3,000 shares of the business’s stock in a transaction dated Thursday, June 4th. The stock was acquired at an average cost of $27.06 per share, for a total transaction of $81,180.00. Following the transaction, the director owned 31,419 shares of the company’s stock, valued at $850,198.14. This represents a 10.56% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders sold 230,440 shares of company stock valued at $6,172,946 in the last ninety days. 9.70% of the stock is currently owned by corporate insiders.
Gen Digital Company Profile (Free Report)
Gen Digital (NASDAQ: GEN) is a global cybersecurity company specializing in consumer- and small-business-focused security, privacy, and identity protection solutions. The company offers a suite of products designed to safeguard devices, networks, and personal information against malware, ransomware, phishing attacks and other digital threats. With a focus on user-friendly interfaces and cross-platform compatibility, Gen Digital develops antivirus software, VPN services, parental controls, password management tools, and comprehensive identity-theft monitoring services.
Gen Digital traces its origins to the consumer software division of Symantec Corporation, which was spun off in late 2019 under the NortonLifeLock name.
Featured Articles Five stocks we like better than Gen Digital Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Gen Digital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gen Digital and related companies with MarketBeat.com's FREE daily email newsletter.
Allworth Financial LP bought a new stake in The Sherwin-Williams Company (NYSE:SHW – Free Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 5,081 shares of the specialty chemicals company’s stock, valued at approximately $1,749,000.
Other large investors have also made changes to their positions in the company. Vanguard Group Inc. grew its holdings in Sherwin-Williams by 2.7% during the 4th quarter. Vanguard Group Inc. now owns 23,237,824 shares of the specialty chemicals company’s stock valued at $7,529,752,000 after purchasing an additional 600,119 shares in the last quarter. BlackRock Inc. acquired a new position in Sherwin-Williams in the second quarter valued at approximately $6,100,083,000. State Street Corp grew its holdings in shares of Sherwin-Williams by 2.4% during the fourth quarter. State Street Corp now owns 15,638,974 shares of the specialty chemicals company’s stock valued at $5,067,497,000 after purchasing an additional 364,832 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Sherwin-Williams by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 5,231,615 shares of the specialty chemicals company’s stock valued at $1,687,498,000 after purchasing an additional 37,145 shares during the period. Finally, Norges Bank acquired a new position in shares of Sherwin-Williams during the fourth quarter valued at approximately $1,089,450,000. 77.67% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets SHW has been the topic of a number of recent research reports. BMO Capital Markets restated an “outperform” rating and issued a $405.00 target price (up from $400.00) on shares of Sherwin-Williams in a research note on Wednesday, July 29th. Berenberg Bank set a $380.00 price target on Sherwin-Williams in a report on Monday, June 8th. JPMorgan Chase & Co. raised their target price on Sherwin-Williams from $365.00 to $380.00 and gave the company an “overweight” rating in a report on Wednesday, July 29th. Weiss Ratings upgraded shares of Sherwin-Williams from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, July 31st. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and set a $405.00 price objective (up from $391.00) on shares of Sherwin-Williams in a report on Wednesday, July 8th. Nine investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Sherwin-Williams currently has a consensus rating of “Moderate Buy” and an average target price of $385.44.
Get Our Latest Analysis on SHW Sherwin-Williams Stock Performance SHW stock opened at $347.02 on Friday. The Sherwin-Williams Company has a twelve month low of $289.86 and a twelve month high of $379.65. The company has a market cap of $84.24 billion, a P/E ratio of 31.98, a price-to-earnings-growth ratio of 2.58 and a beta of 1.10. The company has a quick ratio of 0.46, a current ratio of 0.73 and a debt-to-equity ratio of 2.16. The business’s fifty day moving average is $340.16 and its 200-day moving average is $332.81.
Sherwin-Williams (NYSE:SHW – Get Free Report) last posted its earnings results on Tuesday, July 28th. The specialty chemicals company reported $3.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.52 by $0.18. The business had revenue of $6.79 billion during the quarter, compared to analysts’ expectations of $6.60 billion. Sherwin-Williams had a return on equity of 67.97% and a net margin of 11.01%.Sherwin-Williams’s revenue for the quarter was up 7.5% compared to the same quarter last year. During the same period in the prior year, the business earned $3.38 EPS. Sherwin-Williams has set its FY 2026 guidance at 11.800-12.200 EPS. Equities research analysts forecast that The Sherwin-Williams Company will post 12.08 EPS for the current year.
Sherwin-Williams Announces Dividend The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 21st will be paid a $0.80 dividend. This represents a $3.20 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Friday, August 21st. Sherwin-Williams’s dividend payout ratio (DPR) is 29.49%.
Insider Buying and Selling In other Sherwin-Williams news, insider Karl J. Jorgenrud sold 7,886 shares of the business’s stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $368.30, for a total transaction of $2,904,413.80. Following the completion of the transaction, the insider directly owned 11,944 shares in the company, valued at $4,398,975.20. The trade was a 39.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Justin T. Binns sold 13,500 shares of the company’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $352.70, for a total value of $4,761,450.00. Following the sale, the insider owned 21,937 shares of the company’s stock, valued at $7,737,179.90. The trade was a 38.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.23% of the company’s stock.
Sherwin-Williams Profile (Free Report)
Sherwin-Williams (NYSE: SHW) is a global manufacturer and distributor of paints, coatings and related products. Founded in 1866 and headquartered in Cleveland, Ohio, the company supplies a broad range of coatings for residential, commercial and industrial applications. Its product offering includes architectural paints and stains, industrial and protective coatings, automotive finishes, and a variety of sundry products such as primers, sealants and specialty treatments used by professionals and consumers.
The company sells through multiple channels, including a large network of company-operated retail paint stores that serve professional contractors and do-it-yourself consumers, as well as through distributors and mass retailers.
Recommended Stories Five stocks we like better than Sherwin-Williams Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding SHW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Sherwin-Williams Company (NYSE:SHW – Free Report).
Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.
Bank of New York Mellon Corp ve 2. čtvrtletí koupila 1 588 919 akcií společnosti Sherwin-Williams za zhruba 547,1 milionu USD a držela asi 0,65 % firmy.
Bank of New York Mellon Corp bought a new stake in The Sherwin-Williams Company (NYSE:SHW – Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm bought 1,588,919 shares of the specialty chemicals company’s stock, valued at approximately $547,097,000. Bank of New York Mellon Corp owned approximately 0.65% of Sherwin-Williams as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Fideuram Asset Management Ireland dac bought a new stake in shares of Sherwin-Williams in the fourth quarter worth about $2,496,000. Kinsale Capital Group Inc. bought a new stake in shares of Sherwin-Williams in the 4th quarter worth approximately $4,805,000. Calamos Advisors LLC increased its stake in shares of Sherwin-Williams by 5.4% during the fourth quarter. Calamos Advisors LLC now owns 180,602 shares of the specialty chemicals company’s stock valued at $58,520,000 after buying an additional 9,196 shares during the period. Vanguard Group Inc. increased its stake in shares of Sherwin-Williams by 2.7% during the fourth quarter. Vanguard Group Inc. now owns 23,237,824 shares of the specialty chemicals company’s stock valued at $7,529,752,000 after buying an additional 600,119 shares during the period. Finally, Blueline Advisors LLC purchased a new stake in Sherwin-Williams in the fourth quarter worth $1,694,000. Institutional investors own 77.67% of the company’s stock.
Wall Street Analyst Weigh In SHW has been the subject of a number of research analyst reports. Guggenheim started coverage on Sherwin-Williams in a research note on Monday, August 3rd. They issued a “buy” rating and a $400.00 target price for the company. Morgan Stanley reiterated an “overweight” rating and issued a $395.00 price target (up from $385.00) on shares of Sherwin-Williams in a research note on Wednesday, July 29th. Royal Bank Of Canada reissued an “outperform” rating and set a $405.00 price objective (up from $391.00) on shares of Sherwin-Williams in a research note on Wednesday, July 8th. Jefferies Financial Group restated a “hold” rating and issued a $375.00 price objective on shares of Sherwin-Williams in a report on Tuesday, July 28th. Finally, BMO Capital Markets reiterated an “outperform” rating and set a $405.00 target price (up from $400.00) on shares of Sherwin-Williams in a report on Wednesday, July 29th. Nine analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $385.44.
Read Our Latest Stock Analysis on Sherwin-Williams Sherwin-Williams Stock Performance NYSE:SHW opened at $347.02 on Friday. The company has a debt-to-equity ratio of 2.16, a quick ratio of 0.46 and a current ratio of 0.73. The stock has a 50-day simple moving average of $340.16 and a two-hundred day simple moving average of $332.81. The firm has a market capitalization of $84.24 billion, a PE ratio of 31.98, a P/E/G ratio of 2.58 and a beta of 1.10. The Sherwin-Williams Company has a 52-week low of $289.86 and a 52-week high of $379.65.
Sherwin-Williams (NYSE:SHW – Get Free Report) last posted its quarterly earnings data on Tuesday, July 28th. The specialty chemicals company reported $3.70 earnings per share for the quarter, beating analysts’ consensus estimates of $3.52 by $0.18. The firm had revenue of $6.79 billion for the quarter, compared to analysts’ expectations of $6.60 billion. Sherwin-Williams had a return on equity of 67.97% and a net margin of 11.01%.The business’s quarterly revenue was up 7.5% on a year-over-year basis. During the same period in the previous year, the firm earned $3.38 EPS. Sherwin-Williams has set its FY 2026 guidance at 11.800-12.200 EPS. Analysts forecast that The Sherwin-Williams Company will post 12.08 EPS for the current year.
Sherwin-Williams Dividend Announcement The company also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 21st will be given a $0.80 dividend. This represents a $3.20 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Friday, August 21st. Sherwin-Williams’s dividend payout ratio is presently 29.49%.
Insider Buying and Selling In related news, insider Karl J. Jorgenrud sold 7,886 shares of Sherwin-Williams stock in a transaction on Friday, August 7th. The shares were sold at an average price of $368.30, for a total transaction of $2,904,413.80. Following the transaction, the insider owned 11,944 shares in the company, valued at approximately $4,398,975.20. The trade was a 39.77% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Justin T. Binns sold 13,500 shares of the company’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $352.70, for a total transaction of $4,761,450.00. Following the completion of the transaction, the insider directly owned 21,937 shares of the company’s stock, valued at $7,737,179.90. This represents a 38.10% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.23% of the company’s stock.
(Free Report)
Sherwin-Williams (NYSE: SHW) is a global manufacturer and distributor of paints, coatings and related products. Founded in 1866 and headquartered in Cleveland, Ohio, the company supplies a broad range of coatings for residential, commercial and industrial applications. Its product offering includes architectural paints and stains, industrial and protective coatings, automotive finishes, and a variety of sundry products such as primers, sealants and specialty treatments used by professionals and consumers.
The company sells through multiple channels, including a large network of company-operated retail paint stores that serve professional contractors and do-it-yourself consumers, as well as through distributors and mass retailers.
Read More Five stocks we like better than Sherwin-Williams Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.
Bank of New York Mellon Corp acquired a new position in shares of Ecolab Inc. (NYSE:ECL – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 1,483,725 shares of the basic materials company’s stock, valued at approximately $413,381,000. Bank of New York Mellon Corp owned approximately 0.53% of Ecolab at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Wexford Capital LP acquired a new stake in Ecolab during the third quarter valued at approximately $25,000. JPL Wealth Management LLC acquired a new position in shares of Ecolab in the 3rd quarter worth approximately $26,000. Costello Asset Management INC acquired a new position in shares of Ecolab in the 1st quarter worth approximately $27,000. Kemnay Advisory Services Inc. bought a new stake in shares of Ecolab in the 4th quarter valued at approximately $27,000. Finally, Meeder Asset Management Inc. acquired a new stake in shares of Ecolab during the 4th quarter valued at approximately $29,000. Institutional investors own 74.91% of the company’s stock.
Ecolab Trading Up 0.2% NYSE:ECL opened at $281.91 on Friday. The stock has a fifty day simple moving average of $276.56 and a 200 day simple moving average of $273.73. The firm has a market capitalization of $79.03 billion, a price-to-earnings ratio of 37.84, a price-to-earnings-growth ratio of 2.43 and a beta of 0.88. Ecolab Inc. has a 1-year low of $243.15 and a 1-year high of $309.27. The company has a quick ratio of 1.57, a current ratio of 1.84 and a debt-to-equity ratio of 1.18.
Ecolab (NYSE:ECL – Get Free Report) last posted its quarterly earnings data on Tuesday, July 28th. The basic materials company reported $2.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.08 by $0.01. Ecolab had a return on equity of 22.72% and a net margin of 12.57%.The firm had revenue of $4.42 billion for the quarter, compared to the consensus estimate of $4.38 billion. During the same quarter in the previous year, the company earned $1.89 EPS. The business’s revenue for the quarter was up 9.7% compared to the same quarter last year. Ecolab has set its Q3 2026 guidance at 2.130-2.230 EPS. Sell-side analysts forecast that Ecolab Inc. will post 8.17 earnings per share for the current year. Ecolab Dividend Announcement The company also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Tuesday, September 15th will be paid a dividend of $0.73 per share. This represents a $2.92 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Tuesday, September 15th. Ecolab’s payout ratio is 39.19%.
Wall Street Analysts Forecast Growth Several research firms have weighed in on ECL. Jefferies Financial Group lowered their target price on shares of Ecolab from $352.00 to $345.00 and set a “buy” rating for the company in a research note on Wednesday, May 20th. JPMorgan Chase & Co. lifted their price target on shares of Ecolab from $295.00 to $305.00 and gave the company an “overweight” rating in a report on Wednesday, July 29th. Zacks Research downgraded shares of Ecolab from a “hold” rating to a “strong sell” rating in a research report on Monday, July 20th. BMO Capital Markets increased their price objective on shares of Ecolab from $345.00 to $360.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 29th. Finally, Oppenheimer upgraded Ecolab from a “market perform” rating to an “outperform” rating and set a $320.00 price target on the stock in a research report on Friday, July 17th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $327.56.
Check Out Our Latest Research Report on ECL
Insider Activity at Ecolab In other Ecolab news, Director Michel D. Doukeris purchased 7,750 shares of the stock in a transaction dated Wednesday, June 10th. The shares were acquired at an average price of $258.00 per share, for a total transaction of $1,999,500.00. Following the completion of the acquisition, the director owned 8,326 shares of the company’s stock, valued at $2,148,108. This represents a 1,345.49% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Suzanne M. Vautrinot sold 1,004 shares of the company’s stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $264.98, for a total value of $266,039.92. Following the transaction, the director directly owned 11,651 shares in the company, valued at $3,087,281.98. The trade was a 7.93% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 28,866 shares of company stock worth $7,878,801. Insiders own 0.50% of the company’s stock.
About Ecolab (Free Report)
Ecolab, Inc is a global provider of water, hygiene and infection prevention solutions and services. The company develops and supplies cleaning and sanitizing chemicals, dispensing equipment, water-treatment systems, pest elimination services and related technologies designed to help businesses maintain clean, safe and efficient operations. Its offerings span both products and onsite services, often paired with technical support and training.
Ecolab serves a broad range of end markets including hospitality and foodservice, food and beverage processing, healthcare, manufacturing and industrial operations, and energy and utilities.
See Also Five stocks we like better than Ecolab Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding ECL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ecolab Inc. (NYSE:ECL – Free Report).
Receive News & Ratings for Ecolab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ecolab and related companies with MarketBeat.com's FREE daily email newsletter.
B. Metzler seel. Sohn & Co. AG ve 2. čtvrtletí koupila 26 592 akcií společnosti Cardinal Health za zhruba 6,317 mil. USD. Akcie zároveň podpořily silné výsledky: EPS 2,91 USD překonal odhad 2,42 USD.
B. Metzler seel. Sohn & Co. AG acquired a new stake in Cardinal Health, Inc. (NYSE:CAH – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 26,592 shares of the company’s stock, valued at approximately $6,317,000.
Several other large investors have also added to or reduced their stakes in CAH. Kornitzer Capital Management Inc. KS increased its holdings in shares of Cardinal Health by 100.8% in the 4th quarter. Kornitzer Capital Management Inc. KS now owns 18,164 shares of the company’s stock worth $3,733,000 after buying an additional 9,120 shares during the last quarter. Abacus FCF Advisors LLC purchased a new position in shares of Cardinal Health in the 4th quarter worth about $7,182,000. Byrne Financial Freedom LLC bought a new position in shares of Cardinal Health during the 4th quarter valued at about $1,574,000. Belleair Asset Management LLC purchased a new position in shares of Cardinal Health in the fourth quarter worth about $1,100,000. Finally, Axecap Investments LLC bought a new position in shares of Cardinal Health in the fourth quarter worth approximately $2,371,000. Institutional investors own 87.17% of the company’s stock.
Analyst Ratings Changes CAH has been the subject of a number of recent analyst reports. Wells Fargo & Company upped their target price on Cardinal Health from $245.00 to $277.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. William Blair began coverage on Cardinal Health in a report on Tuesday, April 28th. They issued an “outperform” rating on the stock. Evercore restated an “outperform” rating and set a $270.00 price objective on shares of Cardinal Health in a research note on Wednesday, August 12th. Bank of America lifted their target price on shares of Cardinal Health from $240.00 to $260.00 and gave the stock a “buy” rating in a report on Thursday, July 2nd. Finally, Royal Bank Of Canada assumed coverage on shares of Cardinal Health in a research report on Wednesday. They set an “outperform” rating and a $276.00 price target for the company. Sixteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and an average target price of $266.56.
Check Out Our Latest Research Report on Cardinal Health Insider Buying and Selling at Cardinal Health In other news, CEO Jason M. Hollar sold 44,529 shares of the company’s stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $236.18, for a total value of $10,516,859.22. Following the completion of the sale, the chief executive officer directly owned 190,603 shares of the company’s stock, valued at approximately $45,016,616.54. This represents a 18.94% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Deborah Weitzman sold 7,354 shares of the firm’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $235.45, for a total transaction of $1,731,499.30. Following the completion of the transaction, the chief executive officer directly owned 77,901 shares in the company, valued at approximately $18,341,790.45. The trade was a 8.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 210,271 shares of company stock worth $49,626,657. 0.12% of the stock is owned by insiders.
Cardinal Health Trading Up 0.4% Shares of Cardinal Health stock opened at $229.48 on Friday. The firm has a market cap of $53.37 billion, a PE ratio of 31.74, a PEG ratio of 1.22 and a beta of 0.49. Cardinal Health, Inc. has a 12 month low of $145.87 and a 12 month high of $258.30. The stock has a 50 day moving average of $232.02 and a 200 day moving average of $217.86.
Cardinal Health (NYSE:CAH – Get Free Report) last announced its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, beating analysts’ consensus estimates of $2.42 by $0.49. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The business had revenue of $63.67 billion for the quarter, compared to analyst estimates of $65.15 billion. During the same quarter in the prior year, the business earned $2.08 EPS. Cardinal Health’s quarterly revenue was up 5.8% on a year-over-year basis. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, equities research analysts forecast that Cardinal Health, Inc. will post 12.54 earnings per share for the current fiscal year.
Cardinal Health Dividend Announcement The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be paid a dividend of $0.5158 per share. The ex-dividend date is Thursday, October 1st. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is currently 28.49%.
Key Headlines Impacting Cardinal Health Here are the key news stories impacting Cardinal Health this week:
Positive Sentiment: Royal Bank of Canada initiated coverage with an “outperform” rating and a $276 price target, implying meaningful upside from recent trading levels. RBC cited Cardinal Health’s higher-margin services as a potential earnings-growth driver. RBC initiates coverage of Cardinal Health Positive Sentiment: Wall Street remains broadly constructive, with 16 analysts rating CAH a Buy and three assigning a Hold rating. The consensus rating is “Moderate Buy,” with an average price target of approximately $266.56. Zacks also identified Cardinal Health as a potentially attractive long-term value stock. Zacks value-stock analysis Positive Sentiment: Cardinal Health’s latest quarter delivered adjusted earnings per share of $2.91, well above the $2.42 consensus estimate, while revenue increased 5.8% year over year. Fiscal 2027 EPS guidance of $12.40–$12.60 supports the longer-term earnings case. Neutral Sentiment: The company declared a quarterly dividend of $0.5158 per share, equivalent to $2.06 annually and a yield of about 0.9%. The payout offers modest income support but is unlikely to be a major near-term catalyst. Negative Sentiment: Several executives sold sizable holdings around $235–$237 per share. CEO Jason Hollar sold 124,529 shares worth about $29.4 million, while other executive and insider sales—including those by Deborah Weitzman, Stephen Mason, Michelle Greene, Jessica Mayer and Mary Scherer—totaled roughly $20 million more. The concentrated selling and substantial reductions in insider ownership may encourage profit-taking concerns after CAH’s strong advance. Cardinal Health insider sales Negative Sentiment: Investors may also question the durability of the latest earnings beat because part of the improvement reportedly reflected a one-time tariff refund, potentially limiting the stock’s upside if recurring earnings growth does not match expectations. Cardinal Health earnings analysis Cardinal Health Company Profile (Free Report)
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Recommended Stories Five stocks we like better than Cardinal Health Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
Atlatl Advisers ve 2. čtvrtletí zvýšil podíl v Lam Research o 816,9 % na 16 210 akcií. Firma zároveň oznámila výnosy 6,72 miliardy USD a EPS 1,82 USD, nad odhady.
Atlatl Advisers LLC grew its holdings in shares of Lam Research Corporation (NASDAQ:LRCX – Free Report) by 816.9% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 16,210 shares of the semiconductor company’s stock after purchasing an additional 14,442 shares during the quarter. Lam Research makes up approximately 1.7% of Atlatl Advisers LLC’s holdings, making the stock its 11th biggest position. Atlatl Advisers LLC’s holdings in Lam Research were worth $7,024,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of LRCX. Bayban purchased a new stake in shares of Lam Research during the 4th quarter valued at $26,000. Vermillion Wealth Management Inc. acquired a new stake in Lam Research in the 1st quarter valued at approximately $26,000. Cedar Mountain Advisors LLC boosted its stake in shares of Lam Research by 242.9% in the first quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company’s stock valued at $26,000 after purchasing an additional 85 shares during the period. Mcguire Capital Advisors Inc. acquired a new stake in Lam Research in the 4th quarter valued at about $27,000. Finally, Triumph Capital Management purchased a new position in Lam Research in the third quarter valued at $27,000. 84.61% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Lam Research In other news, Director Abhijit Y. Talwalkar sold 18,282 shares of Lam Research stock in a transaction dated Monday, July 13th. The stock was sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the sale, the director directly owned 87,142 shares of the company’s stock, valued at approximately $29,192,570. This trade represents a 17.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the firm’s stock in a transaction on Thursday, June 11th. The stock was sold at an average price of $350.80, for a total value of $19,118,600.00. Following the transaction, the director directly owned 199,205 shares of the company’s stock, valued at approximately $69,881,114. This represents a 21.48% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 80,441 shares of company stock worth $27,614,296. 0.31% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth A number of brokerages have commented on LRCX. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $320.00 target price on shares of Lam Research in a report on Thursday, July 30th. Citigroup restated a “buy” rating and set a $450.00 price objective (up from $315.00) on shares of Lam Research in a research note on Wednesday, June 17th. B. Riley Financial reduced their target price on shares of Lam Research from $385.00 to $350.00 and set a “buy” rating for the company in a report on Thursday, July 30th. Stifel Nicolaus lifted their target price on Lam Research from $325.00 to $425.00 and gave the company a “buy” rating in a research note on Friday, July 10th. Finally, Jefferies Financial Group set a $335.00 target price on Lam Research and gave the company a “buy” rating in a research note on Thursday, July 30th. One analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $358.47. View Our Latest Research Report on Lam Research
Lam Research Stock Up 1.1% Shares of LRCX stock opened at $314.00 on Friday. The firm has a market capitalization of $392.91 billion, a P/E ratio of 54.51, a PEG ratio of 1.23 and a beta of 1.84. The company has a current ratio of 2.63, a quick ratio of 1.91 and a debt-to-equity ratio of 0.30. Lam Research Corporation has a 1 year low of $94.11 and a 1 year high of $438.50. The firm’s fifty day moving average price is $337.47 and its two-hundred day moving average price is $286.09.
Lam Research (NASDAQ:LRCX – Get Free Report) last issued its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share for the quarter, topping analysts’ consensus estimates of $1.69 by $0.13. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. The business had revenue of $6.72 billion for the quarter, compared to the consensus estimate of $6.66 billion. During the same period in the previous year, the company earned $1.33 earnings per share. The firm’s revenue for the quarter was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. On average, equities analysts predict that Lam Research Corporation will post 9.32 EPS for the current fiscal year.
Lam Research Profile (Free Report)
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Featured Stories Five stocks we like better than Lam Research Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
Advisors Capital Management LLC bought a new stake in shares of CSX Corporation (NASDAQ:CSX – Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 15,928 shares of the transportation company’s stock, valued at approximately $757,000.
Several other institutional investors and hedge funds have also recently modified their holdings of CSX. BlackRock Inc. purchased a new position in shares of CSX during the 2nd quarter valued at approximately $7,655,277,000. Bank of New York Mellon Corp purchased a new stake in CSX in the 2nd quarter worth $950,325,000. Deutsche Bank AG acquired a new position in CSX during the second quarter worth $685,418,000. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in CSX during the second quarter worth $224,809,000. Finally, Great Lakes Advisors LLC purchased a new position in CSX during the second quarter valued at $171,908,000. Hedge funds and other institutional investors own 73.57% of the company’s stock.
CSX Trading Up 1.2% CSX opened at $51.59 on Friday. The firm has a market capitalization of $95.57 billion, a price-to-earnings ratio of 29.82, a price-to-earnings-growth ratio of 2.33 and a beta of 1.21. The company’s 50 day simple moving average is $49.38 and its two-hundred day simple moving average is $45.15. CSX Corporation has a 1-year low of $31.80 and a 1-year high of $53.60. The company has a debt-to-equity ratio of 1.22, a current ratio of 0.82 and a quick ratio of 0.72.
CSX (NASDAQ:CSX – Get Free Report) last posted its quarterly earnings results on Wednesday, July 22nd. The transportation company reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.52 by $0.02. CSX had a return on equity of 24.98% and a net margin of 22.21%.The business had revenue of $3.94 billion during the quarter, compared to analyst estimates of $3.89 billion. During the same period in the prior year, the business earned $0.44 earnings per share. The business’s revenue was up 10.1% compared to the same quarter last year. Analysts expect that CSX Corporation will post 2 EPS for the current fiscal year. CSX Announces Dividend The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Monday, August 31st will be issued a $0.14 dividend. This represents a $0.56 annualized dividend and a yield of 1.1%. The ex-dividend date is Monday, August 31st. CSX’s dividend payout ratio is presently 32.37%.
Wall Street Analysts Forecast Growth CSX has been the subject of a number of research reports. Raymond James Financial reissued an “outperform” rating and set a $56.00 target price on shares of CSX in a research note on Monday, July 13th. Stifel Nicolaus set a $54.00 price target on shares of CSX in a research note on Thursday, July 23rd. Citizens Jmp initiated coverage on CSX in a report on Wednesday, July 15th. They issued a “market perform” rating on the stock. TD Cowen boosted their price objective on CSX from $46.00 to $54.00 and gave the stock a “buy” rating in a research note on Thursday, July 23rd. Finally, Royal Bank Of Canada reissued an “outperform” rating and set a $54.00 target price (up from $51.00) on shares of CSX in a report on Thursday, July 23rd. Eighteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $51.31.
Get Our Latest Stock Report on CSX
Insider Buying and Selling In other news, CFO Kevin S. Boone sold 136,708 shares of the business’s stock in a transaction dated Wednesday, June 3rd. The shares were sold at an average price of $46.70, for a total transaction of $6,384,263.60. Following the transaction, the chief financial officer owned 208,622 shares of the company’s stock, valued at approximately $9,742,647.40. The trade was a 39.59% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Michael S. Burns sold 13,000 shares of the company’s stock in a transaction dated Friday, July 24th. The shares were sold at an average price of $52.68, for a total transaction of $684,840.00. Following the completion of the sale, the senior vice president directly owned 59,643 shares of the company’s stock, valued at $3,141,993.24. This represents a 17.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 189,708 shares of company stock valued at $9,132,304 over the last 90 days. Insiders own 0.30% of the company’s stock.
CSX Profile (Free Report)
CSX Corporation is a leading North American transportation company that provides rail-based freight services and supply-chain solutions. Its operating subsidiary, CSX Transportation, moves a wide range of goods for customers across multiple industries, using a combination of long-haul rail service, intermodal operations and terminal and yard services. The company focuses on delivering efficient, reliable freight transportation between major production centers, consumption markets and port gateways.
CSX’s freight portfolio includes intermodal containers and trailers, bulk commodities, industrial products and specialized unit trains.
Recommended Stories Five stocks we like better than CSX Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for CSX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSX and related companies with MarketBeat.com's FREE daily email newsletter.
B. Metzler seel. Sohn & Co. AG ve 2. čtvrtletí získala nový podíl v CSX za zhruba 6,598 milionu USD, když zakoupila 138 826 akcií. CSX zároveň oznámila čtvrtletní dividendu ve výši 0,14 USD na akcii.
B. Metzler seel. Sohn & Co. AG acquired a new stake in CSX Corporation (NASDAQ:CSX – Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 138,826 shares of the transportation company’s stock, valued at approximately $6,598,000.
Other hedge funds have also made changes to their positions in the company. N.E.W. Advisory Services LLC bought a new position in CSX during the second quarter valued at about $27,000. WFA of San Diego LLC bought a new stake in CSX in the second quarter worth about $28,000. Arlington Trust Co LLC raised its position in CSX by 58.0% in the second quarter. Arlington Trust Co LLC now owns 681 shares of the transportation company’s stock worth $32,000 after acquiring an additional 250 shares in the last quarter. Wilkerson Advisory Group LLC lifted its holdings in CSX by 97.4% in the 1st quarter. Wilkerson Advisory Group LLC now owns 829 shares of the transportation company’s stock valued at $34,000 after acquiring an additional 409 shares during the last quarter. Finally, Meeder Asset Management Inc. acquired a new stake in CSX in the 2nd quarter valued at about $34,000. Institutional investors and hedge funds own 73.57% of the company’s stock.
CSX Price Performance CSX stock opened at $51.59 on Friday. The company has a debt-to-equity ratio of 1.22, a current ratio of 0.82 and a quick ratio of 0.72. The company has a market capitalization of $95.57 billion, a PE ratio of 29.82, a price-to-earnings-growth ratio of 2.33 and a beta of 1.21. CSX Corporation has a one year low of $31.80 and a one year high of $53.60. The business has a 50 day simple moving average of $49.38 and a 200 day simple moving average of $45.15.
CSX (NASDAQ:CSX – Get Free Report) last posted its earnings results on Wednesday, July 22nd. The transportation company reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.52 by $0.02. CSX had a net margin of 22.21% and a return on equity of 24.98%. The company had revenue of $3.94 billion during the quarter, compared to analysts’ expectations of $3.89 billion. During the same quarter in the previous year, the company posted $0.44 earnings per share. CSX’s quarterly revenue was up 10.1% compared to the same quarter last year. On average, sell-side analysts forecast that CSX Corporation will post 2 EPS for the current fiscal year. CSX Announces Dividend The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Monday, August 31st will be given a $0.14 dividend. This represents a $0.56 annualized dividend and a yield of 1.1%. The ex-dividend date is Monday, August 31st. CSX’s dividend payout ratio (DPR) is presently 32.37%.
Insider Transactions at CSX In other news, CFO Kevin S. Boone sold 136,708 shares of the company’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were sold at an average price of $46.70, for a total value of $6,384,263.60. Following the completion of the transaction, the chief financial officer owned 208,622 shares in the company, valued at $9,742,647.40. This represents a 39.59% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director John J. Zillmer sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 3rd. The stock was sold at an average price of $46.45, for a total value of $464,500.00. Following the transaction, the director directly owned 353,714 shares of the company’s stock, valued at approximately $16,430,015.30. This trade represents a 2.75% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 189,708 shares of company stock valued at $9,132,304 over the last quarter. Corporate insiders own 0.30% of the company’s stock.
Wall Street Analysts Forecast Growth Several research firms recently commented on CSX. Benchmark reissued a “buy” rating and set a $54.00 target price (up from $48.00) on shares of CSX in a research note on Wednesday, July 15th. Susquehanna raised CSX from a “neutral” rating to a “positive” rating and upped their price target for the company from $50.00 to $58.00 in a report on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $59.00 price target on shares of CSX in a research note on Friday, July 24th. Weiss Ratings upgraded CSX from a “buy (b-)” rating to a “buy (b)” rating in a report on Tuesday, August 11th. Finally, JPMorgan Chase & Co. upped their price target on shares of CSX from $56.00 to $58.00 and gave the company an “overweight” rating in a research report on Thursday, July 23rd. Eighteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $51.31.
Check Out Our Latest Research Report on CSX
CSX Profile (Free Report)
CSX Corporation is a leading North American transportation company that provides rail-based freight services and supply-chain solutions. Its operating subsidiary, CSX Transportation, moves a wide range of goods for customers across multiple industries, using a combination of long-haul rail service, intermodal operations and terminal and yard services. The company focuses on delivering efficient, reliable freight transportation between major production centers, consumption markets and port gateways.
CSX’s freight portfolio includes intermodal containers and trailers, bulk commodities, industrial products and specialized unit trains.
Recommended Stories Five stocks we like better than CSX Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding CSX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CSX Corporation (NASDAQ:CSX – Free Report).
Receive News & Ratings for CSX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSX and related companies with MarketBeat.com's FREE daily email newsletter.
B. Metzler seel. Sohn & Co. AG purchased a new position in NetApp, Inc. (NASDAQ:NTAP – Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 40,897 shares of the data storage provider’s stock, valued at approximately $6,329,000.
A number of other hedge funds also recently bought and sold shares of NTAP. BlackRock Inc. purchased a new stake in NetApp in the 2nd quarter worth $2,925,168,000. Norges Bank purchased a new position in NetApp during the fourth quarter valued at $458,060,000. First Trust Advisors LP lifted its holdings in NetApp by 127.0% during the first quarter. First Trust Advisors LP now owns 3,658,066 shares of the data storage provider’s stock valued at $374,549,000 after purchasing an additional 2,046,912 shares in the last quarter. Deutsche Bank AG acquired a new stake in shares of NetApp in the second quarter valued at about $195,203,000. Finally, Bank of New York Mellon Corp acquired a new stake in shares of NetApp in the second quarter valued at about $181,772,000. Hedge funds and other institutional investors own 92.17% of the company’s stock.
Wall Street Analysts Forecast Growth Several research analysts recently weighed in on NTAP shares. Citigroup upped their price target on shares of NetApp from $150.00 to $209.00 and gave the stock a “neutral” rating in a research report on Tuesday. The Goldman Sachs Group reiterated a “buy” rating and issued a $200.00 price objective on shares of NetApp in a report on Tuesday, June 2nd. Susquehanna boosted their price objective on NetApp from $110.00 to $185.00 and gave the stock a “neutral” rating in a research note on Friday, May 29th. Barclays increased their target price on NetApp from $120.00 to $199.00 and gave the company an “overweight” rating in a report on Friday, May 29th. Finally, Wall Street Zen downgraded NetApp from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 29th. Five investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $177.25.
View Our Latest Report on NetApp NetApp Price Performance NASDAQ:NTAP opened at $192.27 on Friday. NetApp, Inc. has a 52 week low of $93.69 and a 52 week high of $209.06. The company has a quick ratio of 1.39, a current ratio of 1.44 and a debt-to-equity ratio of 1.84. The company has a market capitalization of $37.73 billion, a P/E ratio of 30.23, a P/E/G ratio of 3.46 and a beta of 1.45. The stock’s fifty day moving average is $172.93 and its two-hundred day moving average is $134.89.
NetApp (NASDAQ:NTAP – Get Free Report) last released its quarterly earnings results on Thursday, May 28th. The data storage provider reported $2.03 earnings per share for the quarter, missing analysts’ consensus estimates of $2.27 by ($0.24). The business had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.87 billion. NetApp had a return on equity of 117.23% and a net margin of 18.43%.The business’s revenue for the quarter was up 12.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.93 earnings per share. NetApp has set its FY 2027 guidance at 8.700-9.000 EPS and its Q1 2027 guidance at 2.050-2.150 EPS. Equities analysts expect that NetApp, Inc. will post 7.3 EPS for the current year.
NetApp Announces Dividend The business also recently declared a quarterly dividend, which was paid on Wednesday, July 29th. Stockholders of record on Friday, July 10th were paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date of this dividend was Friday, July 10th. NetApp’s payout ratio is 32.70%.
Insider Activity In other NetApp news, CAO Lorenzo Daniel De sold 225 shares of the business’s stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $171.09, for a total value of $38,495.25. Following the sale, the chief accounting officer owned 1,090 shares of the company’s stock, valued at $186,488.10. The trade was a 17.11% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, President Cesar Cernuda sold 2,608 shares of the company’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $204.48, for a total value of $533,283.84. Following the transaction, the president owned 46,530 shares in the company, valued at $9,514,454.40. This trade represents a 5.31% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 55,297 shares of company stock valued at $8,758,016. Company insiders own 0.36% of the company’s stock.
NetApp Company Profile (Free Report)
NetApp, Inc (NASDAQ: NTAP) is a data management and storage company that delivers hybrid cloud data services for applications and data. Founded in 1992 as Network Appliance and rebranded as NetApp in 2008, the company is headquartered in Sunnyvale, California. NetApp’s offering focuses on enabling organizations to store, manage, protect and move data across on-premises environments and major public clouds.
The company’s product portfolio centers on the ONTAP data management software and a range of storage systems and services built around it.
Featured Articles Five stocks we like better than NetApp Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for NetApp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NetApp and related companies with MarketBeat.com's FREE daily email newsletter.
Allworth Financial LP ve 2. čtvrtletí nakoupila novou pozici v Keysight Technologies: 6 616 akcií za zhruba 2,316 milionu USD. Keysight zároveň oznámila EPS 3,07 USD a výnosy 1,85 miliardy USD, obojí nad odhady.
Allworth Financial LP purchased a new position in Keysight Technologies Inc. (NYSE:KEYS – Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 6,616 shares of the scientific and technical instruments company’s stock, valued at approximately $2,316,000.
Several other hedge funds have also bought and sold shares of KEYS. Quarry LP purchased a new stake in Keysight Technologies during the 4th quarter valued at about $25,000. IMG Wealth Management Inc. bought a new position in shares of Keysight Technologies in the second quarter worth approximately $29,000. Cornerstone Planning Group LLC increased its stake in shares of Keysight Technologies by 36.1% in the first quarter. Cornerstone Planning Group LLC now owns 113 shares of the scientific and technical instruments company’s stock worth $32,000 after buying an additional 30 shares during the period. Virtus Advisers LLC bought a new stake in Keysight Technologies during the 2nd quarter valued at $35,000. Finally, Oslo Pensjonsforsikring AS purchased a new position in shares of Keysight Technologies in the first quarter valued at about $44,000. 84.58% of the stock is currently owned by institutional investors.
Analyst Ratings Changes Several research firms have recently issued reports on KEYS. Wall Street Zen cut Keysight Technologies from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 1st. Truist Financial boosted their price objective on shares of Keysight Technologies from $376.00 to $400.00 and gave the company a “hold” rating in a research report on Wednesday. Weiss Ratings upgraded Keysight Technologies from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday. Citigroup reaffirmed a “buy” rating on shares of Keysight Technologies in a research report on Wednesday. Finally, Morgan Stanley increased their target price on Keysight Technologies from $400.00 to $425.00 and gave the stock an “overweight” rating in a research note on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, Keysight Technologies currently has a consensus rating of “Moderate Buy” and a consensus target price of $392.83.
View Our Latest Report on Keysight Technologies More Keysight Technologies News Here are the key news stories impacting Keysight Technologies this week:
Positive Sentiment: Strong results and raised outlook: Keysight reported fiscal third-quarter EPS of $3.07, well above the $2.48 consensus, while revenue reached $1.85 billion versus expectations of $1.75 billion. Revenue increased 36.5% year over year, and management issued upbeat fourth-quarter guidance. Keysight Technologies Gains Attention After Results Update Positive Sentiment: AI growth opportunity: Analysts view Keysight’s testing and measurement equipment as a potential durable beneficiary of AI data-center and networking investment, supporting the company’s raised outlook. Keysight Raised Its Outlook Positive Sentiment: Multiple growth drivers: Coverage highlights momentum in AI infrastructure, advanced semiconductors, 6G, automotive technology and energy-transition applications, particularly within Keysight’s Electronic Industrial Solutions Group. Keysight Focuses on AI Infrastructure Keysight Rides on EISG Strength Positive Sentiment: Analyst support: JPMorgan and Robert W. Baird commentary points to further price appreciation, reinforcing bullish sentiment following the earnings update. JPMorgan Forecasts Strong Price Appreciation Baird Analyst Expects Keysight Stock to Rise Neutral Sentiment: Additional analyst coverage remains focused on whether AI-related equipment demand can sustain Keysight’s growth, with broader market attention supporting visibility but not necessarily creating a new company-specific catalyst. Analyst Insights on Keysight Technologies Negative Sentiment: Valuation and technical factors could temper enthusiasm: KEYS trades at a forward-looking premium, and its recent retreat has left the shares below the 50-day moving average, potentially encouraging profit-taking despite strong fundamentals. Why Keysight Technologies Is in Focus Keysight Technologies Price Performance NYSE:KEYS opened at $315.95 on Friday. The business’s 50-day simple moving average is $332.86 and its two-hundred day simple moving average is $315.34. Keysight Technologies Inc. has a 52 week low of $158.79 and a 52 week high of $374.96. The stock has a market cap of $54.00 billion, a PE ratio of 43.40, a P/E/G ratio of 1.80 and a beta of 1.22. The company has a quick ratio of 1.51, a current ratio of 2.02 and a debt-to-equity ratio of 0.28.
Keysight Technologies (NYSE:KEYS – Get Free Report) last released its quarterly earnings data on Tuesday, August 18th. The scientific and technical instruments company reported $3.07 earnings per share for the quarter, topping analysts’ consensus estimates of $2.48 by $0.59. The firm had revenue of $1.85 billion during the quarter, compared to analyst estimates of $1.75 billion. Keysight Technologies had a return on equity of 24.34% and a net margin of 19.08%.The business’s quarterly revenue was up 36.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.72 earnings per share. Keysight Technologies has set its Q4 2026 guidance at 3.340-3.400 EPS and its FY 2026 guidance at 11.460-11.460 EPS. As a group, analysts forecast that Keysight Technologies Inc. will post 9.03 EPS for the current fiscal year.
Insider Activity In related news, SVP Ingrid A. Estrada sold 2,000 shares of the firm’s stock in a transaction on Tuesday, June 30th. The shares were sold at an average price of $340.87, for a total transaction of $681,740.00. Following the completion of the transaction, the senior vice president directly owned 105,861 shares of the company’s stock, valued at approximately $36,084,839.07. This trade represents a 1.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Satish Dhanasekaran sold 507 shares of Keysight Technologies stock in a transaction on Thursday, June 25th. The shares were sold at an average price of $361.32, for a total transaction of $183,189.24. Following the completion of the sale, the chief executive officer owned 121,391 shares in the company, valued at approximately $43,860,996.12. This represents a 0.42% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 5,507 shares of company stock worth $1,904,669 over the last quarter. Insiders own 0.40% of the company’s stock.
Keysight Technologies Company Profile (Free Report)
Keysight Technologies is a global provider of electronic design, test, measurement and optimization solutions for communications, electronics and related industries. The company was formed as a corporate spin-off from Agilent Technologies in 2014; its origins trace back to the electronic measurement business that was part of Hewlett‑Packard before Agilent. Keysight develops hardware and software used throughout the product development lifecycle, from design and simulation to prototype validation and manufacturing test.
Keysight’s product portfolio includes electronic test and measurement instruments such as oscilloscopes, network and spectrum analyzers, signal generators, vector network analyzers and modular PXI-based systems, together with software platforms for simulation, automated test and data analysis.
Featured Articles Five stocks we like better than Keysight Technologies Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Keysight Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keysight Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
B. Metzler seel. Sohn & Co. AG acquired a new stake in ConocoPhillips (NYSE:COP – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 66,330 shares of the energy producer’s stock, valued at approximately $6,896,000.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. TrinityBridge Ltd acquired a new position in shares of ConocoPhillips during the 2nd quarter valued at $86,000. NFJ Investment Group LLC bought a new position in ConocoPhillips during the second quarter valued at approximately $895,000. Silvant Capital Management LLC acquired a new position in ConocoPhillips during the second quarter worth $104,000. LaSalle St. Investment Advisors LLC acquired a new stake in shares of ConocoPhillips in the second quarter worth $535,000. Finally, Mystic Asset Management Inc. acquired a new stake in ConocoPhillips in the 2nd quarter valued at approximately $940,000. Institutional investors and hedge funds own 82.36% of the company’s stock.
More ConocoPhillips News Here are the key news stories impacting ConocoPhillips this week:
Positive Sentiment: ConocoPhillips reported adjusted earnings of $3.24 per share, exceeding the $2.90 consensus estimate, while revenue reached $19.52 billion. The company also generated $7.2 billion in operating cash flow, doubled share repurchases and declared an $0.84 quarterly dividend, reinforcing confidence in cash generation and shareholder returns. ConocoPhillips Beats Earnings and Names New CEO Positive Sentiment: Higher crude prices have supported a broader energy-sector rally and improved the near-term earnings outlook for upstream producers such as COP. Analysts have also issued mostly favorable ratings, with a reported median price target of $146. ConocoPhillips Gains as Higher Oil Prices Add to Post-Earnings Momentum Positive Sentiment: Investors see additional upside if the company successfully executes its LNG strategy and Willow development. One analysis estimates COP could be approximately 6% below fair value under that growth scenario. ConocoPhillips Could Be 6% Below Fair Value If LNG and Willow Deliver Neutral Sentiment: Management is undergoing succession changes, including CEO Ryan Lance’s retirement and internal finance leadership appointments. The insider promotions provide continuity, but investors will monitor whether the new leadership maintains disciplined capital allocation. ConocoPhillips Gives Finance Chief Role to Insider Negative Sentiment: After its sharp advance, COP trades at a premium valuation, increasing sensitivity to oil prices and execution. Recent disclosures also show substantial insider selling, which could temper enthusiasm even though institutional and analyst activity remains broadly supportive. Is ConocoPhillips Stock a Buy as Growth Meets a Premium Valuation? ConocoPhillips Stock Performance COP opened at $135.45 on Friday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.39 and a current ratio of 1.54. ConocoPhillips has a 52-week low of $85.57 and a 52-week high of $135.88. The firm has a market cap of $162.72 billion, a P/E ratio of 17.92, a price-to-earnings-growth ratio of 1.43 and a beta of 0.11. The business’s fifty day moving average is $115.30 and its 200-day moving average is $117.66. ConocoPhillips (NYSE:COP – Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The energy producer reported $3.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.90 by $0.34. ConocoPhillips had a return on equity of 14.72% and a net margin of 14.22%.The company had revenue of $19.52 billion for the quarter, compared to analyst estimates of $18.79 billion. During the same quarter last year, the company posted $1.42 EPS. The company’s revenue for the quarter was up 32.4% compared to the same quarter last year. Sell-side analysts expect that ConocoPhillips will post 10.46 EPS for the current fiscal year.
ConocoPhillips Dividend Announcement The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 1st. Shareholders of record on Monday, August 17th will be given a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, August 17th. This represents a $3.36 dividend on an annualized basis and a yield of 2.5%. ConocoPhillips’s dividend payout ratio is 44.44%.
Analyst Ratings Changes COP has been the topic of a number of analyst reports. BMO Capital Markets lowered their target price on shares of ConocoPhillips from $140.00 to $135.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 13th. Susquehanna raised their target price on shares of ConocoPhillips from $155.00 to $161.00 and gave the company a “positive” rating in a research note on Tuesday, August 11th. Freedom Capital raised ConocoPhillips from a “hold” rating to a “strong-buy” rating in a research note on Monday, August 10th. Wall Street Zen upgraded shares of ConocoPhillips from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Finally, Royal Bank Of Canada set a $130.00 price target on ConocoPhillips in a report on Monday, June 22nd. One research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $139.21.
Read Our Latest Analysis on COP
About ConocoPhillips (Free Report)
ConocoPhillips (NYSE: COP) is a Houston-based international energy company focused on exploration and production of oil and natural gas. Formed in 2002 through the merger of Conoco Inc and Phillips Petroleum Company, the firm operates as an independent upstream company that explores for, develops and produces crude oil, natural gas and natural gas liquids across a portfolio of global assets.
The company’s activities span conventional and unconventional resources and include onshore and offshore operations in multiple regions around the world.
Featured Stories Five stocks we like better than ConocoPhillips Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding COP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ConocoPhillips (NYSE:COP – Free Report).
Receive News & Ratings for ConocoPhillips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConocoPhillips and related companies with MarketBeat.com's FREE daily email newsletter.
By nearly every operating measure, Rocket Lab (RKLB -0.52%) is delivering. The space company's second-quarter revenue was a record. Its backlog was a record. Its third-quarter guidance calls for another record. And in June, the company announced an $8 billion agreement to acquire satellite operator Iridium Communications (IRDM +1.09%).
The stock reflects all of it. Even at about $73 as of this writing (roughly half its 52-week high of $151), Rocket Lab carries a market value near $45 billion. That is about 59 times the roughly $769 million of revenue the company generated over the four quarters through June 30, based on its last two earnings reports.
To me, that is the figure to hold onto. Because the rocket anchoring the growth story behind that multiple, the medium-lift Neutron, has never flown.
Image source: The Motley Fool.
Records everywhere but the bottom lineSecond-quarter revenue rose 62% year over year to $234 million, which was $34 million above the prior quarter's record. Backlog reached $2.36 billion -- up 137% year over year, and up from $1.85 billion at the end of 2025. And founder and CEO Sir Peter Beck said the company had already signed more than $1 billion in new contracts across launch and space systems since the quarter closed.
Guidance points the same direction. Management expects third-quarter revenue of $250 million to $265 million, which would be another record. And 2025's full-year revenue of $602 million grew 38% from 2024. The growth isn't cooling.
Profitability is the missing piece. Rocket Lab posted a $94 million net loss for the first half of 2026, and its guidance calls for a third-quarter adjusted loss of $17 million to $23 million in earnings before interest, taxes, depreciation, and amortization (EBITDA), with gross margins of 29% to 31% under generally accepted accounting principles (GAAP).
About $2.1 billion of cash and equivalents gives the company plenty of room to keep investing. But this remains a money-losing business valued at $45 billion.
Neutron is the revenue the price assumesFor the growth stock to trade at even 10 times revenue (still arguably a premium price for a hardware-heavy business) with shares simply holding their current value, revenue would need to reach about $4.5 billion -- nearly six times the current trailing figure.
The path there runs through Neutron, the reusable rocket designed to carry payloads far beyond what the company's small Electron vehicle can. After all, part of the new backlog depends on it, including a $397 million Space Force contract to deliver satellites that will launch on Neutron.
So the schedule matters more than usual. In its Aug. 10 second-quarter update, Rocket Lab said production of Neutron's first-stage tank remains aligned with delivering the rocket to the launch pad in the fourth quarter of 2026.
The same day, the company acknowledged the window for a launch this year "is narrowing," saying it is "balancing the schedule of the first launch with entering Neutron into service as a system ready for full-scale production."
The first flight may well slip into 2027.
To be fair, Neutron is not the only growth lever. The Iridium acquisition would fold in an operating satellite network and its subscription revenue when it closes, which the companies expect in mid-2027. The deal values Iridium at $54 per share, with half in cash.
But that revenue isn't free. The roughly $8 billion headline value includes Iridium's debt, and the cash half of the offer relies on a $3.6 billion bridge loan, with the remainder delivered as new Rocket Lab stock. The deal adds debt and share count, as well as sales.
Today's Change
(
-0.52
%) $
-0.38
Current Price
$
72.57
A valuation that assumes the next company arrivesRocket Lab is one of the most impressive operators in the space industry, and its launch record, backlog, and contract wins are all evidence that demand for what it builds continues to grow.
However, at 59 times revenue, the market isn't pricing the $769 million company that exists today. It is pricing the company Rocket Lab intends to become, one where Neutron flies routinely, the Space Force contracts convert into revenue, and Iridium's subscribers are folded in. Those steps can all still happen, but the price only works if they do.
I'd want to see Neutron leave the ground before calling this valuation reasonable. Until then, the multiple prices at milestones the company hasn't reached yet make the stock one I'd personally pass on.
Bank of New York Mellon Corp reduced its holdings in Targa Resources, Inc. (NYSE:TRGP – Free Report) by 8.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,343,665 shares of the pipeline company’s stock after selling 118,380 shares during the period. Bank of New York Mellon Corp owned about 0.63% of Targa Resources worth $360,290,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also made changes to their positions in the company. Atlantic Union Bankshares Corp purchased a new stake in Targa Resources in the 4th quarter worth $27,000. Miller Capital Partners Inc. purchased a new position in Targa Resources during the fourth quarter valued at $30,000. Leonteq Securities AG acquired a new stake in shares of Targa Resources in the fourth quarter valued at about $31,000. CoreCap Advisors LLC increased its stake in shares of Targa Resources by 245.9% during the second quarter. CoreCap Advisors LLC now owns 128 shares of the pipeline company’s stock worth $34,000 after purchasing an additional 91 shares in the last quarter. Finally, Godfrey Financial Associates Inc. acquired a new position in shares of Targa Resources during the 4th quarter worth about $37,000. 92.13% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets Several research firms recently issued reports on TRGP. TD Cowen lifted their price objective on Targa Resources from $270.00 to $275.00 and gave the stock a “hold” rating in a report on Friday, August 7th. Wolfe Research set a $335.00 price target on Targa Resources in a research note on Friday, August 7th. Stifel Nicolaus set a $268.00 price target on Targa Resources in a research report on Friday, May 8th. Scotiabank raised their price objective on Targa Resources from $249.00 to $257.00 and gave the company an “outperform” rating in a report on Tuesday, May 12th. Finally, Raymond James Financial set a $335.00 target price on shares of Targa Resources in a research note on Friday, August 7th. One research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, Targa Resources currently has a consensus rating of “Buy” and an average target price of $297.18.
Check Out Our Latest Stock Analysis on Targa Resources Targa Resources Price Performance TRGP opened at $300.01 on Friday. The stock’s 50-day moving average price is $271.98 and its 200 day moving average price is $254.10. Targa Resources, Inc. has a 12-month low of $144.14 and a 12-month high of $307.94. The firm has a market cap of $64.33 billion, a price-to-earnings ratio of 28.68, a PEG ratio of 1.46 and a beta of 0.72. The company has a current ratio of 0.77, a quick ratio of 0.68 and a debt-to-equity ratio of 5.01.
Targa Resources (NYSE:TRGP – Get Free Report) last released its earnings results on Thursday, August 6th. The pipeline company reported $3.54 earnings per share for the quarter, beating the consensus estimate of $2.83 by $0.71. The company had revenue of $4.44 billion during the quarter, compared to the consensus estimate of $4.90 billion. Targa Resources had a return on equity of 69.26% and a net margin of 13.55%. As a group, sell-side analysts expect that Targa Resources, Inc. will post 11.05 earnings per share for the current year.
Targa Resources Dividend Announcement The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Stockholders of record on Friday, July 31st were paid a $1.25 dividend. The ex-dividend date of this dividend was Friday, July 31st. This represents a $5.00 annualized dividend and a dividend yield of 1.7%. Targa Resources’s dividend payout ratio (DPR) is presently 47.80%.
More Targa Resources News Here are the key news stories impacting Targa Resources this week:
Positive Sentiment: Long-term ExxonMobil contracts strengthen growth visibility. Targa secured 20-year, fee-based agreements with ExxonMobil covering the Permian Delaware and Midland basins. The arrangements support new processing and takeaway infrastructure through 2046, potentially improving cash-flow visibility and extending Targa’s Permian growth runway. Targa Resources Secures 20-Year Deal With ExxonMobil Positive Sentiment: Jefferies initiated or reiterated a Buy rating. The endorsement provides additional analyst support for TRGP’s long-term growth and infrastructure outlook. Targa Resources Gets a Buy from Jefferies Neutral Sentiment: Higher capital spending raises execution risk. The ExxonMobil-related infrastructure buildout could create meaningful future growth, but increased 2026 spending may pressure near-term free cash flow and heighten construction and execution demands. How Targa’s ExxonMobil Deal Could Extend Its Permian Growth Runway Negative Sentiment: US Capital Advisors reduced multiple EPS forecasts. The firm cut estimates for late 2026, all quarters of 2027, FY2027 EPS from $11.75 to $11.05, and FY2028 EPS from $13.42 to $12.73. Although it maintained a “Moderate Buy” rating, the revisions suggest expectations for slower earnings growth. Negative Sentiment: Premium valuation may limit upside. TRGP is trading close to its 52-week high following an approximately 85% rally, while heavy spending and potentially moderating marketing gains have raised questions about whether the current valuation fully reflects future growth. Targa Resources’ Stock Near 52-Week High Targa Resources Company Profile (Free Report)
Targa Resources Corporation (NYSE: TRGP) is a U.S.-focused midstream energy company that provides gathering, processing, transportation, storage and marketing services for natural gas, natural gas liquids (NGLs), and condensate. Its operations span the midstream value chain, including gas gathering systems that collect production from wells, processing plants that separate and recover NGLs and other hydrocarbons, fractionation and purification facilities that prepare NGLs for market, and pipeline and terminal assets that move and store products for producers, refiners and other customers.
The company operates a network of pipelines, processing plants, fractionators and storage facilities that serve producers and consumers across major U.S.
Recommended Stories Five stocks we like better than Targa Resources Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Targa Resources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Targa Resources and related companies with MarketBeat.com's FREE daily email newsletter.
CFO QuantumScape Kevin Hettrich prodal 31 095 akcií za 179 000 USD v rámci automatického prodeje kvůli daňovým srážkám. Po transakci dál drží 1,8 milionu akcií.
Kevin Hettrich, the chief financial officer of QuantumScape Corporation (QS +4.91%), disposed of 31,095 shares of Class A Common Stock on August 18, according to an SEC Form 4 filing.
Transaction summaryMetricValueShares sold31,095Transaction value$179,000Post-transaction shares (directly held)1,785,162Post-transaction value$10.28 millionTransaction value based on SEC Form 4 weighted average sale price ($5.74); post-transaction value based on the August 18 market close ($5.76).
Key questionsWhat were the specific circumstances of this disposition?
The transaction was a non-discretionary sale-to-cover, conducted automatically to satisfy tax withholding requirements upon the vesting of equity awards, and does not reflect a discretionary change in the insider's investment thesis.How much equity does the CFO maintain in the company?
Following this reduction, Hettrich continues to hold 1.8 million shares of Class A Common Stock directly and also holds derivative securities in the form of restricted and performance restricted stock units.What is the company's current financial and market position?
Headquartered in San Jose, the company is developing solid-state lithium-metal batteries for electric vehicles and reported a trailing twelve-month net loss of $405.0 million as of the August 18 transaction date.How has the stock performed leading up to this filing?
At the time of the transaction, shares were priced at $5.74, reflecting a one-year return of -30% as of August 18, while the stock closed at $5.88 as of the August 19 market close.Company OverviewMetricValueShare Price (as of market close 2026-08-19)$5.88Market Capitalization$3.6 billionNet Income (TTM)-$405.0 millionCompany SnapshotQuantumScape develops and commercializes advanced solid-state lithium-metal battery technology designed primarily for electric vehicle applications, with additional use cases across various industrial and consumer segments.The company operates a technology development and licensing business model, focusing on advancing next-generation battery solutions with enhanced energy density and performance compared to conventional lithium-ion alternatives.QuantumScape's primary target market consists of electric vehicle manufacturers and automotive suppliers seeking differentiated battery technology to improve vehicle range, charging speed, and overall performance metrics.QuantumScape Corporation, headquartered in San Jose, California, is a specialized battery technology company with 700 employees focused on solid-state lithium-metal battery innovation. The company is currently in a pre-revenue or early commercialization phase, as evidenced by its TTM net loss of $405.0 million, reflecting substantial research and development investments required to bring advanced battery technology to market. With a market capitalization of $3.6 billion, QuantumScape represents a capital-intensive venture positioned at the intersection of automotive electrification and advanced materials science.
What this transaction means for investorsHettrich's sale isn't a one-off. He's sold shares every month this year under the same 10b5-1 plan he set up back in June 2025, including 9,800 shares in June and another 9,800 in July, both well before this quarter's news. August's batch is bigger at 31,095 shares, but it fits the same pattern and comes out of the 1.8 million shares he still holds directly.
As CFO, Hettrich is the one actually managing the balance sheet that QuantumScape is burning through to get to commercialization. He reiterated full-year adjusted EBITDA loss guidance of $250 million to $275 million on the July call, while lowering capital expenditure guidance to $27 million to $37 million, and he called the quarter's $64.2 million adjusted EBITDA loss "in line with expectations." Meanwhile, customer billings reached $21.8 million through midyear, already ahead of the $19.5 million QuantumScape booked in all of 2025, and the company ended the quarter with $859 million in liquidity to fund the Eagle Line ramp. For long-term investors, whether that cash lasts long enough to reach real commercial volume is the number worth tracking, not another month of scheduled selling.
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
CEO společnosti Tempus AI Eric P. Lefkofsky prodal 132 591 akcií za 6,6 milionu USD, šlo však o rutinní prodej kvůli daňovým povinnostem. Akcie pak následující den vyskočily o 24 %.
Eric P. Lefkofsky, the chairman and CEO of Tempus AI, Inc. (TEM +9.06%), disposed of about 133,000 shares of Class A Common Stock on August 18, according to an SEC Form 4 filing
Transaction summaryMetricValueTransaction value$6.6 millionShares sold (directly held)132,591Post-transaction shares (directly held)2,098,130Transaction value based on SEC Form 4 weighted average sale price ($49.61); post-transaction value based on the August 18 market close ($49.36).
Key questionsWhat was the structural nature of this share disposition?
The sale was non-discretionary, executed to cover tax obligations, and does not reflect the insider's view on the stock. This "sell to cover" mechanism is a standard arrangement used by the company to fund minimum statutory tax withholdings upon the vesting of equity awards.What is the current scale of the CEO's equity exposure?
Lefkofsky continues to control a small but meaningful percentage of the company through his direct and indirect holdings. The insider also holds derivative securities. As of the August 19 market close, the stock was priced at $61.25, following a one-year total return of -37%.Company OverviewMetricValueShare Price (as of market close 2026-08-19)$61.25Market Capitalization$10.7 billionRevenue (TTM)$1.4 billionNet Income (TTM)-$254.4 millionCompany SnapshotTempus AI operates a comprehensive healthcare technology platform that integrates clinical diagnostic capabilities with advanced analytics and multimodal data repositories, generating revenue through its Tempus platform and Hub clinical application for next-generation sequencing testing.The company operates a closed-loop, full-stack business model that establishes bi-directional integrations between clinician workflows and laboratory diagnostic services, enabling end-to-end solutions for healthcare providers and diagnostic testing.The company serves physicians, healthcare providers, and clinical laboratories seeking advanced diagnostic capabilities and data-driven clinical decision support, with a primary focus on oncology and precision medicine applications.Tempus AI is a healthcare technology company based in Chicago with a $10.7 billion market capitalization and approximately 3,800 employees. The company has achieved TTM revenue of $1.4 billion while investing heavily in research and development, reflected in a TTM net loss of $254.4 million. The company's competitive advantage stems from its integrated platform architecture, which combines diagnostic capabilities, advanced analytics, and proprietary multimodal data repositories to deliver differentiated clinical decision support solutions.
What this transaction means for investorsLefkofsky's sale itself is routine, a sell-to-cover on vested equity, but the timing is nevertheless interesting for Tempu stock. He disposed of about 133,000 shares on August 18, at a weighted average price of $49.61. The very next day, Tempus stock jumped 24% to $61.25, then another 9% the day after that, to $66.65, after Moderna and Merck reported Phase 3 melanoma trial results that validate the genomic sequencing technology behind Tempus's pending $1.5 billion Personalis acquisition. Of course, Lefkofsky sold the day before, not after, so there's no story here despite how it looks on a chart.
The business context makes clear why investors are excited regardless of one CEO's tax bill. Tempus posted its first GAAP profit in the second quarter, with revenue up 22% to $382.5 million and oncology volume growth of 31%. The company raised full-year guidance to roughly $1.6 billion, about 25% annual growth. Lefkofsky described the quarter plainly, saying "Q2 was another exceptional quarter for us." None of that was priced in before this week. For long-term investors, whether Tempus can turn a single trial readout into durable testing volume is the real question now, not a routine Form 4 filed a day too early to matter.
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Tempus AI. The Motley Fool has a disclosure policy.
Šéf diagnostiky společnosti Tempus AI Thomas Edward Schoenherr prodal 17 314 akcií v rámci předem stanoveného plánu 10b5-1. Po transakci drží přímo 89 715 akcií.
Thomas Edward Schoenherr, the CEO of diagnostics at Tempus AI, Inc. (TEM +9.06%), sold 17,314 shares of Class A Common Stock on August 18 and August 19, according to an SEC Form 4 filing.
Transaction summaryMetricValueTransaction value~$930,000Shares sold17,314Post-transaction shares (directly held)89,715Post-transaction value$5.5 millionTransaction value based on SEC Form 4 weighted average sale price ($53.71); post-transaction value based on the August 19 market close ($61.25).
Key questionsWhat was the primary driver behind this share disposition?
The sales were conducted under a Rule 10b5-1 trading plan adopted on March 3 and included non-discretionary transactions required to cover statutory tax withholding obligations resulting from the vesting of restricted stock units.How does this move align with the company's recent financial scale?
The roughly $930,000 transaction occurred within a company that reported trailing twelve-month revenue of $1.4 billion and a net income of -$254.4 million as of the most recent reporting period.What is the insider's remaining exposure to the company's valuation?
Schoenherr continues to hold 89,715 shares directly, representing a 0.05% ownership stake in the $10.7 billion healthcare technology firm.What has been the recent performance context for the stock?
The shares were priced at $53.71 for this transaction as the stock has generated a -16% total return over the 12 months ending August 19.Company OverviewMetricValueShare Price (as of market close 2026-08-19)$61.25Market Capitalization$10.7 billionRevenue (TTM)$1.4 billionNet Income (TTM)-$254.4 millionCompany SnapshotTempus AI operates a closed-loop healthcare technology platform that integrates clinician workflows with laboratory diagnostic capabilities, analytics, and multimodal data repositories, generating revenue through its Tempus platform and Hub clinical application for next-generation sequencing (NGS) testing.The company operates a software-as-a-service and diagnostic services business model, monetizing through platform subscriptions, clinical application licensing, and laboratory testing services delivered to healthcare providers and medical institutions.Tempus AI primarily serves physicians, healthcare providers, and clinical laboratories seeking advanced diagnostic capabilities and data-driven clinical decision support tools for oncology and precision medicine applications.Tempus AI is a healthcare technology company with a $10.7 billion market capitalization and 3,800 employees headquartered in Chicago. The company has established a vertically integrated platform that combines clinical software, diagnostic analytics, and laboratory services to address the precision medicine market, though it remains unprofitable on a TTM basis, with negative net income of $254.4 million, as it invests in platform expansion and market penetration.
What this transaction means for investorsAs noted, this sale was on a 10b5-1 plan Schoenherr adopted back in March, so the mechanics were locked in long before anyone knew Moderna and Merck would report trial results that revalued Tempus's pending Personalis deal by massively boosting the stock's price. The sale straddled both August 18 and August 19, catching some shares before the stock jumped and some after, which is exactly what a pre-set plan looks like when news breaks in the middle of it.
Schoenherr runs diagnostics, the larger of Tempus's two segments, and it had a solid quarter on its own terms. Diagnostics revenue grew 20% year over year to $289.3 million, driven by oncology volume growth of 31%, and MRD testing volume rose to 9,000 cases from 6,500 the prior quarter. That's the business actually generating the reimbursement dollars, as opposed to the Personalis deal getting all the attention this week. CEO Eric Lefkofsky summed up the underlying quarter by simply saying, it "was another exceptional quarter for us." Schoenherr still holds 89,715 shares, and ultimately, a scheduled plan crossing a volatile week isn't a signal in either direction, so long-term investors should stay focused on performance and execution.
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Tempus AI. The Motley Fool has a disclosure policy.
CFO společnosti Tempus AI James William Rogers prodal 48 842 akcií třídy A za 2,7 milionu USD v rámci plánu 10b5-1 kvůli srážkové dani. Po transakci drží 106 000 akcií.
James William Rogers, the chief financial officer of Tempus AI, Inc. (TEM +9.06%), sold 48,842 shares of Class A Common Stock on August 18 and August 19, according to a recent SEC Form 4 filing.
Transaction summaryMetricValueTransaction value$2.7 millionShares sold (direct)48,842Post-transaction shares (directly held)106,024Post-transaction value$6.49 millionTransaction value based on SEC Form 4 weighted average sale price ($55.21); post-transaction value based on the August 19 market close ($61.25).
Key questionsWhat was the primary driver of this transaction?
The disposition was a non-discretionary sell-to-cover event intended to satisfy statutory tax withholding requirements upon the vesting of restricted stock units. The activity was conducted under a Rule 10b5-1 trading plan adopted on September 11, 2025, and does not reflect a change in the insider's fundamental outlook on the company.How much direct equity does the CFO retain?
Following this sale, James William Rogers retains direct ownership of 106,000 shares of Class A Common Stock. This position represents an insider ownership stake of roughly 0.06% of the company's outstanding equity.What is the recent performance context for the stock?
As of the August 19 transaction date, the one-year total return for the stock was -16%. The transaction was executed at a weighted-average price of $55.21 per share, while the stock finished the August 19 session at $61.25.What is the company's current financial profile?
Tempus AI, based in Chicago, operates in the healthcare information services industry with approximately 3,800 employees. The company reported trailing twelve-month revenue of $1.4 billion and a net loss of $254.4 million, maintaining a total market capitalization of $10.7 billion as of the latest data.Company OverviewMetricValueShare Price (as of market close 2026-08-19)$61.25Market Capitalization$10.7 billionRevenue (TTM)$1.4 billionNet Income (TTM)-$254.4 millionCompany SnapshotTempus AI operates a closed-loop, full-stack healthcare technology platform that integrates clinician workflows with laboratory diagnostic capabilities, analytics, and multimodal data repositories, generating revenue primarily through its diagnostic testing services and platform licensing.The company employs a technology-enabled laboratory services model that combines next-generation sequencing (NGS) testing with artificial intelligence-driven analytics to deliver actionable clinical insights to healthcare providers.Tempus AI serves physicians, healthcare systems, and diagnostic laboratories seeking advanced genomic testing and data analytics solutions, with particular focus on oncology and precision medicine applications.Tempus AI is a healthcare technology company headquartered in Chicago, with approximately 3,800 employees, that has achieved $1.4 billion in TTM revenue while building a comprehensive platform integrating clinical diagnostics with AI-powered analytics. The company's competitive differentiation lies in its proprietary multimodal data repository and closed-loop integration between clinician workflows and laboratory capabilities, positioning it as a full-stack solution provider in precision medicine. Despite current net losses of $254.4 million TTM, the company maintains significant market valuation of $10.7 billion, reflecting investor confidence in its technology platform and market opportunity within healthcare information services.
What this transaction means for investorsRogers's sale seems to run on the same 10b5-1 plan structure as the diagnostics chief's, adopted back in September 2025, and it split across August 18 and August 19 the same way, catching shares on both sides of the Moderna and Merck trial news that sent Tempus stock up 24% in a single session.
As CFO, Rogers is the one who effectively delivered the number that mattered most this quarter, Tempus's first GAAP profit. Net income came in at $5.6 million for the second quarter, helped by $98.5 million in unrealized gains on marketable securities, alongside revenue growth of 22% to $382.5 million. The company also raised full-year guidance to $1.6 billion and closed a $460 million convertible note offering during the quarter, fortifying the kind of balance sheet that funds a $1.5 billion acquisition without straining cash. That's what long-term investors should ultimately be paying more attention to than routine transactions like this one.
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Tempus AI. The Motley Fool has a disclosure policy.
EVP a hlavní právní zástupce Tempus AI Andrew Polovin prodal 30 075 akcií za 51,29 USD za akcii, celkem za 1,5 milionu USD, v rámci plánu 10b5-1 kvůli povinnému zadržení daně při vestingu RSU. Prodej nesouvisí s jeho pohledem na akcii.
Andrew Polovin, the firm's EVP and chief legal officer, sold 30,075 shares of Tempus AI, Inc. (TEM +9.06%) at $51.29 per share in a transaction totaling $1.5 million, according to an SEC Form 4 filing.
Transaction summaryMetricValueTransaction value$1.5 millionShares sold30,075Post-transaction shares (directly held)138,140Post-transaction value$8.5 millionTransaction value based on SEC Form 4 weighted average sale price ($51.29); post-transaction value based on the August 19 market close ($61.25).
Key questionsWhat was the primary driver for this share disposition?
The transaction was non-discretionary, executed to cover minimum statutory tax withholding obligations tied to the vesting of restricted stock units, and does not reflect the insider's discretionary view on the stock.How significant is the remaining equity stake?
Following the disposition, Polovin retains 138,140 shares with an estimated market value of $8.5 million as of the August 19 close.Does this transaction follow a pre-established strategy?
The sale was conducted under a Rule 10b5-1 trading plan established on August 12, 2025, which provides for systematic liquidity while ensuring compliance with securities regulations regarding material non-public information.Company OverviewMetricValueShare Price (as of market close 2026-08-19)$61.25Market Capitalization$10.7 billionRevenue (TTM)$1.4 billionNet Income (TTM)-$254.4 millionCompany SnapshotTempus AI operates a closed-loop healthcare technology platform that integrates clinician workflows with laboratory diagnostic capabilities, analytics, and multimodal data repositories, generating revenue through its Tempus platform and Hub clinical application for next-generation sequencing (NGS) testing.The company operates a software-as-a-service and diagnostic services business model, monetizing through platform subscriptions, clinical application licensing, and laboratory testing services delivered to healthcare providers and medical institutions.Tempus AI primarily serves physicians, healthcare providers, and clinical laboratories seeking advanced diagnostic capabilities and data-driven clinical decision support tools for oncology and precision medicine applications.Tempus AI is a healthcare technology company headquartered in Chicago, with a $10.7 billion market capitalization and 3,800 employees. The company has established a vertically integrated platform combining clinical software, diagnostic analytics, and laboratory services to address the precision medicine market, though it remains unprofitable on a TTM basis with negative net income of $254.4 million as it invests in platform expansion and market penetration.
What this transaction means for investorsPolovin's sale is a routine sell-to-cover on a 10b5-1 plan he set up back in August 2025, executing on schedule the same week Tempus stock happened to explode, which says nothing about his read on the company.
The more useful question, and the one investors should be watching for, is whether Tempus is worth buying after the swing it just had. The stock is down roughly 10% over the past year, but it's rallied about 75% since late last month, and even after that run, it's still sitting something like 30% below its all-time high near $104. Notably, the staggering run higher this past week wasn't driven by anything Tempus itself announced. It came from a Moderna and Merck cancer vaccine trial hitting its endpoints, which validates the genomic sequencing technology behind Tempus's pending $1.5 billion Personalis deal. The business backed that up with real numbers too, revenue up 22% to $382.5 million last quarter and its first GAAP profit, a quarter CEO Eric Lefkofsky called "another exceptional quarter for us." Whether that combination justifies the current price, or whether the rally has already priced in more than one trial readout confirms, is the real debate here rather than Polovin's tax bill.
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Tempus AI. The Motley Fool has a disclosure policy.
Nebius tento týden spadl o 21,1 % poté, co oznámil, že chce vydat konvertibilní dluhopisy za 5 miliard USD. Trh se obává zadlužení i možné diluce akcionářů.
Nebius Group (NBIS -0.45%) stock plunged 21.1% this week, according to data provided by S&P Global Market Intelligence. That shouldn't bother existing shareholders who have enjoyed the 231% gain in Nebius stock over the past year.
For those who think they missed out on the huge run in Nebius stock, it could be an opportunity, though. Investments in data centers continue to accelerate, and Nebius has customers lined up to use its compute capacity.
Image source: Nebius Group.
Capital spending by the four largest hyperscalers has already reached $300 billion through June this year. That's about 75% of what those same companies spent in all of 2025, according to recent research from The Motley Fool. Some of that money is going to Nebius. The company has generated more than $4.5 billion in net cash from operating activities in the first half of 2026. That compares to over $350 million spent on operations in the year-ago period.
Today's Change
(
-0.45
%) $
-0.98
Current Price
$
219.13
But the company needs to continue adding capacity to satisfy demand. That's why Nebius announced it would raise $5 billion by issuing convertible notes this week. Shares dropped on the news, as it adds debt and could lead to shareholder dilution should those notes be converted to common stock.
In its second-quarter letter to shareholders, Nebius detailed how growing demand is also increasing the value of its compute capacity. Contract value per megawatt of capacity has soared this year.
Returns on its invested capital look to be growing. That makes dips in the stock a good time to buy shares if investors believe the artificial intelligence infrastructure build-out has several years to go. That, and the stock's already lofty valuation, are the risks one has to balance.
Howard Smith has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Akcie Opery po zveřejnění výsledků za 2. čtvrtletí za týden klesly o 6,7 %, protože zisk na akcii sice splnil odhady, ale investory zklamal nedostatek výraznějšího překvapení. Tržby vzrostly o 24,6 % na zhruba 178,1 milionu USD a firma zvýšila celoroční výhled tržeb na 734 až 742 milionů USD.
Opera (OPRA +3.66%) stock moved lower this week following the release of the company's second-quarter report. The company's share price ended the week down 6.7% and had been off as much as 9.2% from where it stood at the end of the previous week's market close before seeing some recovery.
Opera published its Q2 report before the market opened on Wednesday and reported a sales beat in the quarter. While the company's non-GAAP (adjusted) earnings met the average Wall Street analyst estimate, some investors were betting on a beat and sold out of the stock in response.
Image source: Getty Images.
Opera's Q2 results weren't exciting enough for investors Opera recorded adjusted earnings of $0.33 in the second quarter, which was in line with the profit called for by the average analyst estimate. Meanwhile, revenue increased 24.6% year over year to reach roughly $178.1 million and topped the average analyst forecast by $0.8 million. Adjusted earnings per share were up roughly 27% year over year.
Opera's average monthly active users (MAUs) held flat on a sequential basis at $288 million, but its second-quarter report wasn't bad by any stretch of the imagination. Advertising segment revenue increased 27% year over year, query revenue increased 21%, and average revenue per user (ARPU) increased roughly 25%.
Today's Change
(
3.66
%) $
0.67
Current Price
$
18.96
What's next for Opera? With its Q2 report, Opera announced that it now anticipates full-year sales to be between $734 million and $742 million -- up from its previous guidance for sales between $727 million and $740 million. Prior to the Q2 report, the average analyst estimate had targeted revenue of roughly $736.7 million.
Opera isn't finding much success growing its MAUs, but the company is doing a better job of monetizing engagement across its services. The software specialist may be able to score more wins by improving ARPU, but the company still needs to improve user acquisition in order to strengthen its long-term growth outlook.
Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Coca-Cola testuje automaty pro dirty soda, refreshery a ledovou kávu, aby nabídla více přizpůsobitelné nápoje. Firma zároveň vyvíjí prototyp energetického nápoje, který chce uvést v první polovině roku 2027.
ATLANTA — Coca-Cola is branching out into new customizable drinks and trend-driven equipment as consumers — and food service operators — increasingly want more options.
Tucked away in an anonymous office park not far from its global headquarters here, Coke has been working on a flood of innovation at its secretive labs, including a way for its Freestyle drink dispensers to make dirty sodas, which combine pop with flavored syrups, cream or other ingredients. In partnership with AMC Theatres, it is testing a Micro Matic dispenser that can make brightly colored refreshers. And Coke has more white-label beverage options on the way, like an energy drink that can be customized by color and flavor.
For many restaurants, handcrafted drinks like refreshers or iced coffee have become an important way to drive traffic and sales, even as diners broadly cut their spending. In the second quarter of this year, beverage servings at restaurants outpaced both servings of food alone and food with beverages, according to Circana data. When consumers are away from home, a drink often represents more than hydration, particularly for Generation Z.
"Oftentimes these beverages are an opportunity to take a break, get some energy or protein, have a treat, at a lower price point," David Portalatin, Circana senior vice president and food service industry advisor, told CNBC.
From McDonald's to Wendy's, longtime Coke customers have been expanding their beverage offerings to meet the shift in consumer behavior and boost their profit margins. As operators seek to add more drinks to their menus, Coke must add more convenient beverage options — or risk losing sales to a competitor.
"It's our job to ensure that we're providing unique experiences and beverages because it's not a bonus now with consumers — it's the norm, they expect it," said Megan Tallman, Coke's vice president of dispensed equipment and innovation for its North American business. "When you think about Gen Z, they are okay paying $10 for a drink that is craveable and that they can show on their Instagram or on TikTok, which is helping our customers drive margin and also beverage attachment."
"Honestly, if you fast forward to today, Freestyle is more relevant today than probably it was over a decade ago," Tallman said, crediting the machine's dozens of flavors.
Even with the variety it offers, Coke is still trying to evolve to keep up.
In the time since the Freestyle was introduced, the number of specialty beverage chains has exploded, offering customers nearly unlimited ways to customize their drinks, from sugar content to toppings. Market research firm Technomic tracks more than 100 different chains, with more than 41,000 locations across the U.S. combined, selling everything from coffee to juice to boba.
Ever since Freestyle began popping up in restaurants and movie theaters, the dispensers have poured more than 67 billion 8-ounce servings of beverages; Coke has been able to track them all, thanks to the equipment's real-time data collection. That data is coming in handy now.
Inside its Equipment Innovation Center in Atlanta, a massive television screen displays real-time data showing what drinks dispensed by the Freestyle are trending, what time of day and where — from the region to the type of business. AHA sparkling water, for example, is trending up at office buildings and hospitals.
Insights from Freestyle dispensers also help the company discover new drinks that it can launch in grocery stores, like the limited-time Coca-Cola Orange Cream, which combines its namesake soda with vanilla and orange syrup.
"If we see that the flavors that we're offering to consumers in food service are actually resonating — it's the largest testing platform out there," Tallman said.
But Coke has more ideas in store.
First is the Freestyle Mini, which initially launched in Europe. Intended for bars and restaurants with limited space, the dispenser holds up to 16 drink options, more than double the choices available in a traditional soda gun. Coke unveiled the new smaller machine at the National Restaurant Association Show in Chicago this spring, but the company has not yet sold it to customers in the U.S.
And then there are other equipment ideas that aren't as far along, inspired by Coke's desire to branch out into dirty soda, refreshers and coffee.
To automate dirty soda, Coke has created a prototype that adds a dairy module to the classic Freestyle dispenser. Utah-based chain Swig takes credit for its invention of the dirty soda, although the trendy drink has now spread far and wide, from KFC restaurants to grocery store shelves.
The trend has helped to change soda's image from a tired, mass-market drink to a handcrafted beverage that can be a treat.
"Gen Z is the first generation raised to believe that nothing you consume is neutral, so everything is either helping you or costing you," said Matthew Greer, food, agribusiness and beverage analyst for Truist. "So, traditional soda does nothing for me, and it gives me 40 grams of sugar, so that fails the test."
The rise of a dirty soda is boon for Coke, because pop is still its number one category. Coke's sparkling soft drinks business, which houses soda brands like Sprite, Schweppes and Fanta, still accounts for 69% of the company's overall unit case volume, even as other ventures like coffee and dairy-based beverages have grown. Coke's namesake soda alone accounted for 47% of global unit case volume and 42% of U.S. unit case volume in 2025, according to a company filing.
Coke's prototypical dispensed dirty soda comes with a preprogrammed recipe, allowing for little customization but eliminating mess. The prototype, which took roughly three weeks to create, keeps the recognizable drip down the sides of the cup, giving the dirty soda its trademark visual appeal.
Refreshing its offeringsBeyond the Freestyle, Coke is also testing Micro Matic "mixology" dispensers to make refreshers and iced coffee drinks.
Starbucks created the refresher back in 2012 to appeal to non-coffee drinkers who wanted a boost, especially in the afternoon, when traffic to its cafes slowed. Customers can pick their bases, flavors and even caffeine level. Refreshers now represent about $2 billion in annual sales for Starbucks.
Other restaurant chains, such as Panera Bread to Dunkin', have taken note. Refreshers can be found on 8.1% of menus at national restaurant chains, according to Datassential.
"It's almost, I think, a compliment, the fact that our Refresher business is being imitated in so many places," Starbucks CEO Brian Niccol said on the company's earnings conference call in late April.
For its part, Coke is hoping to make its mark on the refresher category — whatever that means.
"There's no real definition for what a refresher is, so we're trying to take a stand on what that can be and what function that we believe it should deliver to the guest," said Sarah Kate Sims, director of dispensed innovation for Coca-Cola North America.
To Sims, a refresher is a "healthier" beverage that delivers some kind of pick-me-up without a traditional coffee caffeine base, instead using a green tea or a natural coffee extract as a base. And a refresher must look good, too, she said.
"So that's what I'm working on for next year," Sims said.
Inside 'The Vault'Coke's innovation efforts aren't restricted to equipment either. Across the parking lot from its Global Equipment Platforms office is "The Vault," where the company tests new drinks.
"We bring a lot of our top customers here to showcase our innovation and mixology, but also to collaborate and problem-solve and tackle the biggest challenges in the business," said Caroline Zambataro, collaboration architect at Coke.
One of those customers is Whataburger. Coke worked with the Texas-based burger chain for about 18 months on its line of "Whatafreshers," which launched in July.
In some cases, consumers might not even realize that they are drinking a Coke product. For example, the company considers itself a "pioneer" of premium lemonade after launching a white-label version more than a decade ago.
More than 40,000 bubbler dispensers carry the drink, according to Tallman. That number includes Wendy's, which sells it under "Dave's Craft Lemonade," after founder Dave Thomas.
These days, lemonade is a popular base for a lot of refreshers and other brightly colored drinks. So, too, is Sprite, which ranked fifth among U.S. carbonated soft drink brands by 2025 sales volume, according to Beverage Digest.
But Coke is also working on a new blank slate for handcrafted beverages: a colorless, relatively unflavored energy drink that comes in frozen or liquid form. The company plans to launch the beverage with food service operators in the first half of 2027.
Energy drinks are a much smaller category than sparkling beverages, but the segment has the highest expected growth projections for the next 10 years, according to Tallman.
"We believe this solution really meets many consumers because more female consumers are interested in energy if it's a handcrafted solution," Tallman said.
Starting with Celsius, the conversation around energy drinks has changed, widening their audience and the number of occasions where they can be consumed, Truist's Greer said. Rather than a beverage that you buy at the gas station for a pick-me-up, now energy drinks can become a part of some consumers' workout routines.
Coke's take on energy drinks will be designed to be served by employees to "limit consumption," according to Tallman. A 12-ounce serving of Coke's version contains 106 milligrams of caffeine, roughly the same amount as the same size can of Red Bull and half of the caffeine content of a Celsius can. Excessive caffeine consumption has become a liability concern after Panera Bread's Charged Lemonade was named in at least two wrongful death lawsuits.
A golden opportunityBroadly, Coke has been fielding more inquiries from food service partners these days about customizable drinks, according to Melinda Pritchett, director of innovation for Coke's North American business.
"If you're looking at what McDonald's is doing with the handcrafted beverages, all of our customers are saying, 'We should be in that as well,'" she said.
As the largest U.S. restaurant chain by system sales, McDonald's playbook is often replicated elsewhere. In May, the fast-food giant expanded its McCafe menu in the U.S. to include refreshers and crafted sodas, including Coke's Sprite and Hi-C, as part of its broader strategy to lean into beverages.
"In the U.S., [drink] sales are ahead of plan. Guest checks are higher, and we're seeing new occasions emerge throughout the day," McDonald's CEO Chris Kempczinski said on the company's earnings conference call earlier in August. "We've also seen strong food attachment rates on these orders."
But the drink launch arrived during what was otherwise a lackluster quarter for McDonald's U.S. business, which reported same-store sales growth of just 0.8%. The company has replaced its U.S. president in the hopes of accelerating its domestic division.
On Monday, McDonald's further expanded its beverage options with the Red Bull Dragonberry Energizer. Red Bull is privately owned, with no connection to Coke. The chain's choice to partner with a competitor rather than using an energy drink affiliated with Coke, like Monster, has sparked speculation about the state of the companies' more than 70-year-long relationship.
"We have a fantastic and very long-standing partnership with McDonald's, and that's intact, right? We continue to be very happy with that partnership," Coke CEO Henrique Braun said on the company's earnings conference call in late April, answering an analyst question about the partnership. "… We do respect the decisions on other choices about their relationships with other companies."
Ultimately, the most important part of any business relationship is the effect on sales.
When testing a new beverage with a food service partner, Coke tracks a couple of different performance metrics, like "incremental volume." In other words, would a customer buy one of the new refreshers even if they wouldn't otherwise buy a drink?
A survey of several dozen U.S. McDonald's franchisees conducted by Kalinowski Equity Research found that more than half of operators said the specialty drinks are performing in line with their expectations.
"They are selling great, but most of it is a trade-off from other beverages," one anonymous franchisee said in the survey. "Not many new transaction counts."
Walmart klesl o 9,2 % po výsledcích hospodaření, protože investory znepokojil slabší výhled a známky tlaku na amerického spotřebitele. Zákazníci dál nakupují, ale menší a promyšlenější nákupy.
US consumers are continuing to spend, but recent results from major retailers suggest they are becoming more selective about where and how they spend their money.
Walmart's sharp stock decline following its latest earnings report has added to concerns that higher prices, elevated gasoline costs, and economic uncertainty are increasingly influencing household spending.
The shift is particularly important because Walmart is often viewed as a bellwether for the US consumer.
While shoppers continue to visit stores, recent results from Walmart, Target and Home Depot indicate that customers are making smaller and more deliberate purchases.
Walmart shares fell 9.2% on Thursday after investors looked beyond the retailer's latest profit beat and focused on its weaker third-quarter outlook and signs of pressure on consumers.
Bryan Hayes, a strategist at Zacks Investment Research, told MarketWatch that the market reaction suggested investors believe current consumer spending may be close to its peak, particularly given the valuations previously assigned to major retailers.
Walmart's results showed that customers were still visiting its stores, but spending less per trip.
US store traffic increased 1.5%, while spending per trip rose 1.1%. At Sam's Club, visits increased 7%, but spending per visit declined 2.5%.
Alexander Lis, chief investment officer at Social Discovery Ventures, told Invezz that consumers are becoming increasingly price-sensitive, forcing retailers to cut prices to attract and retain shoppers.
Lis pointed to Walmart's use of 11,000 price rollbacks in the second quarter, up from about 7,000 in the first quarter, as evidence that consumers are becoming more cautious.
Hayes described this as a more deliberate consumer rather than necessarily a weak one. He said shoppers are making more frequent, smaller, and more considered purchases as they seek value.
The distinction is important because Walmart has traditionally benefited when consumers become more cautious.
Lower-income households often turn to the retailer for cheaper products, while higher-income shoppers can also use Walmart to reduce household expenses.
Lis noted that Walmart is also gaining market share among higher-income consumers in discretionary categories such as fashion, suggesting that wealthier households are increasingly choosing cheaper alternatives. This points to a broader "trade down" trend rather than weakness being confined to lower-income consumers.
That makes the company's first comparable-sales decline in six years particularly notable, even though Walmart attributed the decline partly to temporary pricing pressure in its pharmacy business.
Walmart is not the only major retailer seeing signs of changing consumer behavior.
At Target, foot traffic increased 3.6% in the second quarter, but spending per trip remained flat.
The retailer has been working to attract customers with lower prices, while management said clothing and home goods remain areas requiring significant improvement.
Target CEO Michael Fiddelke said the company still has "much more work to do" to win back customers who have moved toward competitors offering deeper discounts.
Home Depot has also seen consumers continue to spend, but increasingly on smaller projects.
Plumbing, kitchen and gardening categories performed better, while demand for larger home-improvement projects remained under pressure.
Home Depot CFO Richard McPhail said consumer uncertainty and housing affordability were continuing to weigh on larger projects. Rival Lowe's similarly pointed to persistent macroeconomic pressures and softer discretionary spending.
The pattern suggests households are prioritizing necessities and lower-cost purchases while delaying larger expenditures.
The shift in spending comes as consumers face elevated costs for everyday necessities.
US gasoline prices have been around $4 a gallon, according to AAA, while higher energy costs linked to the artificial-intelligence boom have also contributed to rising costs for some goods, including electronics.
Walmart CFO John David Rainey said the company was facing "arguably a softer consumer environment than in February." He also noted that higher fuel prices appeared to influence consumer decisions.
Rainey said June provided clearer evidence of shoppers making trade-offs as gasoline prices moved above $4 a gallon. Walmart has responded by placing greater emphasis on lower prices.
The company's strategy is aimed at protecting market share by making products more affordable as consumers become more price-sensitive.
Recent economic data have also pointed toward more cautious household spending.
US retail sales fell 0.6% in July, marking the first decline in almost a year and significantly missing expectations for 0.1% growth.
The decline was partly influenced by cheaper fuel and a slowdown following Amazon's summer sales activity, but analysts also pointed to weaker discretionary spending.
Brian Mulberry, chief market strategist at Zacks, said the figures indicated that consumers were easing spending on more expensive purchases such as automobiles, electronics and appliances.
He also pointed to the continued divide between asset owners and consumers without significant assets.
Other indicators have added to the concerns.
The University of Michigan's consumer sentiment index declined in August for the first time in three months, while the July jobs report showed the US economy lost 23,000 nonfarm payrolls, compared with expectations for an increase of 80,000.
The weakening consumer comes as investors continue to assess the Federal Reserve's interest-rate path.
Lis said that if the softening consumer trend continues, it could remove rate hikes from consideration. "But given the persistent inflation, it would be hard for Fed to support the economy as well. So it is hard to anticipate a V-shaped this time", he added.
Markets are still pricing in at least one rate hike by year-end, but signs of softer consumer activity could complicate the case for tighter monetary policy.
At the same time, inflation remains a concern. Persistent geopolitical tensions, particularly the conflict involving Iran, could push energy prices higher and create additional inflationary pressure.
That could leave policymakers facing a difficult balance between containing inflation and avoiding additional pressure on an already more cautious consumer.
For retailers, the coming months will provide further evidence of whether the current slowdown is temporary or represents a broader change in household spending patterns.
Results from Costco and smaller specialty retailers are expected to offer additional clues.
Walmart's sharp stock decline shows that investors are increasingly sensitive to even modest signs of weakening demand from the US consumer.
With shoppers still spending but becoming more selective, the strength of household demand could become an increasingly important factor for both retailers and the Federal Reserve.